BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V; CANONIC Study Investigators of the EASL–CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013;144:1426-37, 1437.e1-9. [PMID: 23474284 DOI: 10.1053/j.gastro.2013.02.042] [Cited by in Crossref: 1662] [Cited by in F6Publishing: 1725] [Article Influence: 184.7] [Reference Citation Analysis]
Number Citing Articles
1 Matiollo C, Rateke ECM, Moura EQA, Andrigueti M, Augustinho FC, Zocche TL, Silva TE, Gomes LO, Farias MR, Narciso-Schiavon JL, Schiavon LL. Elevated calprotectin levels are associated with mortality in patients with acute decompensation of liver cirrhosis. World J Hepatol 2022; 14(11): 1964-1976 [DOI: 10.4254/wjh.v14.i11.1964] [Reference Citation Analysis]
2 Zhao Y, He W, Wang C, Cui N, Yang C, You Z, Shi B, Xia L, Chen X. Characterization of intrahepatic B cells in acute-on-chronic liver failure. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1041176] [Reference Citation Analysis]
3 Assem NM, Mohammed AI, Barry HMA, El Sayed IET, Elmadbouh I. Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus. Egypt Liver Journal 2022;12:67. [DOI: 10.1186/s43066-022-00231-x] [Reference Citation Analysis]
4 Mani I, Alexopoulos T, Vasilieva L, Alexopoulou A. Serum troponin is elevated in acute decompensation and acute-on-chronic liver failure and is associated with severity of liver disease and short-term mortality. Scandinavian Journal of Gastroenterology 2022. [DOI: 10.1080/00365521.2022.2131333] [Reference Citation Analysis]
5 Teerasarntipan T, Thanapirom K, Chirapongsathorn S, Suttichaimongkol T, Chamroonkul N, Bunchorntavakul C, Siramolpiwat S, Chainuvati S, Sobhonslidsuk A, Leerapun A, Piratvisuth T, Sukeepaisarnjaroen W, Tanwandee T, Treeprasertsuk S. Validation of prognostic scores predicting mortality in acute liver decompensation or acute-on-chronic liver failure: A Thailand multicenter study. PLoS ONE 2022;17:e0277959. [DOI: 10.1371/journal.pone.0277959] [Reference Citation Analysis]
6 Swaroop S, Arora U, Biswas S, Vaishnav M, Pathak P, Agarwal A, Golla R, Thakur B, Coshic P, Andriyas V, Gupta K, Elhence A, Nayak B, Kumar R, Shalimar. Therapeutic plasma‐exchange improves short‐term, but not long‐term, outcomes in patients with acute‐on‐chronic liver failure: A propensity score‐matched analysis. J of Clinical Apheresis 2022. [DOI: 10.1002/jca.22033] [Reference Citation Analysis]
7 Rodríguez S, Motta FD, Balbinotto Neto G, Brandão A. WAITING LIST FOR LIVER TRANSPLANTATION: CLINICAL AND ECONOMIC BURDEN. Arq Gastroenterol 2022. [DOI: 10.1590/s0004-2803.202204000-87] [Reference Citation Analysis]
8 Gao S, Han L, Fan Y, Wang K. Early prediction model for prognosis of patients with hepatitis-B-virus-related acute-on-chronic liver failure received glucocorticoid therapy. Eur J Med Res 2022;27:248. [DOI: 10.1186/s40001-022-00891-w] [Reference Citation Analysis]
9 Xiao P, Xu H, Zhang F, Liu T, Gao Y. Significance of metagenomic next-generation sequencing in the diagnosis and prognosis for spontaneous peritonitis in patients with cirrhosis.. [DOI: 10.21203/rs.3.rs-2244778/v1] [Reference Citation Analysis]
10 Würstle S, Hapfelmeier A, Karapetyan S, Studen F, Isaakidou A, Schneider T, Schmid RM, von Delius S, Gundling F, Triebelhorn J, Burgkart R, Obermeier A, Mayr U, Heller S, Rasch S, Lahmer T, Geisler F, Chan B, Turner PE, Rothe K, Spinner CD, Schneider J. A Novel Machine Learning-Based Point-Score Model as a Non-Invasive Decision-Making Tool for Identifying Infected Ascites in Patients with Hydropic Decompensated Liver Cirrhosis: A Retrospective Multicentre Study. Antibiotics 2022;11:1610. [DOI: 10.3390/antibiotics11111610] [Reference Citation Analysis]
11 Philipp M, Blattmann T, Bienert J, Fischer K, Hausberg L, Kröger JC, Heller T, Weber MA, Lamprecht G. Transjugular intrahepatic portosystemic shunt vs conservative treatment for recurrent ascites: A propensity score matched comparison. World J Gastroenterol 2022; 28(41): 5944-5956 [DOI: 10.3748/wjg.v28.i41.5944] [Reference Citation Analysis]
12 Watanabe Y, Osaki A, Waguri N, Tsuchiya A, Terai S. Prognostic study of acute-on-chronic liver failure patients: Usefulness of the fibrosis-4 index. Medicine 2022;101:e31328. [DOI: 10.1097/md.0000000000031328] [Reference Citation Analysis]
13 Mikkelsen ACD, Thomsen KL, Mookerjee RP, Hadjihambi A. The role of brain inflammation and abnormal brain oxygen homeostasis in the development of hepatic encephalopathy. Metab Brain Dis 2022. [DOI: 10.1007/s11011-022-01105-2] [Reference Citation Analysis]
14 Li P, Liang X, Luo J, Li J, Xin J, Jiang J, Shi D, Lu Y, Hassan HM, Zhou Q, Hao S, Zhang H, Wu T, Li T, Yao H, Ren K, Guo B, Zhou X, Chen J, He L, Yang H, Hu W, Ma S, Li B, You S, Xin S, Chen Y, Li J. Predicting the survival benefit of liver transplantation in HBV-related acute-on-chronic liver failure: An observational cohort study. The Lancet Regional Health - Western Pacific 2022. [DOI: 10.1016/j.lanwpc.2022.100638] [Reference Citation Analysis]
15 Khatua CR, Panigrahi MK, Choudhury AK, Nath G, Khandelwal R, Anirvan P, Singh SP. Acute kidney injury (AKI) at admission predicts mortality in patients with severe alcoholic hepatitis (SAH) A manuscript submitted to THE JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.11.008] [Reference Citation Analysis]
16 Kumar A. Statin Exposure is Associated with Reduced Development of Acute-on-chronic Liver Failure in a Veterans Affairs Cohort. Journal of Clinical and Experimental Hepatology 2022;12:1572-1573. [DOI: 10.1016/j.jceh.2022.07.240] [Reference Citation Analysis]
17 Tonon M, Moreau R. Using machine learning for predicting outcomes in ACLF. Liver Int 2022;42:2354-5. [PMID: 36162084 DOI: 10.1111/liv.15399] [Reference Citation Analysis]
18 Zhao H, Ye W, Yu X, Hu J, Zhang X, Yang M, Sheng J, Shi Y. Hepatitis E virus superinfection impairs long-term outcome in hospitalized patients with hepatitis B virus-related decompensated liver cirrhosis. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100878] [Reference Citation Analysis]
19 Tacke F, Cornberg M, Sterneck M, Trebicka J, Settmacher U, Bechstein WO, Berg T, Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), vertreten durch Frank Tacke, Markus Cornberg, Martina Sterneck, Jonel Trebicka, Thomas Berg, Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV), vertreten durch Wolf Bechstein. S1-Leitlinie zur Versorgung von Lebertransplantierten während der COVID-19-Pandemie – AWMF-Registernummer: 021-031 – Stand 15. Juni 2022. Z Gastroenterol 2022;60:1678-1698. [DOI: 10.1055/a-1934-1989] [Reference Citation Analysis]
20 Yao J, Lei Y, Yi H, Yang Y. Clinical strategies to improve the survival rate of liver recipients with acute-on-chronic liver failure. Hepatobiliary & Pancreatic Diseases International 2022. [DOI: 10.1016/j.hbpd.2022.11.007] [Reference Citation Analysis]
21 Kwon H, Kim JH, Kim J, Hwang G. Five-year all-cause mortality in critically ill liver transplant patients with coronary artery disease: analysis of acute-on chronic liver failure. Anesth Pain Med 2022;17:412-419. [DOI: 10.17085/apm.22168] [Reference Citation Analysis]
22 Cervantes-Alvarez E, Vilatoba M, Limon-de la Rosa N, Mendez-Guerrero O, Kershenobich D, Torre A, Navarro-Alvarez N. Liver transplantation is beneficial regardless of cirrhosis stage or acute-on-chronic liver failure grade: A single-center experience. World J Gastroenterol 2022; 28(40): 5881-5892 [DOI: 10.3748/wjg.v28.i40.5881] [Reference Citation Analysis]
23 Morris SM, Chauhan A. The role of platelet mediated thromboinflammation in acute liver injury. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1037645] [Reference Citation Analysis]
24 Choi JW, Kwak JY, Lee SS, Kim H, Son HJ, Jeon H, Kim HJ, Cha RR, Lee JM, Kim HJ. Clinical Features of Hepatitis C Virus-related Acute-on-chronic Liver Failure in a Korean Population. Korean J Gastroenterol 2022;80:169-176. [DOI: 10.4166/kjg.2022.050] [Reference Citation Analysis]
25 Zhang W, Zhang Y, Liu Q, Nie Y, Zhu X. Development and validation of a prognostic nomogram for decompensated liver cirrhosis. World J Clin Cases 2022; 10(29): 10467-10477 [DOI: 10.12998/wjcc.v10.i29.10467] [Reference Citation Analysis]
26 He Z, Zhou J, Tian Y, Wu S, Sun Y, Ou X, Jia J, Wang B, Wu X, You H. Two-year free of complications during antiviral therapy predicts stable re-compensation in immediate-treatment HBV-related decompensated cirrhosis. Scand J Gastroenterol 2022;:1-9. [PMID: 36227688 DOI: 10.1080/00365521.2022.2132532] [Reference Citation Analysis]
27 Mcentire CRS, Lesser CF, Venna N. Case Report and Clinical Reasoning: Fulminant Liver Failure and Invasive Aspergillosis Following Ocrelizumab Treatment in a 21 Year-Old Woman. The Neurohospitalist. [DOI: 10.1177/19418744221130385] [Reference Citation Analysis]
28 Vogg J, Maier-Stocker C, Munker S, Mehrl A, Schlosser S, Tews HC, Gülow K, Müller M, Schmid S. Hepatic perfusion as a new predictor of prognosis and mortality in critical care patients with acute-on-chronic liver failure. Front Med (Lausanne) 2022;9:1008450. [PMID: 36300192 DOI: 10.3389/fmed.2022.1008450] [Reference Citation Analysis]
29 Li J, Liu G, Li F, Yang W, Zhang R, Yang J. Development and Validation of a Novel Nomogram to Predict Hypoalbuminemia among Patients with Stroke in the Neurocritical Care Unit. Clin Nurs Res 2022;:10547738221128412. [PMID: 36196927 DOI: 10.1177/10547738221128412] [Reference Citation Analysis]
30 Jalan R, Sundaram V. A new model for identification of HBV-related pre-ACLF. JHEP Rep 2022;4:100554. [PMID: 36119720 DOI: 10.1016/j.jhepr.2022.100554] [Reference Citation Analysis]
31 Perez Ruiz de Garibay A, Kortgen A, Leonhardt J, Zipprich A, Bauer M. Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients. Crit Care 2022;26:289. [DOI: 10.1186/s13054-022-04163-1] [Reference Citation Analysis]
32 Monet C, De Jong A, Aarab Y, Piron L, Prades A, Carr J, Belafia F, Chanques G, Guiu B, Pageaux G, Jaber S. Adverse events, short- and long-term outcomes of extra corporeal liver therapy in the intensive care unit: 16 years experience with MARS® in a single center. Crit Care 2022;26:282. [DOI: 10.1186/s13054-022-04165-z] [Reference Citation Analysis]
33 Igna R, Gîrleanu I, Cojocariu C, Huiban L, Muzîca C, Sîngeap A, Sfarti C, Chiriac S, Petrea OC, Zenovia S, Nastasa R, Cuciureanu T, Stafie R, Stratina E, Rotaru A, Stanciu C, Blaj M, Trifan A. The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure. JCM 2022;11:5410. [DOI: 10.3390/jcm11185410] [Reference Citation Analysis]
34 Gao S, Han L, Fan Y, Wang K. Early prediction model for prognosis of patients with hepatitis-B-virus-related acute-on-chronic liver failure received glucocorticoid therapy.. [DOI: 10.21203/rs.3.rs-2058438/v1] [Reference Citation Analysis]
35 Qian K, Xue Y, Sun H, Lu T, Wang Y, Shi X, Granito A. The Prognostic Value of Serum HBV-RNA during Hepatitis B Virus Infection is Related to Acute-on-Chronic Liver Failure. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-8. [DOI: 10.1155/2022/8422242] [Reference Citation Analysis]
36 Zhu CX, Yang L, Zhao H, Zhang Y, Tu S, Guo J, Yan D, Hu CX, Lu HF, Xu KJ, Huang JR, Li LJ. Impact of cirrhosis-related complications on posttransplant survival in patients with acute-on-chronic liver failure. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00205-3. [PMID: 36151023 DOI: 10.1016/j.hbpd.2022.09.004] [Reference Citation Analysis]
37 Mahmud N, Reddy KR, Taddei TH, Kaplan DE. Type of Infection Is Associated with Prognosis in Acute-on-Chronic Liver Failure: A National Veterans Health Administration Study. Dig Dis Sci 2022. [PMID: 36083379 DOI: 10.1007/s10620-022-07680-9] [Reference Citation Analysis]
38 Bassegoda O, Rivera-Esteban J, Serra I, Morillas R, Broquetas T, Vergara M, Rodriguez A, Aracil C, Virolés S, Carrión JA, Pardo A, Rodríguez-Tajes S, Serra-Burriel M, Pericàs JM, Augustin S, Ginès P, Graupera I. High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: A retrospective cohort study. Hepatol Commun 2022. [PMID: 36073343 DOI: 10.1002/hep4.2056] [Reference Citation Analysis]
39 Zhang L, Hu J, Gou C, Jin H, Zhang C, Liu Y, Wang Y, Wang X, Yokota S. Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure. Mediators of Inflammation 2022;2022:1-13. [DOI: 10.1155/2022/7794890] [Reference Citation Analysis]
40 de Mattos ÂZ, Simonetto DA, Terra C, Farias AQ, Bittencourt PL, Pase THS, Toazza MR, de Mattos AA, Alliance of Brazilian Centers for Cirrhosis Care – the ABC Group. Albumin administration in patients with cirrhosis: Current role and novel perspectives. World J Gastroenterol 2022; 28(33): 4773-4786 [DOI: 10.3748/wjg.v28.i33.4773] [Reference Citation Analysis]
41 Gan PL, Huang S, Pan X, Xia HF, Zeng XY, Ren WS, Zhou X, Lv MH, Tang XW. Global research trends in the field of liver cirrhosis from 2011 to 2020: A visualised and bibliometric study. World J Gastroenterol 2022; 28(33): 4909-4919 [DOI: 10.3748/wjg.v28.i33.4909] [Reference Citation Analysis]
42 Romero-Cristóbal M, Clemente-Sánchez A, Peligros MI, Ramón E, Matilla AM, Colón A, Alonso S, Catalina MV, Fernández-Yunquera A, Caballero A, García R, López-Baena JÁ, Salcedo MM, Bañares R, Rincón D. Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history. United European Gastroenterol J 2022. [PMID: 36065767 DOI: 10.1002/ueg2.12301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Ngu NL, Saxby E, Worland T, Anderson P, Stothers L, Figredo A, Hunter J, Elford A, Ha P, Hartley I, Roberts A, Seah D, Tambakis G, Liew D, Rogers B, Sievert W, Bell S, Le S. A home-based, multidisciplinary liver optimisation programme for the first 28 days after an admission for acute-on-chronic liver failure (LivR well): a study protocol for a randomised controlled trial. Trials 2022;23:744. [PMID: 36064596 DOI: 10.1186/s13063-022-06679-x] [Reference Citation Analysis]
44 Laici C, Guizzardi C, Morelli MC, Vitale G, Caraceni P, Cescon M, Ravaioli M, Bacchi Reggiani ML, Baldassarre M, Siniscalchi A. Predictive factors of inhospital mortality for ICU patients with acute-on-chronic liver failure undergoing liver transplantation. Eur J Gastroenterol Hepatol 2022;34:967-74. [PMID: 35913780 DOI: 10.1097/MEG.0000000000002413] [Reference Citation Analysis]
45 Pande G, Hatti M, Rai MK, Rai P, Kumar K, Vp K, Nehra A, Kumar S, Ranjan Rout S, Mishra SK, Kumar D, Kumar U, Mishra P, Majeed A, Saraswat VA, Singh K, Singh H, Misra DP, Agarwal V. . JIR 2022;Volume 15:5027-39. [DOI: 10.2147/jir.s377494] [Reference Citation Analysis]
46 Jiang X, Chai S, Huang Y, Huang Z, Tan W, Gao Y, Lu X, Meng Z, Zhou H, Kong W, Tang X, Tang Y, Qi T, Liao C, Gan Q, Xiang X, Zhang Y, Wang S, Chen Y, Chen J. Design for a Multicentre Prospective Cohort for the Assessment of Platelet Function in Patients with Hepatitis-B-Virus-Related Acute-on-Chronic Liver Failure. Clin Epidemiol 2022;14:997-1011. [PMID: 36042872 DOI: 10.2147/CLEP.S376068] [Reference Citation Analysis]
47 Yang C, Xiong B. A comprehensive review of prognostic scoring systems to predict survival after transjugular intrahepatic portosystemic shunt placement. Portal Hypertension & Cirrhosis 2022;1:133-144. [DOI: 10.1002/poh2.28] [Reference Citation Analysis]
48 Li TT, Wang ZR, Yao WQ, Linghu EQ, Wang FS, Shi L. Stem Cell Therapies for Chronic Liver Diseases: Progress and Challenges. Stem Cells Transl Med 2022:szac053. [PMID: 35993521 DOI: 10.1093/stcltm/szac053] [Reference Citation Analysis]
49 Wong F, Pappas SC, Reddy KR, Vargas H, Curry MP, Sanyal A, Jamil K. Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure. Aliment Pharmacol Ther 2022. [PMID: 35995728 DOI: 10.1111/apt.17195] [Reference Citation Analysis]
50 Shen ZX, Wu DD, Xia J, Wang XB, Zheng X, Huang Y, Li BL, Meng ZJ, Gao YH, Qian ZP, Liu F, Lu XB, Shang J, Yan HD, Zheng YB, Gu WY, Zhang Y, Wei JY, Tan WT, Hou YX, Zhang Q, Xiong Y, Zou CC, Chen J, Huang ZB, Jiang XH, Luo S, Chen YY, Gao N, Liu CY, Yuan W, Mei X, Li J, Li T, Zhou XY, Deng GH, Chen JJ, Ma X, Li H. Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China. World J Gastroenterol 2022; 28(31): 4417-4430 [DOI: 10.3748/wjg.v28.i31.4417] [Reference Citation Analysis]
51 Liu G, Wang X, Fan X, Luo X. Metabolomics profiles in acute-on-chronic liver failure: Unveiling pathogenesis and predicting progression. Front Pharmacol 2022;13:953297. [DOI: 10.3389/fphar.2022.953297] [Reference Citation Analysis]
52 Xu X, Yu X, Gong K, Tu H, Yao J, Lan Y, Ye S, Weng H, Shi Y, Sheng J. Acute decompensation events differentially impact the risk of nosocomial infections and short-term outcomes in patients with cirrhosis. Front Med 2022;9. [DOI: 10.3389/fmed.2022.962541] [Reference Citation Analysis]
53 Ye QX, Huang JF, Xu ZJ, Yan YY, Yan Y, Liu LG. Short-term prognostic factors for hepatitis B virus-related acute-on-chronic liver failure. World J Clin Cases 2022; 10(23): 8186-8195 [DOI: 10.12998/wjcc.v10.i23.8186] [Reference Citation Analysis]
54 Würstle S, Hapfelmeier A, Karapetyan S, Studen F, Isaakidou A, Schneider T, Schmid RM, von Delius S, Gundling F, Triebelhorn J, Burgkart R, Obermeier A, Mayr U, Heller S, Rasch S, Lahmer T, Geisler F, Chan B, Turner PE, Rothe K, Spinner CD, Schneider J. Novel machine learning-based point-score model as a non-invasive decision-making tool for infected ascites in patients with hydropic decompensated liver cirrhosis: A retrospective multicentre study.. [DOI: 10.21203/rs.3.rs-1930434/v1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Freire MP, Rinaldi M, Terrabuio DRB, Furtado M, Pasquini Z, Bartoletti M, de Oliveira TA, Nunes NN, Lemos GT, Maccaro A, Siniscalchi A, Laici C, Cescon M, D Albuquerque LAC, Morelli MC, Song ATW, Abdala E, Viale P, Filho ADPC, Giannella M. Prediction models for carbapenem-resistant Enterobacterales carriage at liver transplantation: A multicenter retrospective study. Transpl Infect Dis 2022;:e13920. [PMID: 35942941 DOI: 10.1111/tid.13920] [Reference Citation Analysis]
56 G V, James R. PREVALENCE OF HYPOMAGNESEMIA IN CIRRHOSIS OF LIVER AND ITS ASSOCIATION WITH SEVERITYOF THE DISEASE. Asian J Pharm Clin Res 2022. [DOI: 10.22159/ajpcr.2022.v15i8.45029] [Reference Citation Analysis]
57 Im GY. Emerging Biomarkers in Alcohol-associated Hepatitis. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.07.246] [Reference Citation Analysis]
58 Tujios S, Stravitz RT, Lee WM. Management of Acute Liver Failure: Update 2022. Semin Liver Dis 2022;42:362-78. [PMID: 36001996 DOI: 10.1055/s-0042-1755274] [Reference Citation Analysis]
59 Hackstein C, Spitzer J, Symeonidis K, Horvatic H, Bedke T, Steglich B, Assmus LM, Odainic A, Kessler N, Klein S, Beyer M, Schmithausen R, Latz E, Kurts C, Trebicka J, Flavell RA, Garbi N, Roers A, Huber S, Schmidt SV, Knolle PA, Abdullah Z. Suppression of systemic T cell immunity to viral infection during liver injury is prevented by inhibition of interferon and IL-10 signaling.. [DOI: 10.1101/2022.07.21.501031] [Reference Citation Analysis]
60 Tuifua TS, Partovi S, Remer EM, Ragheb J, Bullen JA, Kattan MW, Kapoor B. Assessment of Clinical Outcomes, Clinical Manifestations, and Risk Factors for Hepatic Infarction After Transjugular Intrahepatic Portosystemic Shunt Placement (TIPS): A Retrospective Comparative Study. Cardiovasc Intervent Radiol. [DOI: 10.1007/s00270-022-03219-7] [Reference Citation Analysis]
61 Geng A, Flint E, Bernsmeier C. Plasticity of monocytes and macrophages in cirrhosis of the liver. Front Netw Physiol 2022;2. [DOI: 10.3389/fnetp.2022.937739] [Reference Citation Analysis]
62 Qiang R, Liu X, Xu J. The Immune Pathogenesis of Acute-On-Chronic Liver Failure and the Danger Hypothesis. Front Immunol 2022;13:935160. [DOI: 10.3389/fimmu.2022.935160] [Reference Citation Analysis]
63 Al Mahtab M, Al Mamun A, Khondaker FA, Moben AL, Akbar SM, Das DC, Al Mukit A, Rahim MA, Noor-e-alam SM, Alam MA, Begum R, Haque ME, Islam MA. Plasma Exchange in Patients of Acute on Chronic Liver Failure: An Observational Study in Bangladesh. Euroasian Journal of Hepato-Gastroenterology 2022;12:1-5. [DOI: 10.5005/jp-journals-10018-1354] [Reference Citation Analysis]
64 Zhu Y, Li H, Wang X, Zheng X, Huang Y, Chen J, Meng Z, Gao Y, Qian Z, Liu F, Lu X, Shi Y, Shang J, Yan H, Zheng Y, Qiao L, Zhang Y, Xiang X, Dan Y, Sun S, Hou Y, Zhang Q, Xiong Y, Li S, Chen J, Huang Z, Li B, Jiang X, Luo S, Chen Y, Gao N, Liu C, Ji L, Yuan W, Li J, Li T, Zheng R, Zhou X, Ren H, Zhou Y, Xu B, Yu R, Tan W, Deng G. Hepatitis B Virus Reactivation Increased the Risk of Developing Hepatic Failure and Mortality in Cirrhosis With Acute Exacerbation. Front Microbiol 2022;13:910549. [DOI: 10.3389/fmicb.2022.910549] [Reference Citation Analysis]
65 Chen JF, Weng WZ, Huang M, Peng XH, Zhang J, Xiong J, He JR, Zhang SQ, Cao HJ, Gao B, Lin DN, Gao J, Gao ZL, Lin BL. The impact of serum thyroid-stimulation hormone levels on the outcome of hepatitis B virus related acute-on-chronic liver failure: an observational study. BMC Gastroenterol 2022;22:330. [PMID: 35799116 DOI: 10.1186/s12876-022-02406-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Zhang Q, Shi B, Wu L. Characteristics and risk factors of infections in patients with HBV-related acute-on-chronic liver failure: a retrospective study. PeerJ 2022;10:e13519. [DOI: 10.7717/peerj.13519] [Reference Citation Analysis]
67 Chen G, Wu R, Huang F, Wang G, Zheng M, Yu X, Wang W, Hou L, Ye Z, Zhang X, Zhao H. Liver Transplantation in Acute-on-Chronic Liver Failure: Excellent Outcome and Difficult Posttransplant Course. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.914611] [Reference Citation Analysis]
68 Abbas N, Rajoriya N, Elsharkawy AM, Chauhan A. Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived? Expert Rev Gastroenterol Hepatol 2022. [PMID: 35786130 DOI: 10.1080/17474124.2022.2097070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Yi J, Zhou Z, Li Q, Chen G, He Z, Ma Y, Luo X, Si Z, Li J. Risk Factors of Early Allograft Dysfunction in Patients With Hepatitis B Virus-Related Acute-on-Chronic Liver Failure After Deceased Donor Liver Transplant. Exp Clin Transplant 2022;20:668-673. [DOI: 10.6002/ect.2022.0079] [Reference Citation Analysis]
70 Wang T, Tan W, Wang X, Zheng X, Huang Y, Li B, Meng Z, Gao Y, Qian Z, Liu F, Lu X, Yan H, Zheng Y, Zhang W, Yin S, Gu W, Zhang Y, Dong F, Wei J, Deng G, Xiang X, Zhou Y, Hou Y, Zhang Q, Xiong S, Liu J, Long L, Chen R, Chen J, Jiang X, Luo S, Chen Y, Jiang C, Zhao J, Ji L, Mei X, Li J, Li T, Zheng R, Zhou X, Ren H, Shi Y, Li H. Role of precipitants on transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Sun J, Yu X, Weng Z, Jin L, Yang J, Zhang H, Gu J, Wang N, Yang J. The impact of hepatotoxic drugs on the outcome of patients with acute deterioration of hepatitis B virus-related chronic disease. Eur J Gastroenterol Hepatol 2022;34:782-90. [PMID: 35506899 DOI: 10.1097/MEG.0000000000002365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Tan J, He Y, Li Z, Zhang Q, Yang Y, Xu Q, Xu X. Analysis of the Dose-Response Relationship Between the International Normalized Ratio and Hepatic Encephalopathy in Patients With Liver Cirrhosis Using Restricted Cubic Spline Functions. Front Public Health 2022;10:919549. [DOI: 10.3389/fpubh.2022.919549] [Reference Citation Analysis]
73 Ning Q, Chen T, Wang G, Xu D, Yu Y, Mao Q, Li T, Li L, Li J, Lu X, Li J, Li Z, Zhang W, Xiao Y, Meng Q, Mi Y, Shang J, Yu Y, Zhao Y, Zhao C, Zhao H, Huang J, Peng J, Tang H, Tang X, Hu J, Hu B, Guo W, Zheng B, Chen B, Zhang Y, Wei J, Sheng J, Chen Z, Wang M, Xie Q, Wang Y, Wang F, Hou J, Duan Z, Wei L, Jia J, Chinese Society of Infectious Disease of Chinese Medical Association. Expert Consensus on Diagnosis and Treatment of End-Stage Liver Disease Complicated with Infections. Infectious Diseases & Immunity 2022;2:168-178. [DOI: 10.1097/id9.0000000000000055] [Reference Citation Analysis]
74 Häussinger D, Dhiman RK, Felipo V, Görg B, Jalan R, Kircheis G, Merli M, Montagnese S, Romero-Gomez M, Schnitzler A, Taylor-Robinson SD, Vilstrup H. Hepatic encephalopathy. Nat Rev Dis Primers 2022;8:43. [PMID: 35739133 DOI: 10.1038/s41572-022-00366-6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
75 Bera C, Wong F. Management of hepatorenal syndrome in liver cirrhosis: a recent update. Therap Adv Gastroenterol 2022;15:17562848221102679. [PMID: 35721838 DOI: 10.1177/17562848221102679] [Reference Citation Analysis]
76 Kalo E, Sheriff N, Isaac M, Baig A, Read S, Ahlenstiel G. A Call for Implementation of an Evidence-Based, Quality Improvement, Decompensated Cirrhosis Discharge Care Bundle in Australia. Livers 2022;2:97-104. [DOI: 10.3390/livers2020007] [Reference Citation Analysis]
77 Fischer P, Pandrea S, Dan Grigorescu M, Stefanescu H, Tefas C, Hadade A, Procopet B, Ionescu D. The threat of carbapenem resistance in Eastern Europe in patients with decompensated cirrhosis admitted to intensive care unit. Dig Liver Dis 2022:S1590-8658(22)00510-2. [PMID: 35732546 DOI: 10.1016/j.dld.2022.05.011] [Reference Citation Analysis]
78 Gananandan K, Mookerjee R, Jalan R. Use of Non-selective Beta blockers in Decompensated Cirrhosis and ACLF. Curr Hepatology Rep 2022;21:29-36. [DOI: 10.1007/s11901-022-00584-2] [Reference Citation Analysis]
79 Zhang J, Chen Y, Ding M, Duan Z. Correlation between dynamic changes in free triiodothyronine levels and 90-day prognosis in patients with HBV-related acute-on-chronic liver failure. Eur J Med Res 2022;27. [DOI: 10.1186/s40001-022-00718-8] [Reference Citation Analysis]
80 Li X, Gong M, Fu S, Zhang J, Wu S. Establishment of MELD-lactate clearance scoring system in predicting death risk of critically ill cirrhotic patients. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02351-5] [Reference Citation Analysis]
81 Maheshwari D, Kumar D, Jagdish RK, Nautiyal N, Hidam A, Kumari R, Sehgal R, Trehanpati N, Baweja S, Kumar G, Sinha S, Bajpai M, Pamecha V, Bihari C, Maiwall R, Sarin SK, Kumar A. Bioenergetic Failure Drives Functional Exhaustion of Monocytes in Acute-on-Chronic Liver Failure. Front Immunol 2022;13:856587. [DOI: 10.3389/fimmu.2022.856587] [Reference Citation Analysis]
82 Kumar Yadav D, Kumar Yadav R, Liang T. Acute Decompensated Liver: When to Transplant? Controversies in Liver Transplantation - Recent Challenges and Future Perspectives [Working Title] 2022. [DOI: 10.5772/intechopen.105350] [Reference Citation Analysis]
83 Acharya P, Saha R, Quadri JA, Sarwar S, Khan MA, Sati HC, Gauniyal N, Shariff A, Swaroop S, Pathak P, Shalimar. Quantitative Plasma Proteomics Identifies Metallothioneins as a Marker of Acute-on-Chronic Liver Failure Associated Acute Kidney Injury.. [DOI: 10.1101/2022.05.30.22275767] [Reference Citation Analysis]
84 Toshima T, Harada N, Itoh S, Morita K, Nagao Y, Kurihara T, Tomino T, Kosai-Fujimoto Y, Morinaga A, Tomiyama T, Yoshizumi T. Outcomes of living-donor liver transplantation for acute-on-chronic liver failure based on newly proposed criteria in Japan. Clin Transplant 2022;:e14739. [PMID: 35642940 DOI: 10.1111/ctr.14739] [Reference Citation Analysis]
85 Masnou H, Luna D, Castillo E, Galindo M, Ardèvol A, Clos A, Sarrias MR, Armengol C, Bargalló A, Morillas RM, Domènech E. Prevalence and outcomes of acute-on-chronic liver failure among cirrhotic patients admitted for an acute decompensation. Gastroenterología y Hepatología (English Edition) 2022;45:424-431. [DOI: 10.1016/j.gastre.2022.06.003] [Reference Citation Analysis]
86 Sturm L, Reincke M, Bettinger D. [Current pathophysiological concepts of acute decompensation in patients with liver cirrhosis and prognostic scores in different stages of disease]. Dtsch Med Wochenschr 2022;147:662-8. [PMID: 35636416 DOI: 10.1055/a-1671-9114] [Reference Citation Analysis]
87 Bajaj JS, Wong F, Kamath PS, Lai JC, O'leary JG. Acute-on-Chronic Liver Failure. Am J Gastroenterol 2022;117:831-834. [DOI: 10.14309/ajg.0000000000001748] [Reference Citation Analysis]
88 Deng L, Sundaram V. Evidence for and Against Liver Transplantation for Acute-on-Chronic Liver Failure. Curr Treat Options Gastro 2022;20:194-204. [DOI: 10.1007/s11938-022-00380-3] [Reference Citation Analysis]
89 Khamri W, Gudd C, Liu T, Nathwani R, Krasniqi M, Azam S, Barbera T, Trovato FM, Possamai L, Triantafyllou E, Seoane RC, Lebosse F, Singanayagam A, Kumar N, Bernsmeier C, Mukherjee S, McPhail M, Weston CJ, Antoniades CG, Thursz MR. Suppressor CD4+ T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis. Gut 2022;71:1192-202. [PMID: 34344786 DOI: 10.1136/gutjnl-2021-324071] [Reference Citation Analysis]
90 Nguyen DT, Kha NH, Thai NTH, Kha TD, Bo PK, Dang KTD, Tran HY, Nguyen T. Correlation between the Lymphocyte-To-Monocyte Ratio (LMR) and Child–Pugh and MELD/MELDNa Scores in Vietnamese Patients with Liver Cirrhosis. Gastroenterology Insights 2022;13:182-91. [DOI: 10.3390/gastroent13020019] [Reference Citation Analysis]
91 Mücke VT, Peiffer K, Kessel J, Schwarzkopf KM, Bojunga J, Zeuzem S, Finkelmeier F, Mücke MM. Impact of colonization with multidrug-resistant organisms on antibiotic prophylaxis in patients with cirrhosis and variceal bleeding. PLoS ONE 2022;17:e0268638. [DOI: 10.1371/journal.pone.0268638] [Reference Citation Analysis]
92 Mochida S, Nakayama N, Terai S, Yoshiji H, Shimizu M, Ido A, Inoue K, Genda T, Takikawa Y, Takami T, Kato N, Abe M, Abe R, Inui A, Ohira H, Kasahara M, Chayama K, Hasegawa K, Tanaka A. Diagnostic criteria for acute-on-chronic liver failure and related disease conditions in Japan. Hepatol Res 2022;52:417-21. [PMID: 35591813 DOI: 10.1111/hepr.13763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Westbrook RH, Burrell EL, Jalan R. PRO: Patients With Acute‐on‐Chronic Liver Failure Should Receive Priority on the Liver Transplant Waiting List. Clinical Liver Disease. [DOI: 10.1002/cld.1194] [Reference Citation Analysis]
94 Queck A, Weiler N, Trebicka J. Transplantation in Acute‐on‐Chronic Liver Failure: Feasibility and Futility. Clinical Liver Disease. [DOI: 10.1002/cld.1195] [Reference Citation Analysis]
95 Zhang J, Chen Y, Duan Z. Development of a FT3-related prognostic model for patients with hepatitis B virus-related acute-on-chronic liver failure. Bioengineered 2022;13:12548-57. [PMID: 35579389 DOI: 10.1080/21655979.2022.2077057] [Reference Citation Analysis]
96 Tejedor M, Selzner N, Berenguer M. Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List? Transplantation 2022. [PMID: 35594480 DOI: 10.1097/TP.0000000000004163] [Reference Citation Analysis]
97 Tong J, Wang H, Xu X, Wan Z, Fang H, Chen J, Mu X, Liu Z, Chen J, Su H, Liu X, Li C, Huang X, Hu J. Granulocyte Colony-Stimulating Factor Accelerates the Recovery of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure by Promoting M2-Like Transition of Monocytes. Front Immunol 2022;13:885829. [DOI: 10.3389/fimmu.2022.885829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Velarde-Ruiz Velasco JA, García-Jiménez ES, Aldana-Ledesma JM, Tapia-Calderón DK, Tornel-Avelar AI, Lazcano-Becerra M, Chávez-Ramírez RM, Cano-Contreras AD, Remes-Troche JM, Colunga-Lozano LE, Montaño-Loza A. Evaluation and management of emergencies in the patient with cirrhosis. Rev Gastroenterol Mex (Engl Ed) 2022:S2255-534X(22)00029-9. [PMID: 35570104 DOI: 10.1016/j.rgmxen.2022.05.001] [Reference Citation Analysis]
99 Chae SA, Pyo MC, Yoo HJ, Lee KW. Ochratoxin a induces hepatic fibrosis through TGF-β receptor I/Smad2/3 signaling pathway. Environ Toxicol 2022. [PMID: 35543154 DOI: 10.1002/tox.23552] [Reference Citation Analysis]
100 Napoleone L, Solé C, Juanola A, Ma AT, Carol M, Pérez-Guasch M, Rubio AB, Cervera M, Avitabile E, Bassegoda O, Gratacós-Ginès J, Morales-Ruiz M, Fabrellas N, Graupera I, Pose E, Crespo G, Solà E, Ginès P. Patterns of kidney dysfunction in acute-on-chronic liver failure: Relationship with kidney and patients' outcome. Hepatol Commun 2022. [PMID: 35535681 DOI: 10.1002/hep4.1963] [Reference Citation Analysis]
101 Téllez L, Guerrero A. Management of Liver Decompensation in Advanced Liver Disease (Renal Impairment, Liver Failure, Adrenal Insufficiency, Cardiopulmonary Complications). Clin Drug Investig 2022. [PMID: 35522396 DOI: 10.1007/s40261-022-01149-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Raszeja-Wyszomirska J, Niewiński G, Graczyńska A, Morawiec S, Janik MK, Kornasiewicz O. Clinical Implication of Plasma CD163 in Patients With Acute-on-Chronic Liver Failure. Transplant Proc 2022:S0041-1345(22)00192-0. [PMID: 35523597 DOI: 10.1016/j.transproceed.2022.02.048] [Reference Citation Analysis]
103 Deep A, Alexander EC, Ricci Z, Grazioli S, Ronco C, Goldstein S, Akcan-arikan A. Commentary: “PCRRT Expert Committee ICONIC Position Paper on Prescribing Kidney Replacement Therapy in Critically Sick Children With Acute Liver Failure”. Front Pediatr 2022;10:897308. [DOI: 10.3389/fped.2022.897308] [Reference Citation Analysis]
104 Yadav P, Trehanpati N, Maiwall R, Sehgal R, Singh R, Islam M, Jagdish RK, Vijayaraghavan R, Maheshwari D, Bhat S, Kale P, Kumar A, Baweja S, Kumar G, Ramakrishna G, Sarin SK. Soluble factors and suppressive monocytes can predict early development of sepsis in acute-on-chronic liver failure. Hepatol Commun 2022. [PMID: 35502507 DOI: 10.1002/hep4.1949] [Reference Citation Analysis]
105 Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, Sonika U, Dalal A. L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial. Hepatology 2022;75:1194-203. [PMID: 34822189 DOI: 10.1002/hep.32255] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
106 Trivedi HD. The Evolution of the MELD Score and Its Implications in Liver Transplant Allocation: A Beginner's Guide for Trainees. ACG Case Rep J 2022;9:e00763. [DOI: 10.14309/crj.0000000000000763] [Reference Citation Analysis]
107 Görgülü E, Gu W, Trebicka J, Mücke VT, Muecke MM, Friedrich-Rust M, Bojunga J, Zeuzem S, Finkelmeier F, Peiffer KH. Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic? Gut 2022;71:1036-8. [PMID: 35396231 DOI: 10.1136/gutjnl-2021-325278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Alabsawy E, Shalimar, Jalan R. Letter: de novo infection in hepatic encephalopathy-The culprit or the victim? Authors' reply. Aliment Pharmacol Ther 2022;55:1231-2. [PMID: 35429039 DOI: 10.1111/apt.16906] [Reference Citation Analysis]
109 Pestaña MÍ, Pérez-garcía A, Abad RF. Infecciones en el paciente inmunocomprometido (III). Diabetes mellitus, insuficiencia renal, cirrosis y enfermedad pulmonar obstructiva crónica. Medicine - Programa de Formación Médica Continuada Acreditado 2022;13:3298-3307. [DOI: 10.1016/j.med.2022.05.013] [Reference Citation Analysis]
110 Mochida S, Nakayama N, Terai S, Yoshiji H, Shimizu M, Ido A, Inoue K, Genda T, Takikawa Y, Takami T, Kato N, Abe M, Abe R, Inui A, Ohira H, Kasahara M, Chayama K, Hasegawa K, Tanaka A. Diagnostic Criteria for Acute-on-Chronic Liver Failure and Related Disease Conditions in Japan. Acta hepatologica Japonica 2022;63:219-223. [DOI: 10.2957/kanzo.63.219] [Reference Citation Analysis]
111 Brozat JF, Hanses F, Haelberger M, Stecher M, Dreher M, Tometten L, Ruethrich MM, Vehreschild JJ, Trautwein C, Borgmann S, Vehreschild MJGT, Jakob CEM, Stallmach A, Wille K, Hellwig K, Isberner N, Reuken PA, Geisler F, Nattermann J, Bruns T; LEOSS study group. COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry. United European Gastroenterol J 2022. [PMID: 35482663 DOI: 10.1002/ueg2.12232] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Kim JH, Kim SE, Song DS, Kim HY, Yoon EL, Kim TH, Jung YK, Suk KT, Jun BG, Yim HJ, Kwon JH, Lee SW, Kang SH, Kim MY, Jeong SW, Jang JY, Yoo JJ, Kim SG, Jin YJ, Cheon GJ, Kim BS, Seo YS, Kim HS, Sinn DH, Chung WJ, Kim HY, Lee HA, Nam SW, Kim IH, Suh JI, Kim JH, Chae HB, Sohn JH, Cho JY, Kim YJ, Yang JM, Park JG, Kim W, Cho HC, Kim DJ. Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration. J Clin Med 2022;11:2463. [PMID: 35566588 DOI: 10.3390/jcm11092463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Dar SH, Rahim M, Hosseini DK, Sarfraz K. Impact of liver cirrhosis on ST-elevation myocardial infarction related shock and interventional management, a nationwide analysis. World J Hepatol 2022; 14(4): 766-777 [DOI: 10.4254/wjh.v14.i4.766] [Reference Citation Analysis]
114 Habas E, Ibrahim AR, Moursi MO, Shraim BA, Elgamal ME, Elzouki AN. Update on hepatorenal Syndrome: Definition, Pathogenesis, and management. Arab J Gastroenterol 2022:S1687-1979(22)00005-3. [PMID: 35473682 DOI: 10.1016/j.ajg.2022.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Ma AT, Juanola A, Solà E. Assessment of kidney function in cirrhosis: Are we moving closer to accurate estimation of glomerular filtration rate? Liver Int 2022;42:957-9. [PMID: 35447007 DOI: 10.1111/liv.15238] [Reference Citation Analysis]
116 Kimer N, Meldgaard M, Hamberg O, Kronborg TM, Lund AM, Møller HJ, Bendtsen F, Ytting H. The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial. PLoS One 2022;17:e0264278. [PMID: 35286322 DOI: 10.1371/journal.pone.0264278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Kremer WM, Gairing SJ, Kaps L, Ismail E, Kalampoka V, Hilscher M, Michel M, Siegel E, Schattenberg JM, Galle PR, Sprinzl MF, Wörns MA, Nagel M, Labenz C. Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany. Ann Hepatol 2022;:100719. [PMID: 35460883 DOI: 10.1016/j.aohep.2022.100719] [Reference Citation Analysis]
118 Wang L, Zhu S, Liu Y, Zheng L, Xu W, Luo Q, Zhang Y, Deng H, Li X, Xie C, Peng L. Prognostic value of decline in model for end-stage liver disease score and hepatic encephalopathy in hepatitis B-related acute-on-chronic liver failure patients treated with plasma exchange. Scandinavian Journal of Gastroenterology. [DOI: 10.1080/00365521.2022.2063032] [Reference Citation Analysis]
119 Metawea MI, Moteleub HNAE. Diagnostic role of simple indices in HCV-related liver cirrhosis outcomes: a prospective cross-sectional study. Clin Exp Hepatol 2022;8:29-35. [PMID: 35415262 DOI: 10.5114/ceh.2022.114169] [Reference Citation Analysis]
120 Wehmeyer MH, Horvatits T, Buchholz A, Krause L, Walter S, Zapf A, Lohse AW, Kluwe J; STOPPIT-trial group. Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial. Trials 2022;23:302. [PMID: 35414106 DOI: 10.1186/s13063-022-06232-w] [Reference Citation Analysis]
121 Wang X, Zhong Y, Zhang R, Chen Y, Wang M, Lv C, Mao D. Wenyang Huazhuo Tuihuang Formula Inhibits the Th17/Treg Cell Imbalance and Protects against Acute-on-Chronic Liver Failure. Evid Based Complement Alternat Med 2022;2022:5652172. [PMID: 35399641 DOI: 10.1155/2022/5652172] [Reference Citation Analysis]
122 Ye C, Li W, Li L, Zhang K. Glucocorticoid Treatment Strategies in Liver Failure. Front Immunol 2022;13:846091. [PMID: 35371046 DOI: 10.3389/fimmu.2022.846091] [Reference Citation Analysis]
123 Bai W, Yao C, Mao D, Wu J, Wang K, Wei H, Huang Z, Shi Q, Wang N. The Clinical Efficacy of Double Plasma Molecular Absorption System Combined with Plasma Exchange in the Treatment of Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis. J Healthc Eng 2022;2022:3139929. [PMID: 35368957 DOI: 10.1155/2022/3139929] [Reference Citation Analysis]
124 Zanetto A, Campello E, Bulato C, Gavasso S, Saggiorato G, Shalaby S, Burra P, Angeli P, Senzolo M, Simioni P. Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Kulkarni AV, Ravikumar ST, Tevethia H, Premkumar M, Kumar K, Sharma M, Gupta R, Rao PN, Reddy DN. Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study. Sci Rep 2022;12:5503. [PMID: 35365736 DOI: 10.1038/s41598-022-09505-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Feldman S, Russo A, Ceccarelli G, Borrazzo C, Madge C, Venditti M, Merli M. Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections in Patients with Liver Cirrhosis. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.04.016] [Reference Citation Analysis]
127 Liu W, Pu Y, Zhu C, Qin A. Establishment of a scoring model for early diagnosis of infection associated with liver failure. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100713] [Reference Citation Analysis]
128 Velarde-ruiz Velasco J, García-jiménez E, Aldana-ledesma J, Tapia-calderón D, Tornel-avelar A, Lazcano-becerra M, Chávez-ramírez R, Cano-contreras A, Remes-troche J, Colunga-lozano L, Montaño-loza A. Evaluación y manejo de emergencias en el paciente con cirrosis. Revista de Gastroenterología de México 2022;87:198-215. [DOI: 10.1016/j.rgmx.2021.11.002] [Reference Citation Analysis]
129 Graupera I, Isus L, Coll M, Pose E, Díaz A, Vallverdú J, Rubio-tomás T, Martínez-sánchez C, Huelin P, Llopis M, Solé C, Fondevila C, Lozano JJ, Sancho-bru P, Ginès P, Aloy P. Molecular characterization of chronic liver disease dynamics: from liver fibrosis to acute-on-chronic liver failure. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100482] [Reference Citation Analysis]
130 Chen X, Granito A. Prognostic Role of MELD-Lactate in Cirrhotic Patients’ Short- and Long-Term Prognosis, Stratified by Causes of Cirrhosis. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-8. [DOI: 10.1155/2022/8449579] [Reference Citation Analysis]
131 Sharma A, Roy A, Premkumar M, Verma N, Duseja A, Taneja S, Grover S, Chopra M, Dhiman RK. Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial. Hepatol Int. [DOI: 10.1007/s12072-022-10312-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
132 Damiris K, Aghaie Meybodi M, Niazi M, Pyrsopoulos N. Hepatitis E in immunocompromised individuals. World J Hepatol 2022; 14(3): 482-494 [DOI: 10.4254/wjh.v14.i3.482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Gupta T, Ranga N, Goyal SK. Predictors of mortality at 28-days in infection associated acute kidney injury in cirrhosis. World J Hepatol 2022; 14(3): 592-601 [DOI: 10.4254/wjh.v14.i3.592] [Reference Citation Analysis]
134 Sánchez-Rodríguez MB, Téllez É, Casulleras M, Borràs FE, Arroyo V, Clària J, Sarrias MR. Reduced Plasma Extracellular Vesicle CD5L Content in Patients With Acute-On-Chronic Liver Failure: Interplay With Specialized Pro-Resolving Lipid Mediators. Front Immunol 2022;13:842996. [PMID: 35330909 DOI: 10.3389/fimmu.2022.842996] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Gama JFG, Cardoso LMDF, Lagrota-candido JM, Alves LA. Animal models applied to acute-on-chronic liver failure: Are new models required to understand the human condition? WJCC 2022;10:2687-99. [DOI: 10.12998/wjcc.v10.i9.2687] [Reference Citation Analysis]
136 Gama JFG, Cardoso LMDF, Lagrota-Candido JM, Alves LA. Animal models applied to acute-on-chronic liver failure: Are new models required to understand the human condition? World J Clin Cases 2022; 10(9): 2685-2697 [DOI: 10.12998/wjcc.v10.i9.2685] [Reference Citation Analysis]
137 Schulz MS, Gu W, Schnitzbauer AA, Trebicka J. Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure. Transpl Int 2022;35:10108. [DOI: 10.3389/ti.2022.10108] [Reference Citation Analysis]
138 Schmid S, Schlosser S, Gülow K, Pavel V, Müller M, Kratzer A. Interprofessional Collaboration between ICU Physicians, Staff Nurses, and Hospital Pharmacists Optimizes Antimicrobial Treatment and Improves Quality of Care and Economic Outcome. Antibiotics 2022;11:381. [DOI: 10.3390/antibiotics11030381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
139 Zakareya T, Akl M, Shibl S, El-mazaly M, Abdel-razek W. Utility of prognostic scores in predicting short-term mortality in patients with acute-on-chronic liver failure. Egypt Liver Journal 2022;12. [DOI: 10.1186/s43066-022-00183-2] [Reference Citation Analysis]
140 Shi Y, Fan Y, Chen T. Editorial: Acute-On-Chronic Liver Failure: Natural History, Mechanism, and Treatment. Front Med 2022;9:867436. [DOI: 10.3389/fmed.2022.867436] [Reference Citation Analysis]
141 Chirapongsathorn S, Teerasarntipan T, Tipchaichatt K, Suttichaimongkol T, Chamroonkul N, Bunchorntavakul C, Siramolpiwat S, Chainuvati S, Sobhonslidsuk A, Leerapun A, Piratvisuth T, Sukeepaisarnjaroen W, Tanwandee T, Treeprasertsuk S. Acute‐on‐chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai population. JGH Open. [DOI: 10.1002/jgh3.12719] [Reference Citation Analysis]
142 Wang L, Fan Y. Current Advances of Innate and Adaptive Immunity in Acute-on-Chronic Hepatitis B Liver Failure. Infectious Diseases & Immunity 2022;2:113-121. [DOI: 10.1097/id9.0000000000000051] [Reference Citation Analysis]
143 Sensui M, Yasui S, Ogasawara S, Kamezaki H, Kan M, Maruta S, Yamada T, Miura Y, Asano K, Shima Y, Nagashima H, Yokoyama M, Kusakabe Y, Sugiyama H, Ohno I, Mikata R, Kato J, Tsuyuguchi T, Kato N. Liver cirrhosis is a risk factor for poor prognosis of acute cholangitis caused by choledocholithiasis. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100696] [Reference Citation Analysis]
144 Weng F. The prognostic information of acute kidney injury in patients with decompensated cirrhosis. Eur J Gastroenterol Hepatol 2022;34:358-9. [PMID: 35100178 DOI: 10.1097/MEG.0000000000002214] [Reference Citation Analysis]
145 Figueiredo LM, Rafael MA, Alexandrino G, Branco JC, Carvalho R, Costa MN, Martins A. Risk factors for the emergence of multidrug-resistant organisms in liver cirrhosis. Gastroenterología y Hepatología (English Edition) 2022;45:186-191. [DOI: 10.1016/j.gastre.2021.04.006] [Reference Citation Analysis]
146 D’oliveira RAC, Pereira LCD, Codes L, Rocha MDS, Bittencourt PL. ANALYSIS OF HEALTHCARE ASSOCIATED AND HOSPITAL ACQUIRED INFECTIONS IN CRITICALLY ILL PATIENTS WITH CIRRHOSIS. Arq Gastroenterol 2022;59:102-9. [DOI: 10.1590/s0004-2803.202200001-18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Csak T. Hepatorenal Syndrome. Clinics in Liver Disease 2022. [DOI: 10.1016/j.cld.2022.01.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Zellos A, Debray D, Indolfi G, Czubkowski P, Samyn M, Hadzic N, Gupte G, Fischler B, Smets F, de Cléty SC, Grenda R, Mozer Y, Mancell S, Jahnel J, Auzinger G, Worth A, Lisman T, Staufner C, Baumann U, Dhawan A, Alonso E, Squires RH, Verkade HJ. Proceedings of ESPGHAN Monothematic Conference 2020: “Acute Liver Failure in Children”: Diagnosis and Initial Management. Journal of Pediatric Gastroenterology & Nutrition 2022;74:e45-e56. [DOI: 10.1097/mpg.0000000000003341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Riggio O, Ridola L. Editorial: infections and hepatic encephalopathy-does the chicken or the egg come FIRST? A novel perspective at the horizon. Aliment Pharmacol Ther 2022;55:744-5. [PMID: 35245964 DOI: 10.1111/apt.16809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Ntamo Y, Ziqubu K, Chellan N, Nkambule BB, Nyambuya TM, Mazibuko-mbeje SE, Gabuza KB, Orlando P, Tiano L, Dludla PV. Clinical use of N-acetyl cysteine during liver transplantation: Implications of oxidative stress and inflammation as therapeutic targets. Biomedicine & Pharmacotherapy 2022;147:112638. [DOI: 10.1016/j.biopha.2022.112638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
151 Stoffers P, Guckenbiehl S, Welker MW, Zeuzem S, Lange CM, Trebicka J, Herrmann E, Welsch C. Diagnostic and prognostic significance of cell death markers in patients with cirrhosis and acute decompensation. PLoS One 2022;17:e0263989. [PMID: 35176084 DOI: 10.1371/journal.pone.0263989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
152 Maindad DG, Shenoy S, Shenoy S, Gopal S, Tantry BV. Treatment of Hospital-Acquired Infections in Patients with Cirrhosis - New Challenges. Infect Drug Resist 2022;15:1039-48. [PMID: 35313728 DOI: 10.2147/IDR.S283723] [Reference Citation Analysis]
153 Anand A, Nambirajan A, Kumar V, Agarwal S, Sharma S, Mohta S, Gopi S, Kaushal K, Gunjan D, Singh N, Madhusudhan KS, Chauhan SS, Sharma MC, Bansal VK, Saraya A. Alterations in Autophagy and Mammalian Target of Rapamycin (mTOR) Pathways Mediate Sarcopenia in Patients with Cirrhosis. Journal of Clinical and Experimental Hepatology 2022;12:510-8. [DOI: 10.1016/j.jceh.2021.05.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
154 Griemsmann M, Tergast TL, Simon N, Kabbani A, Manns MP, Wedemeyer H, Cornberg M, Maasoumy B. Nosocomial infections in female compared with male patients with decompensated liver cirrhosis. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-07084-9] [Reference Citation Analysis]
155 Thuluvath PJ, Li F. Modified EASL-CLIF criteria that is easier to use and perform better to prognosticate acute-on-chronic liver failure. World J Hepatol 2022; 14(2): 420-428 [DOI: 10.4254/wjh.v14.i2.420] [Reference Citation Analysis]
156 Anderko RR, Gómez H, Canna SW, Shakoory B, Angus DC, Yealy DM, Huang DT, Kellum JA, Carcillo JA, Angus DC, Barnato AE, Eaton TL, Gimbel E, Huang DT, Keener C, Kellum JA, Landis K, Pike F, Stapleton DK, Weissfeld LA, Willochell M, Wofford KA, Yealy DM, Kulstad E, Watts H, Venkat A, Hou PC, Massaro A, Parmar S, Limkakeng AT, Brewer K, Delbridge TR, Mainhart A, Chawla LS, Miner JR, Allen TL, Grissom CK, Swadron S, Conrad SA, Carlson R, Lovecchio F, Bajwa EK, Filbin MR, Parry BA, Ellender TJ, Sama AE, Fine J, Nafeei S, Terndrup T, Wojnar M, Pearl RG, Wilber ST, Sinert R, Orban DJ, Wilson JW, Ufberg JW, Albertson T, Panacek EA, Parekh S, Gunn SR, Rittenberger JS, Wadas RJ, yEdwards AR, Kelly M, Wang HE, Holmes TM, Mccurdy MT, Weinert C, Harris ES, Self WH, Phillips CA, Migues RM; For the ProCESS Investigators. Sepsis with liver dysfunction and coagulopathy predicts an inflammatory pattern of macrophage activation. ICMx 2022;10. [DOI: 10.1186/s40635-022-00433-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
157 Duah A, Duah F, Ampofo-boobi D, Addo BP, Osei-poku F, Agyei-nkansah A, Bellini MI. Acute Kidney Injury in Patients with Liver Cirrhosis: Prevalence, Predictors, and In-Hospital Mortality at a District Hospital in Ghana. BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/4589767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
158 Xiang S, Tan J, Tan C, Xu Q, Wen Y, Wang T, Yang C, Zhao W. Establishment and Validation of a Non-Invasive Diagnostic Nomogram to Identify Spontaneous Bacterial Peritonitis in Patients With Decompensated Cirrhosis. Front Med (Lausanne) 2021;8:797363. [PMID: 35174183 DOI: 10.3389/fmed.2021.797363] [Reference Citation Analysis]
159 Kondo T, Koroki K, Kanzaki H, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Ogasawara S, Ooka Y, Nakamoto S, Chiba T, Arai M, Kato J, Kuboki S, Ohtsuka M, Kato N. Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma. PLoS One 2022;17:e0261619. [PMID: 35085277 DOI: 10.1371/journal.pone.0261619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Zhang X, Han J, Qi X, Zhang Y, Zhou P, Liu X, Ying Y, Zhang W, Zhang J, Huang Y. DIC Score Combined With CLIF-C OF Score Is More Effective in Predicting Prognosis in Patients With Hepatitis B Virus Acute-on-Chronic Liver Failure. Front Med 2022;9:815580. [DOI: 10.3389/fmed.2022.815580] [Reference Citation Analysis]
161 Abbasy M, Zaghla H, Elhelbawy M, Ramadan M, Zakareya T. Predicting in-hospital mortality of cirrhotic patients hospitalized with hepatic encephalopathy. Egypt Liver Journal 2022;12. [DOI: 10.1186/s43066-022-00178-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Driever EG, Lisman T. Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease. Semin Thromb Hemost 2022. [PMID: 35135033 DOI: 10.1055/s-0042-1742438] [Reference Citation Analysis]
163 Gibbs JT, Louissaint J, Tapper EB. Rate of Successful Extubation in Mechanically Ventilated Patients with Cirrhosis and Hepatic Coma. Dig Dis Sci 2022. [PMID: 35107648 DOI: 10.1007/s10620-022-07400-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Raina R, Sethi SK, Filler G, Menon S, Mittal A, Khooblall A, Khooblall P, Chakraborty R, Adnani H, Vijayvargiya N, Teo S, Bhatt G, Koh LJ, Mourani C, de Sousa Tavares M, Alhasan K, Forbes M, Dhaliwal M, Raghunathan V, Broering D, Sultana A, Montini G, Brophy P, Mcculloch M, Bunchman T, Yap HK, Topalglu R, Díaz-gonzález de Ferris M. PCRRT Expert Committee ICONIC Position Paper on Prescribing Kidney Replacement Therapy in Critically Sick Children With Acute Liver Failure. Front Pediatr 2022;9:833205. [DOI: 10.3389/fped.2021.833205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Trebicka J, Gu W, de Ledinghen V, Aubé C, Krag A, Praktiknjo M, Castera L, Dumortier J, Bauer DJM, Friedrich-Rust M, Pol S, Grgurevic I, Zheng R, Francque S, Gottfriedovà H, Mustapic S, Sporea I, Berzigotti A, Uschner FE, Simbrunner B, Ronot M, Cassinotto C, Kjaergaard M, Andrade F, Schulz M, Semmler G, Drinkovic IT, Chang J, Brol MJ, Rautou PE, Vanwolleghem T, Strassburg CP, Boursier J, Ferstl PG, Rasmussen DN, Reiberger T, Vilgrain V, Guibal A, Guillaud O, Zeuzem S, Vassord C, Lu X, Vonghia L, Senkerikova R, Popescu A, Margini C, Wang W, Thiele M, Jansen C. Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease. Gut 2022;71:402-14. [PMID: 33479052 DOI: 10.1136/gutjnl-2020-323419] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
166 Alabsawy E, Shalimar, Sheikh MF, Ballester MP, Acharya SK, Agarwal B, Jalan R. Overt hepatic encephalopathy is an independent risk factor for de novo infection in cirrhotic patients with acute decompensation. Aliment Pharmacol Ther 2022. [PMID: 35106777 DOI: 10.1111/apt.16790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
167 Lin T, Wang S, Munker S, Jung K, Macías-Rodríguez RU, Ruiz-Margáin A, Schierwagen R, Liu H, Shao C, Fan C, Feng R, Yuan X, Wang S, Wandrer F, Meyer C, Wimmer R, Liebe R, Kroll J, Zhang L, Schiergens T, Ten Dijke P, Teufel A, Marx A, Mertens PR, Wang H, Ebert MPA, Bantel H, N De Toni E, Trebicka J, Dooley S, Shin D, Ding H, Weng HL. Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure. Hepatology 2022;75:322-37. [PMID: 34435364 DOI: 10.1002/hep.32119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
168 Cao Z, Xie Q. Acute-on-chronic liver failure in East Asia: an underestimated issue with limited data. Gut 2022;71:445-6. [PMID: 33766912 DOI: 10.1136/gutjnl-2021-324564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Bajaj JS, O'Leary JG, Lai JC, Wong F, Long MD, Wong RJ, Kamath PS. Acute-on-Chronic Liver Failure Clinical Guidelines. Am J Gastroenterol 2022;117:225-52. [PMID: 35006099 DOI: 10.14309/ajg.0000000000001595] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
170 Albillos A, Martin-Mateos R, Van der Merwe S, Wiest R, Jalan R, Álvarez-Mon M. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol 2022;19:112-34. [PMID: 34703031 DOI: 10.1038/s41575-021-00520-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
171 Laique SN, Eghtesad B, Lindenmeyer CC. Surgical Considerations Regarding Transplantation for the Patient With Acute‐on‐Chronic Liver Failure. Clinical Liver Disease. [DOI: 10.1002/cld.1189] [Reference Citation Analysis]
172 Sundaram V. Introduction: The Role of Liver Transplantation in Acute‐on‐Chronic Liver Failure. Clinical Liver Disease. [DOI: 10.1002/cld.1181] [Reference Citation Analysis]
173 Duong N, Bajaj JS. Identifying the patient with acute‐on‐chronic liver failure: navigating through multiple definitions. Clinical Liver Disease. [DOI: 10.1002/cld.1176] [Reference Citation Analysis]
174 Voss A, Schroeder R, Schulz S, Haueisen J, Vogler S, Horn P, Stallmach A, Reuken P. Detection of Liver Dysfunction Using a Wearable Electronic Nose System Based on Semiconductor Metal Oxide Sensors. Biosensors (Basel) 2022;12:70. [PMID: 35200331 DOI: 10.3390/bios12020070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
175 Kitajima T, Kuno Y, Ivanics T, Lu M, Moonka D, Shimada S, Shamaa T, Abouljoud MS, Nagai S. Improved Survival With Higher-risk Donor Grafts in Liver Transplant With Acute-on-chronic Liver Failure. Transplantation Direct 2022;8:e1283. [DOI: 10.1097/txd.0000000000001283] [Reference Citation Analysis]
176 García-rueda JE, Londoño-garcía R, Marín-cuartas T, Hernández-abaunza JE, Osorio-rico S, Bermúdez-flórez AM, Restrepo-gutiérrez JC. Falla hepática aguda sobre crónica: análisis de una serie de casos y revisión de la literatura. Hepatología 2022. [DOI: 10.52784/27112330.149] [Reference Citation Analysis]
177 Miño Bernal JF, López Morales E, Sandino NJ, Molano Franco D. Cirrosis hepática o falla hepática crónica agudizada: definición y clasificación. Repert Med Cir 2022;31:112-122. [DOI: 10.31260/repertmedcir.01217372.1052] [Reference Citation Analysis]
178 Trebicka J, Louvet A, Arroyo V, Jalan R, Shah VH, Moreau R. Severe alcoholic hepatitis as precipitant for organ failure and ACLF. Z Gastroenterol 2022;60:67-76. [PMID: 35042255 DOI: 10.1055/a-1713-3796] [Reference Citation Analysis]
179 Choi JW, Son HJ, Lee SS, Jeon H, Cho J, Kim HJ, Cha RR, Lee JM, Kim HJ, Jung WT, Lee O. Acute hepatitis E virus superinfection increases mortality in patients with cirrhosis. BMC Infect Dis 2022;22. [DOI: 10.1186/s12879-022-07050-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
180 Flint E, Triantafyllou E, Bernsmeier C. TAM Receptors in the Pathophysiology of Liver Disease. Livers 2022;2:15-29. [DOI: 10.3390/livers2010002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Mallik M, Singhai A, Khadanga S, Ingle V. The Significant Morbidity and Mortality Indicators in Patients of Cirrhosis. Cureus 2022. [DOI: 10.7759/cureus.21226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
182 Liu B, Lv T, Zhao X, Zhou M, Song C, Zeng C, Qin T, Xu Z. Fluorescence discrimination of HSA from BSA: A close look at the albumin-induced restricted intramolecular rotation of flavonoid probe. Spectrochim Acta A Mol Biomol Spectrosc 2022;264:120306. [PMID: 34461524 DOI: 10.1016/j.saa.2021.120306] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
183 Rao B H, Nair P, Koshy AK, Krishnapriya S, Greeshma CR, Venu RP. Role of High-Density Lipoprotein Cholesterol (HDL-C) as a Clinical Predictor of Decompensation in Patients with Chronic Liver Disease (CLD). Int J Hepatol 2021;2021:1795851. [PMID: 34976412 DOI: 10.1155/2021/1795851] [Reference Citation Analysis]
184 Chang J, Matheja A, Krzycki S, Lutz P, Böhling N, Glückert K, Weismüller TJ, van Beekum C, Manekeller S, Jansen C, Kalff JC, Strassburg CP, Praktiknjo M. Model for end-stage liver disease underestimates mortality of patients with acute-on-chronic liver failure waiting for liver transplantation. Dig Liver Dis 2022:S1590-8658(21)00899-9. [PMID: 34996730 DOI: 10.1016/j.dld.2021.12.011] [Reference Citation Analysis]
185 Jha P, Jha AK, Dayal VM, Jha SK, Kumar A. Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure. Indian J Gastroenterol 2022. [PMID: 34981441 DOI: 10.1007/s12664-021-01201-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Lin T, Feng R, Liebe R, Weng HL. Liver Progenitor Cells in Massive Hepatic Necrosis-How Can a Patient Survive Acute Liver Failure? Biomolecules 2022;12:66. [PMID: 35053214 DOI: 10.3390/biom12010066] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
187 Faitot F, Artzner T, Michard B, Besch C, Schenck M, Herbrecht JE, Langenstein RJ, Maestraggi Q, Guillot M, Harlay ML, Castelain V, Addeo P, Ellero B, Woehl-Jaegle ML, Serfaty L, Bachellier P, Schneider F, Study Group OBOTSLTS. Immunosuppression in patients with Grade 3 Acute-On-Chronic Liver Failure at transplantation: A practice analysis study. Clin Transplant 2022;:e14580. [PMID: 34974638 DOI: 10.1111/ctr.14580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 Lange CM, Al-juboori K, Rawitzer J, Moellmann D, Schlattjan M, Guckenbiehl S, Willuweit K, Canbay A, Baba HA. Cirrhosis-Based Acute-on-Chronic Liver Failure Is Marked by Inflammation and Impaired Liver Regeneration Despite Stat3 Activation. Gastro Hep Advances 2022;1:520-530. [DOI: 10.1016/j.gastha.2022.03.005] [Reference Citation Analysis]
189 Yang Z, Liu Y, Chen T, Ning Q. Complications of End-Stage Liver Disease: Advances from a Clinical Viewpoint. Infectious Diseases & Immunity 2022;2:1-2. [DOI: 10.1097/id9.0000000000000039] [Reference Citation Analysis]
190 Terres AZ, Balbinot RS, Muscope ALF, Longen ML, Schena B, Cini BT, Luis Rost G, Balensiefer JIL, Eberhardt LZ, Balbinot RA, Balbinot SS, Soldera J. Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortality. Gastroenterología y Hepatología (English Edition) 2022;45:25-39. [DOI: 10.1016/j.gastre.2021.02.009] [Reference Citation Analysis]
191 Verma N, Mishra S, Singh S, De A, Premkumar M, Taneja S, Duseja A, Singh V. Prevalence, Predictors, and Outcomes of Esophageal Candidiasis in Cirrhosis: An Observational Study With Systematic Review and Meta-Analysis (CANDID-VIEW). Journal of Clinical and Experimental Hepatology 2022;12:118-28. [DOI: 10.1016/j.jceh.2021.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
192 Honerkamp I, Sandmann L, Richter N, Manns MP, Voigtländer T, Vondran FW, von Hahn T. Surgical Procedures in Patients Awaiting Liver Transplantation: Complications and Impact on the Liver Function. Journal of Clinical and Experimental Hepatology 2022;12:68-79. [DOI: 10.1016/j.jceh.2021.03.011] [Reference Citation Analysis]
193 Rodrigues SG, Bañares R, Dell’era A, Bosch J, Ripoll C. Definition of First Decompensation in Cirrhosis. Portal Hypertension VII 2022. [DOI: 10.1007/978-3-031-08552-9_29] [Reference Citation Analysis]
194 Burke NT, Maurice JB, Nasralla D, Potts J, Westbrook R. Recent advances in liver transplantation. Frontline Gastroenterol 2022;13:57-63. [PMID: 34970429 DOI: 10.1136/flgastro-2020-101425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
195 Jalan R, Perricone G. Acute-on-Chronic Liver Failure: Definition and Prognosis. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_3] [Reference Citation Analysis]
196 Ren H, Yao J, Zhao R, Gong K, Sun S, Yu X, Shen W, Duan J, Sheng J, Shi Y. Interobserver Agreement for Classifying Infections in Patients with Decompensated Cirrhosis Based on Centers for Disease Control and Prevention Criteria. Infectious Diseases & Immunity 2022;2:21-28. [DOI: 10.1097/id9.0000000000000038] [Reference Citation Analysis]
197 Gambato M, Ferrarese A. Indications to Liver Transplantation for Liver Cirrhosis. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_2] [Reference Citation Analysis]
198 Premkumar M, Roy A, Singh V. Acute on Chronic Liver Failure. Clinical Rounds in Hepatology 2022. [DOI: 10.1007/978-981-16-8448-7_7] [Reference Citation Analysis]
199 Squires JE, McKiernan PJ, Squires RH. Acute Liver Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference. Pediatrics 2022;149:S59-65. [PMID: 34970684 DOI: 10.1542/peds.2021-052888I] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
200 Ginanni Corradini S, Ferri F. Referral to the Liver Transplant Center. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_35] [Reference Citation Analysis]
201 Nazir N, Abbas S, Nasir H, Hussain I. Electrochemical sensing of limonene using thiol capped gold nanoparticles and its detection in the real breath sample of a cirrhotic patient. Journal of Electroanalytical Chemistry 2022;905:115977. [DOI: 10.1016/j.jelechem.2021.115977] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
202 Nathwani R, Selvapatt N, Dhar A. Liver Decompensation and Acute on Chronic Liver Failure. In Clinical Practice 2022. [DOI: 10.1007/978-3-031-10012-3_4] [Reference Citation Analysis]
203 Chang J, Höfer P, Böhling N, Lingohr P, Manekeller S, Kalff JC, Dohmen J, Kaczmarek DJ, Jansen C, Meyer C, Strassburg CP, Trebicka J, Praktiknjo M. Pre-operative TIPS may reduce post-operative ACLF occurrence. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100442] [Reference Citation Analysis]
204 Dandu H, Kumar V, Goel A, Khetan D, Chandra T, Bharti V. A preliminary experience of plasma exchange in liver failure. Asian J Transfus Sci 2022;16:212. [DOI: 10.4103/ajts.ajts_115_21] [Reference Citation Analysis]
205 Langouche L, Gunst J, Reintam Blaser A. Plasma Markers of Cholestasis in Critical Illness. Biomarkers in Trauma, Injury and Critical Care 2022. [DOI: 10.1007/978-3-030-87302-8_11-1] [Reference Citation Analysis]
206 Mezzano G, Juanola A, Cardenas A, Mezey E, Hamilton JP, Pose E, Graupera I, Ginès P, Solà E, Hernaez R. Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis. Gut 2022;71:148-55. [PMID: 33436495 DOI: 10.1136/gutjnl-2020-322161] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 26.0] [Reference Citation Analysis]
207 Li J, Liang X, Jiang J, Yang L, Xin J, Shi D, Lu Y, Li J, Ren K, Hassan HM, Zhang J, Chen P, Yao H, Li J, Wu T, Jin L, Ye P, Li T, Zhang H, Sun S, Guo B, Zhou X, Cai Q, Chen J, Xu X, Huang J, Hao S, He J, Xin S, Wang D, Trebicka J, Chen X, Li J; Chinese Group on the Study of Severe Hepatitis B (COSSH). PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF. Gut 2022;71:163-75. [PMID: 33431576 DOI: 10.1136/gutjnl-2020-323395] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
208 Samonakis DN, Gatselis N, Bellou A, Sifaki-Pistolla D, Mela M, Demetriou G, Thalassinos E, Rigopoulou EI, Kevrekidou P, Tziortziotis I, Azariadi K, Kavousanaki M, Digenakis E, Vassiliadis T, Kouroumalis EA, Dalekos GN. Spontaneous bacterial peritonitis: a prospective Greek multicenter study of its epidemiology, microbiology, and outcomes. Ann Gastroenterol 2022;35:80-7. [PMID: 34987293 DOI: 10.20524/aog.2021.0674] [Reference Citation Analysis]
209 Pinzón Martínez YV, Mercado Díaz M, Romero Castellanos W, Huerfáno Castro M, Vargas MJ. Soporte MARS en un paciente con falla hepática aguda sobre crónica en un hospital universitario en Bogotá - Colombia. Reporte de caso y revisión de la literatura. Acta Colombiana de Cuidado Intensivo 2022;22:75-80. [DOI: 10.1016/j.acci.2020.11.001] [Reference Citation Analysis]
210 Anand A, Mohta S, Agarwal S, Sharma S, Gopi S, Gunjan D, Madhusudhan KS, Singh N, Saraya A. European Working Group on Sarcopenia in Older People (EWGSOP2) Criteria With Population-Based Skeletal Muscle Index Best Predicts Mortality in Asians With Cirrhosis. Journal of Clinical and Experimental Hepatology 2022;12:52-60. [DOI: 10.1016/j.jceh.2021.03.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
211 Sun Y, Li Z, Liao G, Xia M, Xu X, Cai S, Peng J. aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure. IJGM 2022;Volume 15:407-15. [DOI: 10.2147/ijgm.s343457] [Reference Citation Analysis]
212 Lamatsch S, Sittner R, Tacke F, Engelmann C. Novel drug discovery strategies for the treatment of decompensated cirrhosis. Expert Opin Drug Discov 2021;:1-10. [PMID: 34971342 DOI: 10.1080/17460441.2022.2020755] [Reference Citation Analysis]
213 Pose E, Solà E, Lozano JJ, Juanola A, Sidorova J, Zaccherini G, de Wit K, Uschner F, Tonon M, Kazankov K, Jiménez C, Campion D, Napoleone L, Ma AT, Carol M, Morales-Ruiz M, Alessandria C, Beuers U, Caraceni P, Francoz C, Durand F, Mookerjee RP, Trebicka J, Vargas V, Piano S, Watson H, Abraldes JG, Kamath PS, Davis MM, Ginès P; investigators of the LIVERHOPE Consortium. Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis. Hepatol Commun 2021. [PMID: 34964311 DOI: 10.1002/hep4.1881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
214 Yu X, Lu Y, Sun S, Tu H, Xu X, Gong K, Yao J, Shi Y, Sheng J. Clinical Prediction Models for Hepatitis B Virus-related Acute-on-chronic Liver Failure: A Technical Report. J Clin Transl Hepatol 2021;9:838-49. [PMID: 34966647 DOI: 10.14218/JCTH.2021.00005] [Reference Citation Analysis]
215 Rodina AS, Shubina ME, Kurbatova IV, Topchieva LV, Dudanova OP. The role of hepatocellular death and systemic inflammation in the development of acute kidney injury in acute decompensation of alcoholic liver cirrhosis. jour 2021. [DOI: 10.31146/1682-8658-ecg-194-10-66-71] [Reference Citation Analysis]
216 Liu S, Meng Q, Xu Y, Zhou J. Hepatorenal syndrome in acute-on-chronic liver failure with acute kidney injury: more questions requiring discussion. Gastroenterol Rep (Oxf) 2021;9:505-20. [PMID: 34925848 DOI: 10.1093/gastro/goab040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
217 Liang J, Liu L, Cao Y, Zhang Q, Liu F, Chen Y, Liu H, Duan Z, Xu M, Xin S, You S, Song F, Li J, Han T. Hepatitis B-related acute-on-chronic liver failure induced by hepatotropic viral insult is associated with worse prognosis than that induced by non-virus insult. BMC Infect Dis 2021;21:1273. [PMID: 34930163 DOI: 10.1186/s12879-021-06974-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
218 Reißing J, Lutz P, Frissen M, Ibidapo-Obe O, Reuken PA, Wirtz TH, Stengel S, Quickert S, Rooney M, Große K, Zimmermann HW, Trautwein C, Stallmach A, Bruns T. Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality. JHEP Rep 2022;4:100391. [PMID: 34917912 DOI: 10.1016/j.jhepr.2021.100391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Dudanova OP, Shubina ME, Rodina AS, Kurbatova IV, Topchieva LV. Role of tissue molecular pathogens in development of acute chronic liver failure in alcoholic liver cirrhosis. Medicinskij alfavit 2021. [DOI: 10.33667/2078-5631-2021-35-19-22] [Reference Citation Analysis]
220 Kondo T, Macdonald S, Engelmann C, Habtesion A, Macnaughtan J, Mehta G, Mookerjee RP, Davies N, Pavesi M, Moreau R, Angeli P, Arroyo V, Andreola F, Jalan R. The role of RIPK1 mediated cell death in acute on chronic liver failure. Cell Death Dis 2021;13:5. [PMID: 34921136 DOI: 10.1038/s41419-021-04442-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
221 Xu X, Li C, Chen J, Liu X, Su H, Tong J, Hu J. Relationship Between Platelet to White Blood Cell Ratio and 30-Day Prognosis of Patients with Acute-on-Chronic Liver Failure. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.118640] [Reference Citation Analysis]
222 Gu W, Hortlik H, Erasmus HP, Schaaf L, Zeleke Y, Uschner FE, Ferstl P, Schulz M, Peiffer KH, Queck A, Sauerbruch T, Brol MJ, Rohde G, Sanchez C, Moreau R, Arroyo V, Zeuzem S, Welsch C, Trebicka J. Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018). Lancet Reg Health Eur 2022;12:100240. [PMID: 34901909 DOI: 10.1016/j.lanepe.2021.100240] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
223 Blasi A, Patel VC, Spanke ENHE, Adelmeijer J, Stamouli M, Zamalloa A, Corcoran E, Calvo A, Fernandez J, Bernal W, Lisman T. Fibrin clot quality in acutely ill cirrhosis patients: Relation with outcome and improvement with coagulation factor concentrates. Liver Int 2021. [PMID: 34894081 DOI: 10.1111/liv.15132] [Reference Citation Analysis]
224 Zhang IW, López-Vicario C, Duran-Güell M, Clària J. Mitochondrial Dysfunction in Advanced Liver Disease: Emerging Concepts. Front Mol Biosci 2021;8:772174. [PMID: 34888354 DOI: 10.3389/fmolb.2021.772174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Huang W, Ma Y, Du L, Kang S, Liu CH, Bai L, Lei X, Tang H. Effectiveness of granulocyte colony-stimulating factor for patients with acute-on-chronic liver failure: a meta-analysis. Ann Saudi Med 2021;41:383-91. [PMID: 34873932 DOI: 10.5144/0256-4947.2021.383] [Reference Citation Analysis]
226 Uludag K, Arikan T. Longitudinal effects of modified creatinine index on all-cause mortality in individuals receiving hemodialysis treatment. Ann Saudi Med 2021;41:361-8. [PMID: 34873933 DOI: 10.5144/0256-4947.2021.361] [Reference Citation Analysis]
227 Wang Y, Dong F, Sun S, Wang X, Zheng X, Huang Y, Li B, Gao Y, Qian Z, Liu F, Lu X, Liu J, Ren H, Zheng Y, Yan H, Deng G, Qiao L, Zhang Y, Gu W, Xiang X, Zhou Y, Xu B, Hou Y, Zhang Q, Xiong Y, Zou C, Chen J, Huang Z, Jiang X, Qi T, Luo S, Chen Y, Gao N, Liu C, Yuan W, Mei X, Li J, Li T, Zheng R, Zhou X, Zhang W, Li H, Meng Z. Increased INR Values Predict Accelerating Deterioration and High Short-Term Mortality Among Patients Hospitalized With Cirrhosis or Advanced Fibrosis. Front Med (Lausanne) 2021;8:762291. [PMID: 34869468 DOI: 10.3389/fmed.2021.762291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
228 Chen YY, Li H, Xu BY, Zheng X, Li BL, Wang XB, Huang Y, Gao YH, Qian ZP, Liu F, Lu XB, Shang J, Li H, Wang SY, Zhang YH, Meng ZJ; Chinese Chronic Liver Failure (CLIF) Consortium. Plasma Exchange-Based Non-bioartificial Liver Support System Improves the Short-Term Outcomes of Patients With Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure: A Multicenter Prospective Cohort Study. Front Med (Lausanne) 2021;8:779744. [PMID: 34869500 DOI: 10.3389/fmed.2021.779744] [Reference Citation Analysis]
229 Sun S, Ye W, Zhao R, Hu J, Zhang X, Yang M, Zhao H, Sheng J. Proton Pump Inhibitor Therapy Does Not Affect Prognosis of Cirrhosis Patients With Acute Decompensation and Acute-on-Chronic Liver Failure: A Single-Center Prospective Study. Front Med (Lausanne) 2021;8:763370. [PMID: 34859015 DOI: 10.3389/fmed.2021.763370] [Reference Citation Analysis]
230 Patidar KR, Peng JL, Kaur H, Worden A, Kettler CD, Pike F, Buckley CA, Orman ES, Desai AP, Nephew LD, Kubal CA, Gawrieh S, Chalasani N, Ghabril MS. Severe Alcohol-Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver Failure. Hepatol Commun 2021. [PMID: 34860462 DOI: 10.1002/hep4.1874] [Reference Citation Analysis]
231 Hassan HM, Cai Q, Liang X, Xin J, Ren K, Jiang J, Shi D, Lu Y, Li T, Shang Y, He L, Chen X, Sun S, Li P, Guo B, Chen J, Yang H, Hu W, Chen X, Li J. Transcriptomics reveals immune-metabolism disorder in acute-on-chronic liver failure in rats. Life Sci Alliance 2022;5:e202101189. [PMID: 34853163 DOI: 10.26508/lsa.202101189] [Reference Citation Analysis]
232 Simonetti RG, Perricone G, Gluud C. Albumin for people with liver cirrhosis and bacterial infections. Cochrane Database of Systematic Reviews 2021;2021. [DOI: 10.1002/14651858.cd014636] [Reference Citation Analysis]
233 Hartl L, Jachs M, Simbrunner B, Bauer DJM, Semmler G, Gompelmann D, Szekeres T, Quehenberger P, Trauner M, Mandorfer M, Scheiner B, Reiberger T. Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19. J Pers Med 2021;11:1264. [PMID: 34945736 DOI: 10.3390/jpm11121264] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
234 Ballester MP, Sittner R, Jalan R. Alcohol and Acute-on-Chronic Liver Failure. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.12.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Arya P, Kumar U, Sharma S, Durgappa M, Guleria A, Raj R, Pande G, Kumar D. Targeted NMR‐based serum metabolic profiling of serine, glycine and methionine in acute‐on‐chronic liver failure patients: Possible insights into mitochondrial dysfunction. Analytical Science Advances 2021;2:536-545. [DOI: 10.1002/ansa.202000167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Clària J. La aplicación de las ómicas para comprender la base molecular de la insuficiencia hepática aguda sobre crónica. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2021;2:528-540. [DOI: 10.1515/almed-2021-0068] [Reference Citation Analysis]
237 Clària J. Leveraging omics to understand the molecular basis of acute-on-chronic liver failure. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2021;2:516-527. [DOI: 10.1515/almed-2021-0023] [Reference Citation Analysis]
238 Maini AA, Becares N, China L, Tittanegro TH, Patel A, De Maeyer RPH, Zakeri N, Long TV, Ly L, Gilroy DW, O'Brien A. Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway. JHEP Rep 2021;3:100332. [PMID: 34825153 DOI: 10.1016/j.jhepr.2021.100332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
239 Zhang S, Suen SC, Gong CL, Pham J, Trebicka J, Duvoux C, Klein AS, Wu T, Jalan R, Sundaram V. Early transplantation maximizes survival in severe acute-on-chronic liver failure: Results of a Markov decision process model. JHEP Rep 2021;3:100367. [PMID: 34825154 DOI: 10.1016/j.jhepr.2021.100367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
240 Khanam A, Kottilil S. Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and Management. Front Med (Lausanne) 2021;8:752875. [PMID: 34820395 DOI: 10.3389/fmed.2021.752875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
241 Mani I, Vrioni G, Hadziyannis E, Alexopoulos T, Vasilieva L, Tsiriga A, Tsiamis C, Tsakris A, Dourakis SP, Alexopoulou A. Bacterial DNA is a prognostic factor for mortality in patients who recover from spontaneous bacterial peritonitis. Ann Gastroenterol 2021;34:852-61. [PMID: 34815652 DOI: 10.20524/aog.2021.0665] [Reference Citation Analysis]
242 Goussous N, Xie W, Zhang T, Malik S, Alvarez-Casas J, Gray SH, Barth RN, Thuluvath PJ, LaMattina JC. Acute on Chronic Liver Failure: Factors Associated With Transplantation. Transplant Direct 2021;7:e788. [PMID: 34805490 DOI: 10.1097/TXD.0000000000001245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
243 Kerbert AJC, Gupta S, Alabsawy E, Dobler I, Lønsmann I, Hall A, Nielsen SH, Nielsen MJ, Gronbaek H, Amoros À, Yeung D, Macnaughtan J, Mookerjee RP, Macdonald S, Andreola F, Moreau R, Arroyo V, Angeli P, Leeming DJ, Treem W, Karsdal MA, Jalan R. Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure. JHEP Rep 2021;3:100355. [PMID: 34805815 DOI: 10.1016/j.jhepr.2021.100355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
244 Chandna S, Zarate ER, Gallegos-Orozco JF. Management of Decompensated Cirrhosis and Associated Syndromes. Surg Clin North Am 2022;102:117-37. [PMID: 34800381 DOI: 10.1016/j.suc.2021.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
245 Goudsmit BFJ, Braat AE, Tushuizen ME, Coenraad MJ, Vogelaar S, Alwayn IPJ, van Hoek B, Putter H. Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure. JHEP Rep 2021;3:100369. [PMID: 34765960 DOI: 10.1016/j.jhepr.2021.100369] [Reference Citation Analysis]
246 Zhang Y, Wu W, Wang Y, Tong L, Hong M, Xia Q, Chen Z. Gene profiling of Toll-like receptor signalling pathways in neutrophils of patients with acute-on-chronic liver failure. J Transl Med 2021;19:465. [PMID: 34774066 DOI: 10.1186/s12967-021-03135-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
247 Lu Y, Wang G, Li C. Expression of peripheral monocytic programmed death ligand-1 in severe sepsis combined with HBV-related cirrhosis. A pilot observational study. Cent Eur J Immunol 2021;46:217-24. [PMID: 34764790 DOI: 10.5114/ceji.2021.108179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
248 Mataya LA, Srinivasan V, Rand EB, Alcamo AM. Multiple organ involvement and ICU considerations for the care of acute liver failure (ALF) and acute on chronic liver failure (ACLF) in children. Transl Pediatr 2021;10:2749-62. [PMID: 34765498 DOI: 10.21037/tp-20-375] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
249 Tinti F, Umbro I, D'Alessandro M, Lai S, Merli M, Noce A, Di Daniele N, Mazzaferro S, Mitterhofer AP. Cholemic Nephropathy as Cause of Acute and Chronic Kidney Disease. Update on an Under-Diagnosed Disease. Life (Basel) 2021;11:1200. [PMID: 34833076 DOI: 10.3390/life11111200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
250 Ocskay K, Tomescu D, Faltlhauser A, Jacob D, Friesecke S, Malbrain M, Kogelmann K, Bogdanski R, Bach F, Fritz H, Hartjes A, Kortgen A, Soukup J, Utzolino S, van Tellingen M, Träger K, Schumacher U, Brunkhorst FM, Molnar Z. Hemoadsorption in 'Liver Indication'-Analysis of 109 Patients' Data from the CytoSorb International Registry. J Clin Med 2021;10:5182. [PMID: 34768702 DOI: 10.3390/jcm10215182] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
251 Jiménez-Gutiérrez JM, García-Juárez I, Olivas-Martinez A, Ruiz I. One-year outcome of patients with cirrhosis who developed spontaneous bacterial empyema: A cohort study. J Dig Dis 2021. [PMID: 34738327 DOI: 10.1111/1751-2980.13066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
252 Xu M, Kong M, Yu P, Cao Y, Liu F, Zhu B, Zhang Y, Lu W, Zou H, You S, Xin S, Duan Z, Han T, Chen Y. Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis. Front Med (Lausanne) 2021;8:750061. [PMID: 34722587 DOI: 10.3389/fmed.2021.750061] [Reference Citation Analysis]
253 Otero Sanchez L, Karakike E, Njimi H, Putignano A, Degré D, Hites M, Jacobs F, Moreno C, Trepo E, Gustot T. Clinical Course and Risk Factors for Infection in Severe Forms of Alcohol-Associated Liver Disease. Hepatology 2021;74:2714-24. [PMID: 34046927 DOI: 10.1002/hep.31984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
254 Jacques ROC, Massignan LDS, Winkler MS, Balbinot RS, Balbinot SS, Soldera J. ACUTE-ON-CHRONIC LIVER FAILURE IS INDEPENDENTLY ASSOCIATED WITH LOWER SURVIVAL IN PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS. Arq Gastroenterol 2021;58:344-52. [PMID: 34705969 DOI: 10.1590/S0004-2803.202100000-58] [Reference Citation Analysis]
255 Bayramov NY, Ibrahimova AA. Modern concepts of hepatic insufficiency, their advantages and faults: views of a general surgeon and transplantologist. KH 2021;88:86-90. [DOI: 10.26779/2522-1396.2021.5-6.86] [Reference Citation Analysis]
256 Xu MM, Kong M, Yu PF, Cao YY, Liu F, Zhu B, Zhang YZ, Lu W, Zou HB, Duan BW, You SL, Xin SJ, Han T, Duan ZP, Chen Y. Clinical Course and Outcome Patterns of Acute-on-chronic Liver Failure: A Multicenter Retrospective Cohort Study. J Clin Transl Hepatol 2021;9:626-34. [PMID: 34722177 DOI: 10.14218/JCTH.2020.00179] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 Kim SE, Park JW, Kim HS, Jang MK, Suk KT, Kim DJ. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure. Int J Mol Sci 2021;22:11680. [PMID: 34769109 DOI: 10.3390/ijms222111680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 da Silveira F, Soares PHR, Marchesan LQ, da Fonseca RSA, Nedel WL. Assessing the prognosis of cirrhotic patients in the intensive care unit: What we know and what we need to know better. World J Hepatol 2021; 13(10): 1341-1350 [PMID: 34786170 DOI: 10.4254/wjh.v13.i10.1341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Islek A, Tumgor G. Acute-on-chronic liver failure in children. World J Hepatol 2021; 13(10): 1289-1298 [PMID: 34786166 DOI: 10.4254/wjh.v13.i10.1289] [Reference Citation Analysis]
260 Krutikov ES, Vostrikova AN, Krutikova MS. Hepatorenal syndrome: new insights about pathogenesis (part 1)). jour 2021;2:16-21. [DOI: 10.21886/2712-8156-2021-2-4-16-21] [Reference Citation Analysis]
261 Ventura-Cots M, Simón-Talero M, Poca M, Ariza X, Masnou H, Sanchez J, Llop E, Cañete N, Martín-Llahí M, Amador A, Martínez J, Clemente-Sanchez A, Puente A, Torrens M, Alvarado-Tapias E, Napoleone L, Miquel-Planas M, Ardèvol A, Casas Rodrigo M, Calleja JL, Solé C, Soriano G, Genescà J. Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis. J Clin Med 2021;10:4885. [PMID: 34768404 DOI: 10.3390/jcm10214885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
262 Li B, He Q, Rui Y, Chen Y, Jalan R, Chen J. Rapid detection for infected ascites in cirrhosis using metagenome next-generation sequencing: A case series. Liver Int 2021. [PMID: 34687275 DOI: 10.1111/liv.15083] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
263 Nababan SHH, Mansjoer A, Fauzi A, Gani RA. Predictive scoring systems for in-hospital mortality due to acutely decompensated liver cirrhosis in Indonesia. BMC Gastroenterol 2021;21:392. [PMID: 34670501 DOI: 10.1186/s12876-021-01972-6] [Reference Citation Analysis]
264 Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet 2021;398:1359-76. [PMID: 34543610 DOI: 10.1016/S0140-6736(21)01374-X] [Cited by in Crossref: 84] [Cited by in F6Publishing: 99] [Article Influence: 84.0] [Reference Citation Analysis]
265 Sundaram V, Jalan R. Waitlist Priority for Patients with Acute-on-Chronic Liver Failure: Not Just Horseplay. Liver Transpl 2021. [PMID: 34623745 DOI: 10.1002/lt.26330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
266 Costa E Silva PP, Codes L, Rios FF, Esteve CP, Valverde Filho MT, Lima DOC, de Almeida Filho GF, Morais MCA, Lima BC, Chagas PBO, Boa-Sorte N, Bittencourt PL. Comparison of General and Liver-Specific Prognostic Scores in Their Ability to Predict Mortality in Cirrhotic Patients Admitted to the Intensive Care Unit. Can J Gastroenterol Hepatol 2021;2021:9953106. [PMID: 34608435 DOI: 10.1155/2021/9953106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
267 Zaccherini G, Tufoni M, Bernardi M, Caraceni P. Prevention of Cirrhosis Complications: Looking for Potential Disease Modifying Agents. J Clin Med 2021;10:4590. [PMID: 34640608 DOI: 10.3390/jcm10194590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
268 Maruyama H, Shiina S. Connection between HPS and ACLF: a solution of chaos? Hepatol Int 2021;15:1049-52. [PMID: 34606063 DOI: 10.1007/s12072-021-10255-x] [Reference Citation Analysis]
269 Grensemann J, Pfaffendorf C, Wicha SG, König C, Roedl K, Jarczak D, Iwersen-Bergmann S, Manthey C, Kluge S, Fuhrmann V. Voriconazole Pharmacokinetics Are Not Altered in Critically Ill Patients with Acute-on-Chronic Liver Failure and Continuous Renal Replacement Therapy: An Observational Study. Microorganisms 2021;9:2087. [PMID: 34683408 DOI: 10.3390/microorganisms9102087] [Reference Citation Analysis]
270 Artzner T, Legeai C, Antoine C, Jasseron C, Michard B, Faitot F, Schneider F, Bachellier P; Collaborators. Liver transplantation for critically ill cirrhotic patients: results from the French transplant registry. Clin Res Hepatol Gastroenterol 2021;:101817. [PMID: 34607069 DOI: 10.1016/j.clinre.2021.101817] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
271 Baldassarre M, Naldi M, Zaccherini G, Bartoletti M, Antognoli A, Laggetta M, Gagliardi M, Tufoni M, Domenicali M, Waterstradt K, Paterini P, Baldan A, Leoni S, Bartolini M, Viale P, Trevisani F, Bernardi M, Caraceni P. Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications. Hepatology 2021;74:2058-73. [PMID: 33710623 DOI: 10.1002/hep.31798] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
272 Berry P, Theocharidou E, Kotha S. Clinical utility of prognostic scores and models in decompensated liver disease. Journal of Liver Transplantation 2021;4:100048. [DOI: 10.1016/j.liver.2021.100048] [Reference Citation Analysis]
273 Belli LS, Duvoux C, Cortesi PA, Facchetti R, Iacob S, Perricone G, Radenne S, Conti S, Patrono D, Berlakovich G, Hann A, Pasulo L, Castells L, Faitot F, Detry O, Invernizzi F, Magini G, De Simone P, Kounis I, Morelli MC, Díaz Fontenla F, Ericzon BG, Loinaz C, Johnston C, Gheorghe L, Lesurtel M, Romagnoli R, Kollmann D, Perera MTP, Fagiuoli S, Mirza D, Coilly A, Toso C, Zieniewicz K, Elkrief L, Karam V, Adam R, den Hoed C, Merli M, Puoti M, De Carlis L, Oniscu GC, Piano S, Angeli P, Fondevila C, Polak WG; for all the centres contributing to the ELITA-ELTR COVID-19 Registry. COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study. Gut 2021;70:1914-24. [PMID: 34281984 DOI: 10.1136/gutjnl-2021-324879] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
274 Noh BG, Lee N, Lee BC, Yoon M. Selected deceased donor liver transplantation in controlled Fournier’s gangrene: a case report. Korean J Transplant 2021;35:195-199. [DOI: 10.4285/kjt.21.0013] [Reference Citation Analysis]
275 Stockhoff L, Muellner-Bucsics T, Markova AA, Schultalbers M, Keimburg SA, Tergast TL, Hinrichs JB, Simon N, Gerbel S, Manns MP, Mandorfer M, Cornberg M, Meyer BC, Wedemeyer H, Reiberger T, Maasoumy B. Low Serum Cholinesterase Identifies Patients With Worse Outcome and Increased Mortality After TIPS. Hepatol Commun 2021. [PMID: 34585537 DOI: 10.1002/hep4.1829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Gambino C, Piano S, Angeli P. Acute-on-Chronic Liver Failure in Cirrhosis. J Clin Med 2021;10:4406. [PMID: 34640424 DOI: 10.3390/jcm10194406] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
277 Wong F, Reddy KR, Tandon P, Lai JC, Jagarlamudi N, Weir V, Kok B, Kalainy S, Srisengfa YT, Albhaisi S, Reuter B, Acharya C, Shaw J, Thacker LR, Bajaj JS. The Prediction of In-Hospital Mortality in Decompensated Cirrhosis with Acute-on-Chronic Liver Failure. Liver Transpl 2021. [PMID: 34564944 DOI: 10.1002/lt.26311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
278 El Sayed ML, Gouda TES, Khalil ELSAM, Al Arman MMES, Mohamed IE. Clinical profile and outcome among patients with acute-on-chronic liver failure admitted in the intensive care unit. Egypt J Intern Med 2021;33. [DOI: 10.1186/s43162-021-00061-0] [Reference Citation Analysis]
279 Diaz JM, Mauro E, Gutierrez-acevedo MN, Gadano A, Marciano S. Liver Transplantation in Patients with Acute-onChronic Liver Failure: Challenging the Limits. EMJ. [DOI: 10.33590/emj/21-00040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
280 Goosmann L, Buchholz A, Bangert K, Fuhrmann V, Kluge S, Lohse AW, Huber S, Fischer L, Sterneck M, Huebener P. Liver transplantation for acute-on-chronic liver failure predicts post-transplant mortality and impaired long-term quality of life. Liver Int 2021;41:574-84. [PMID: 34542228 DOI: 10.1111/liv.14756] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
281 Crespo G. Long-term outcomes after liver transplantation for ACLF - Don't forget quality of life! Liver Int 2021;41:430-1. [PMID: 34542226 DOI: 10.1111/liv.14789] [Reference Citation Analysis]
282 Skogsberg Dahlgren U, Herlenius G, Gustafsson B, Mölne J, Rydberg L, Socratous A, Bennet W. Excellent outcome following emergency deceased donor ABO-incompatible liver transplantation using rituximab and antigen specific immunoadsorption. Scand J Gastroenterol 2021;:1-10. [PMID: 34541993 DOI: 10.1080/00365521.2021.1976269] [Reference Citation Analysis]
283 Liu J, Li H, Xia J, Wang X, Huang Y, Li B, Meng Z, Gao Y, Qian Z, Liu F, Lu X, Liu J, Deng G, Zheng Y, Yan H, Qiao L, Xiang X, Zhang Q, Chen R, Chen J, Luo S, Gao, Ji L, Li J, Zhou X, Ren H, Lu S, Li S, Zhang W, Zheng X. Baseline Neutrophil-to-Lymphocyte Ratio Is Independently Associated With 90-Day Transplant-Free Mortality in Patients With Cirrhosis. Front Med (Lausanne) 2021;8:726950. [PMID: 34532334 DOI: 10.3389/fmed.2021.726950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
284 Khatua CR, Sahu SK, Meher D, Nath G, Mohapatra A, Thakur B, Singh SP. Admission Serum Urea is a Better Predictor of Mortality than Creatinine in Patients With Acute-On-Chronic Liver Failure and Acute Kidney Injury. J Clin Exp Hepatol 2021;11:565-72. [PMID: 34511817 DOI: 10.1016/j.jceh.2020.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
285 Yan K, Hung A, Parmer C, Yang H, Jain D, Lim B, Goodman AL, Garcia-Tsao G. Obeticholic Acid Decreases Intestinal Content of Enterococcus in Rats With Cirrhosis and Ascites. Hepatol Commun 2021;5:1507-17. [PMID: 34510838 DOI: 10.1002/hep4.1740] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
286 Singal AK, Wong RJ, Jalan R, Asrani S, Kuo YF. Primary biliary cholangitis has the highest waitlist mortality in patients with cirrhosis and acute on chronic liver failure awaiting liver transplant. Clin Transplant 2021;35:e14479. [PMID: 34510550 DOI: 10.1111/ctr.14479] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
287 Kalo E, Read S, Ahlenstiel G. Targeting Gut–Liver Axis for Treatment of Liver Fibrosis and Portal Hypertension. Livers 2021;1:147-79. [DOI: 10.3390/livers1030014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
288 Rui F, Yang H, Guo Z, Ge Z, Hu X, Zhang L, Xue Q, Chen H, Xu Y, Tan M, Qin C, He Z, Li J. Derivation and validation of prognostic models for predicting survival outcomes in Acute-on-chronic liver failure patients. J Viral Hepat 2021;28:1719-28. [PMID: 34496100 DOI: 10.1111/jvh.13611] [Reference Citation Analysis]
289 Kremer WM, Nagel M, Reuter M, Hilscher M, Michel M, Kaps L, Labenz J, Galle PR, Sprinzl MF, Wörns MA, Labenz C. Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis. Clin Transl Gastroenterol 2020;11:e00211. [PMID: 32764204 DOI: 10.14309/ctg.0000000000000211] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
290 Chang J, Meinke J, Geck M, Hebest M, Böhling N, Dolscheid-Pommerich R, Stoffel-Wagner B, Kristiansen G, Overhaus M, Peyman LO, Klein S, Uschner FE, Brol MJ, Vilz TO, Lingohr P, Kalff JC, Jansen C, Strassburg CP, Wehner S, Trebicka J, Praktiknjo M. Extrahepatic Surgery in Cirrhosis Significantly Increases Portal Pressure in Preclinical Animal Models. Front Physiol 2021;12:720898. [PMID: 34489738 DOI: 10.3389/fphys.2021.720898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
291 Limon-De La Rosa N, Cervantes-Alvarez E, Navarro-Alvarez N. Increased Hepatic Expression of SARS-CoV-2 Entry Points and Proinflammatory Cytokines in Cirrhosis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00933-2. [PMID: 34481957 DOI: 10.1016/j.cgh.2021.08.053] [Reference Citation Analysis]
292 Chen D, Qian Z, Su H, Meng Z, Lv J, Huang Y, Gao Y, Liu J, Zhao C, Gao H, Chen Y, Xia J, Peng L, Han T, Li H, Zheng X, Wang X, Lu X, Shi Y, Hu J, Chen J. Invasive Pulmonary Aspergillosis in Acute-on-Chronic Liver Failure Patients: Short-Term Outcomes and Antifungal Options. Infect Dis Ther 2021;10:2525-38. [PMID: 34468963 DOI: 10.1007/s40121-021-00524-5] [Reference Citation Analysis]
293 Caraceni P, Vargas V, Solà E, Alessandria C, de Wit K, Trebicka J, Angeli P, Mookerjee RP, Durand F, Pose E, Krag A, Bajaj JS, Beuers U, Ginès P; Liverhope Consortium. The Use of Rifaximin in Patients With Cirrhosis. Hepatology 2021;74:1660-73. [PMID: 33421158 DOI: 10.1002/hep.31708] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 27.0] [Reference Citation Analysis]
294 Zhang M, Xu X, Liu W, Zhang Z, Cheng Q, Yang Z, Liu T, Liu Y, Ning Q, Chen T, Qi J. Proton Pump Inhibitor Therapy Increases the Risk of Spontaneous Bacterial Peritonitis in Patients with HBV-Related Acute-on-Chronic Liver Failure. Adv Ther 2021;38:4675-94. [PMID: 34308513 DOI: 10.1007/s12325-021-01844-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
295 Jachs M, Hartl L, Schaufler D, Desbalmes C, Simbrunner B, Eigenbauer E, Bauer DJM, Paternostro R, Schwabl P, Scheiner B, Bucsics T, Stättermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes. Gut 2021;70:1758-67. [PMID: 33199442 DOI: 10.1136/gutjnl-2020-322712] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 26.0] [Reference Citation Analysis]
296 O’leary JG. ACLF and Liver Transplantation. Curr Treat Options Gastro 2021;19:473-482. [DOI: 10.1007/s11938-021-00354-x] [Reference Citation Analysis]
297 Tan HK, Teng MLP, Soh AYS, Cheo SHY, Fook-Chong S, Goh GBB, Tan CK, Wong GW, Lee GH, Chang JPE. Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites. Am J Gastroenterol 2021;116:1437-46. [PMID: 33834737 DOI: 10.14309/ajg.0000000000001176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
298 Zanetto A, Shalaby S, Gambato M, Germani G, Senzolo M, Bizzaro D, Russo FP, Burra P. New Indications for Liver Transplantation. J Clin Med 2021;10:3867. [PMID: 34501314 DOI: 10.3390/jcm10173867] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
299 Polyak A, Kuo A, Sundaram V. Evolution of liver transplant organ allocation policy: Current limitations and future directions. World J Hepatol 2021; 13(8): 830-839 [PMID: 34552690 DOI: 10.4254/wjh.v13.i8.830] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
300 Chris-Olaiya A, Kapoor A, Ricci KS, Lindenmeyer CC. Therapeutic plasma exchange in liver failure. World J Hepatol 2021; 13(8): 904-915 [PMID: 34552697 DOI: 10.4254/wjh.v13.i8.904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
301 Michard B, Artzner T, Deridder M, Besch C, Addeo P, Castelain V, Guillot M, Harlay ML, Herbrecht JE, Janssen Langenstein R, Schenck M, Bachellier P, Schneider F, Faitot F. Pretransplant Intensive Care Unit Management and Selection of Grade 3 Acute-on-Chronic Liver Failure Transplant Candidates. Liver Transpl 2022;28:17-26. [PMID: 34431204 DOI: 10.1002/lt.26280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
302 Pantea R, Meister P, Neuhaus JP, Nowak K, Paul A, Saner FH. [Surgery in patients with liver cirrhosis]. Chirurg 2021;92:838-45. [PMID: 33459796 DOI: 10.1007/s00104-020-01319-z] [Reference Citation Analysis]
303 Puchades Renau L, Herreras López J, Cebrià I Iranzo MÀ, Cezón Serrano N, Di Maira T, Berenguer M. Frailty and Sarcopenia in Acute-on-Chronic Liver Failure. Hepatol Commun 2021;5:1333-47. [PMID: 34430779 DOI: 10.1002/hep4.1722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
304 Hariri G, Urbina T, Lavillegrand JR, Gasperment M, Mazerand S, Abdelmalek A, Bigé N, Baudel JL, Guidet B, Maury E, Ait-Oufella H. Exaggerated Microvascular Vasodilating Responses in Cirrhotic Patients With Septic Shock. Crit Care Med 2021;49:e404-11. [PMID: 33591010 DOI: 10.1097/CCM.0000000000004846] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
305 Long L, Li H, Deng G, Wang X, Lu S, Li B, Meng Z, Gao Y, Qian Z, Liu F, Lu X, Ren H, Shang J, Li H, Wang S, Zheng Y, Yan H, Yin S, Tan W, Zhang Q, Zheng X, Chen J, Luo S, Zhao J, Yuan W, Li T, Zheng R, Liu J, Liu X, Gu W, Li S, Mei X, Chen R, Huang Y. Impact of Hepatic Encephalopathy on Clinical Characteristics and Adverse Outcomes in Prospective and Multicenter Cohorts of Patients With Acute-on-Chronic Liver Diseases. Front Med (Lausanne) 2021;8:709884. [PMID: 34409052 DOI: 10.3389/fmed.2021.709884] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
306 Goldberg DS, Bajaj JS. Acute-on-Chronic Liver Failure and Liver Transplantation: Putting the Cart Before the Horse in Data Analyses and Advocating for Model for End-Stage Liver Disease Exceptions. Liver Transpl 2021. [PMID: 34392608 DOI: 10.1002/lt.26267] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
307 Yu J, Shi X, Ma J, Chen R, Dong S, Lu S, Wu J, Yan C, Wu J, Zheng S, Li L, Xu X, Cao H. C-Reactive Protein Is an Independent Predictor of 30-Day Bacterial Infection Post-Liver Transplantation. Biomolecules 2021;11:1195. [PMID: 34439862 DOI: 10.3390/biom11081195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
308 Maccali C, Augustinho FC, Zocche TL, Silva TE, Narciso-Schiavon JL, Schiavon LL. NEUTROPHIL-LYMPHOCYTE RATIO PREDICTS SHORT-TERM MORTALITY IN PATIENTS HOSPITALIZED FOR ACUTE DECOMPENSATION OF CIRRHOSIS. Arq Gastroenterol 2021;58:131-8. [PMID: 34287528 DOI: 10.1590/S0004-2803.202100000-23] [Reference Citation Analysis]
309 El Ray A, Fouad R, ElMakhzangy H, El Beshlawy M, Moreau R, Sherbiny M. Characterizing a cohort of Egyptian patients with acute-on-chronic liver failure. Eur J Gastroenterol Hepatol 2021;33:1023-8. [PMID: 33905215 DOI: 10.1097/MEG.0000000000002165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
310 Su H, Tong J, Liu X, Li C, Chen J, Xu X, Guan C, Peng Y, Yan L, Ning P, Li H, Zhang L, Hu J. Characteristics and outcome of nosocomial bloodstream infection in patients with acute-on-chronic liver failure. Eur J Gastroenterol Hepatol 2021;33:83-8. [PMID: 32118849 DOI: 10.1097/MEG.0000000000001699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
311 Schacher FC, Martins Pezzi da Silva A, Silla LMDR, Álvares-da-Silva MR. Bone Marrow Mesenchymal Stem Cells in Acute-on-Chronic Liver Failure Grades 2 and 3: A Phase I-II Randomized Clinical Trial. Can J Gastroenterol Hepatol 2021;2021:3662776. [PMID: 34395335 DOI: 10.1155/2021/3662776] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
312 Clària J, Flores-Costa R, Duran-Güell M, López-Vicario C. Proresolving lipid mediators and liver disease. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:159023. [PMID: 34352389 DOI: 10.1016/j.bbalip.2021.159023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
313 Chen D, Wen S, Wu Z, Gu Y, Chen Y, Chen X, Zhang Y, Lin B, Peng L, Zheng Y, Gao Z. Association between effective hepatic blood flow and the severity and prognosis of hepatitis B virus-related acute on chronic liver failure. Eur J Gastroenterol Hepatol 2021;32:246-54. [PMID: 32282547 DOI: 10.1097/MEG.0000000000001721] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
314 Trovato FM, Zia R, Napoli S, Wolfer K, Huang X, Morgan PE, Husbyn H, Elgosbi M, Lucangeli M, Miquel R, Wilson I, Heaton ND, Heneghan MA, Auzinger G, Antoniades CG, Wendon JA, Patel VC, Coen M, Triantafyllou E, McPhail MJ. Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute-on-Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid-Dependent Monocyte Activation. Hepatology 2021;74:907-25. [PMID: 33908067 DOI: 10.1002/hep.31738] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
315 Jophlin L, Singal AK. Liver Biopsy in Patients With Alcohol-Associated Liver Disease With Acute-on-Chronic Liver Failure. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.08.009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
316 Jadaun SS, Sharma S, Madhusudhan KS, Sharma R, Nayak B, Kedia S, Singh V, Gunjan D, Acharya SK, Saraya A, Shalimar. Spectrum of Neuroimaging Abnormalities in Brain in Patients of Acute-on-Chronic Liver Failure. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.08.007] [Reference Citation Analysis]
317 Zhao X, Huang R, Wong P, Fiset P, Deschênes M. Renal tubular injury in hyperbilirubinemia: Bile cast nephropathy. CanLivJ 2021;4:332-7. [DOI: 10.3138/canlivj-2020-0031] [Reference Citation Analysis]
318 Biggins SW, Angeli P, Garcia-Tsao G, Ginès P, Ling SC, Nadim MK, Wong F, Kim WR. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1014-48. [PMID: 33942342 DOI: 10.1002/hep.31884] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 75.0] [Reference Citation Analysis]
319 Italian Association for the Study of the Liver (AISF). Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis 2021;53:1089-104. [PMID: 34321192 DOI: 10.1016/j.dld.2021.06.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
320 Sauerbruch T, Hennenberg M, Trebicka J, Beuers U. Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction. Front Physiol 2021;12:718783. [PMID: 34393832 DOI: 10.3389/fphys.2021.718783] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
321 Xiao L, Tang S, Zhang L, Ma S, Zhao Y, Zhang F, Xie Z, Li L. Serum CXCL1 Is a Prognostic Factor for Patients With Hepatitis B Virus-Related Acute-On-Chronic Liver Failure. Front Med (Lausanne) 2021;8:657076. [PMID: 34395462 DOI: 10.3389/fmed.2021.657076] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
322 Karvellas CJ, Francoz C, Weiss E. Liver Transplantation in Acute-on-chronic Liver Failure. Transplantation 2021;105:1471-81. [PMID: 33208692 DOI: 10.1097/TP.0000000000003550] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
323 Christidis G, Karatayli E, Hall RA, Weber SN, Reichert MC, Hohl M, Qiao S, Boehm U, Lütjohann D, Lammert F, Karatayli SC. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury. Int J Mol Sci 2021;22:7898. [PMID: 34360670 DOI: 10.3390/ijms22157898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
324 Atteberry P, Biederman B, Jesudian A, Lucero C, Brown RS Jr, Verna E, Sundaram V, Fortune B, Rosenblatt R. Mortality, sepsis, and organ failure in hospitalized patients with cirrhosis vary by type of infection. J Gastroenterol Hepatol 2021. [PMID: 34293211 DOI: 10.1111/jgh.15633] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
325 Cullaro G, Rubin JB, Fortune BE, Crawford CV, Verna EC, Hsu CY, Liu KD, Brown RS, Lai JC, Rosenblatt R. Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis. Dig Dis Sci 2021. [PMID: 34292470 DOI: 10.1007/s10620-021-07159-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
326 Sharma S, Agarwal S, Gunjan D, Kaushal K, Anand A, Gopi S, Mohta S, Saraya A. Outcomes of Portal Pressure-Guided Therapy in Decompensated Cirrhosis With Index Variceal Bleed in Asian Cohort. J Clin Exp Hepatol 2021;11:443-52. [PMID: 34276151 DOI: 10.1016/j.jceh.2020.11.001] [Reference Citation Analysis]
327 Weiss E, Saner F, Asrani SK, Biancofiore G, Blasi A, Lerut J, Durand F, Fernandez J, Findlay JY, Fondevila C, Francoz C, Gustot T, Jaber S, Karvellas C, Kronish K, Laleman W, Laterre PF, Levesque E, Mandell MS, Mc Phail M, Muiesan P, Olson JC, Olthoff K, Daniele Pinna A, Reiberger T, Reyntjens K, Saliba F, Scatton O, Simpson KJ, Soubrane O, Subramanian RM, Tacke F, Tomescu D, Xia V, Wagener G, Paugam-Burtz C. When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts. Transplantation 2021;105:561-8. [PMID: 32568955 DOI: 10.1097/TP.0000000000003364] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
328 Mahmud N, Goldberg DS, Bittermann T. Best Practices in Large Database Clinical Epidemiology Research in Hepatology: Barriers and Opportunities. Liver Transpl 2021. [PMID: 34265178 DOI: 10.1002/lt.26231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
329 Zhang Y, Huang C, Nie Y, Liu Q, Xiao N, Liu L, Zhu X. Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis. Front Med (Lausanne) 2021;8:698502. [PMID: 34336902 DOI: 10.3389/fmed.2021.698502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
330 Soffientini U, Beaton N, Baweja S, Weiss E, Bihari C, Habtesion A, Patel V, Paradis V, Sharma A, Luong TV, Hall A, Nadar A, Sarin S, Chokshi S, Williams R, Py B, Moreau R, Jalan R, Mehta G. The Lipopolysaccharide-Sensing Caspase(s)-4/11 Are Activated in Cirrhosis and Are Causally Associated With Progression to Multi-Organ Injury. Front Cell Dev Biol 2021;9:668459. [PMID: 34336828 DOI: 10.3389/fcell.2021.668459] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
331 Maiwall R, Sarin SK. Plasma Exchange in Acute and Acute on Chronic Liver Failure. Semin Liver Dis 2021. [PMID: 34261138 DOI: 10.1055/s-0041-1730971] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
332 Kwong A, Kim WR, Kwo PY, Wang U, Cheng X. Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome. Liver Transpl 2021;27:1095-105. [PMID: 33837624 DOI: 10.1002/lt.26065] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
333 Singal AK, Arsalan A, Dunn W, Arab JP, Wong RJ, Kuo YF, Kamath PS, Shah VH. Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics. Aliment Pharmacol Ther 2021;54:451-61. [PMID: 34247424 DOI: 10.1111/apt.16461] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
334 Xiao LL, Wu XX, Chen JJ, Yan D, Shi DY, Huang JR, Xu XW, Li LJ. Progress in hepatitis B virus-related acute-on-chronic liver failure treatment in China: A large, multicenter, retrospective cohort study using a propensity score matching analysis. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00119-3. [PMID: 34303609 DOI: 10.1016/j.hbpd.2021.05.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
335 Wu D, Zhang L, Ma S, Zhao Y, Chen R, Zhang F, Liu Q, Xu X, Xie Z. Low Growth Hormone Levels Predict Poor Outcome of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Front Med (Lausanne) 2021;8:655863. [PMID: 34295909 DOI: 10.3389/fmed.2021.655863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
336 Campello E, Zanetto A, Bulato C, Maggiolo S, Spiezia L, Russo FP, Gavasso S, Mazzeo P, Tormene D, Burra P, Angeli P, Senzolo M, Simioni P. Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. Liver Int 2021. [PMID: 34219335 DOI: 10.1111/liv.15001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
337 Fernández J, Piano S, Bartoletti M, Wey EQ. Management of bacterial and fungal infections in cirrhosis: The MDRO challenge. Journal of Hepatology 2021;75:S101-S117. [DOI: 10.1016/j.jhep.2020.11.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 22.0] [Reference Citation Analysis]
338 El-ghannam M, Abdelrahman Y, Abu-taleb H, Hassan M, Hassanien M, El-talkawy MD. Validation of Circom comorbidity score in critically-ill cirrhotic patients. Clinical Epidemiology and Global Health 2021;11:100728. [DOI: 10.1016/j.cegh.2021.100728] [Reference Citation Analysis]
339 Wackenthaler A, Molière S, Artzner T, Michard B, Schenck M, Addeo P, Besch C, Bachellier P, Schneider F, Veillon F, Faitot F. Pre-operative CT scan helps predict outcome after liver transplantation for acute-on-chronic grade 3 liver failure. Eur Radiol 2021. [PMID: 34173847 DOI: 10.1007/s00330-021-08131-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
340 Verma N, Dhiman RK, Singh V, Duseja A, Taneja S, Choudhury A, Sharma MK, Eapen CE, Devarbhavi H, Al Mahtab M, Shukla A, Hamid SS, Jafri W, Butt AS, Ning Q, Chen T, Tan SS, Lesmana LA, Lesmana CRA, Sahu MK, Hu J, Lee GH, Sood A, Midha V, Goyal O, Ghazinian H, Kim DJ, Treeprasertsuk S, Mohan Prasad VG, Dokmeci AK, Sollano JD, Shah S, Payawal DA, Rao PN, Kulkarni A, Lau GK, Duan Z, Chen Y, Yokosuka O, Abbas Z, Karim F, Chowdhury D, Prasad AS, Sarin SK; APASL ACLF Working Party. Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLF. Hepatol Int 2021;15:753-65. [PMID: 34173167 DOI: 10.1007/s12072-021-10175-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
341 Durand F, Roux O, Weiss E, Francoz C. Acute-on-chronic liver failure: Where do we stand? Liver Int 2021;41 Suppl 1:128-36. [PMID: 34155793 DOI: 10.1111/liv.14855] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
342 Herta T, Berg T. COVID-19 and the liver - Lessons learned. Liver Int. 2021;41 Suppl 1:1-8. [PMID: 34155789 DOI: 10.1111/liv.14854] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
343 Qiao L, Tan W, Wang X, Zheng X, Huang Y, Li B, Meng Z, Gao Y, Qian Z, Liu F, Lu X, Shang J, Liu J, Yan H, Gu W, Zhang Y, Xiang X, Hou Y, Zhang Q, Xiong Y, Zou C, Chen J, Huang Z, Jiang X, Luo S, Chen Y, Gao N, Liu C, Yuan W, Mei X, Li J, Li T, Zheng R, Zhou X, Chen J, Deng G, Zhang W, Li H. Different Effects of Total Bilirubin on 90-Day Mortality in Hospitalized Patients With Cirrhosis and Advanced Fibrosis: A Quantitative Analysis. Front Med (Lausanne) 2021;8:704452. [PMID: 34249983 DOI: 10.3389/fmed.2021.704452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
344 Xu X, Wang H, Zhao W, Wang Y, Wang J, Qin B. Recompensation factors for patients with decompensated cirrhosis: a multicentre retrospective case-control study. BMJ Open 2021;11:e043083. [PMID: 34162632 DOI: 10.1136/bmjopen-2020-043083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
345 Duseja A, De A, Taneja S, Choudhury AK, Devarbhavi H, Hu J, Hamid SS, Butt AS, Jafri SMW, Ghazinian H, Chawla YK, Dhiman RK, Duan Z, Chen Y, Tan SS, Lee GH, Lim SG, Kim DJ, Sahu M, Sollano JD, Carpio G, Mohan Prasad VG, Abbas Z, Lesmana LA, Lesmana CR, Eapen CE, Goel A, Sood A, Midha V, Goyal O, Dokmeci AK, Ning Q, Chen T, Ma K, Payawal DA, Lau GKK, Al Mahtab M, Rahman S, Alam MS, Shukla A, Shrestha A, Shah S, Kalal CR, Kumar G, Jain P, Paulson I, Sarin SK; APASL ACLF Working Party, APASL ACLF Research Consortium (AARC). Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure. Liver Int 2021;41:150-7. [PMID: 32970356 DOI: 10.1111/liv.14671] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
346 Godfrey E, Desai M, Lam F, Goss J, Rana A, Miloh T. Higher Waitlist Mortality in Pediatric Acute-on-chronic Liver Failure in the UNOS Database. J Pediatr Gastroenterol Nutr 2021;72:80-7. [PMID: 32796428 DOI: 10.1097/MPG.0000000000002891] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
347 Simbrunner B, Trauner M, Reiberger T, Mandorfer M. Recent advances in the understanding and management of hepatorenal syndrome. Fac Rev 2021;10:48. [PMID: 34131658 DOI: 10.12703/r/10-48] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
348 Chen JF, Weng WZ, Huang M, Peng XH, He JR, Zhang J, Xiong J, Zhang SQ, Cao HJ, Gao B, Lin DN, Gao J, Gao ZL, Lin BL. Derivation and Validation of a Nomogram for Predicting 90-Day Survival in Patients With HBV-Related Acute-on-Chronic Liver Failure. Front Med (Lausanne) 2021;8:692669. [PMID: 34222294 DOI: 10.3389/fmed.2021.692669] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
349 Chirapongsathorn S, Akkarachinores K, Chaiprasert A. Development and validation of prognostic model to predict mortality among cirrhotic patients with acute variceal bleeding: A retrospective study. JGH Open 2021;5:658-63. [PMID: 34124382 DOI: 10.1002/jgh3.12550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
350 Cotter TG, Sundaram V. Living Donor Liver Transplantation in Acute-on-Chronic Liver Failure: Encouraging Outcomes But With Important Caveats. Liver Transpl 2021;27:1532-4. [PMID: 34120409 DOI: 10.1002/lt.26208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
351 Zhang J, Li J, Chen Y, Ding M, Duan Z. Prognostic Factors Related to the Mortality Rate of Acute-on-Chronic Liver Failure Patients. Diabetes Metab Syndr Obes 2021;14:2573-80. [PMID: 34135609 DOI: 10.2147/DMSO.S309641] [Reference Citation Analysis]
352 Masnou H, Luna D, Castillo E, Galindo M, Ardèvol A, Clos A, Sarrias MR, Armengol C, Bargalló A, Morillas RM, Domènech E. Prevalence and outcomes of acute-on-chronic liver failure among cirrhotic patients admitted for an acute decompensation. Gastroenterol Hepatol 2021:S0210-5705(21)00190-4. [PMID: 34118317 DOI: 10.1016/j.gastrohep.2021.05.007] [Reference Citation Analysis]
353 Bertuzzo VR, Renzulli M, Clemente A, Cucchetti A, Maroni L, Frascaroli G, Pellegrini S, Dajti E, Spinelli D, Peta G, Maria Ierardi A, Carrafiello G, Strigari L, Colecchia A, Golfieri R, Pinna AD, Ravaioli M, Cescon M. Pre-transplant Psoas Muscle Density as a Ready-to-Use and Low-cost Predictor of Patient Survival After Liver Transplant. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.99690] [Reference Citation Analysis]
354 Schulz M, Diehl V, Trebicka J, Wygrecka M, Schaefer L. Biglycan: A regulator of hepatorenal inflammation and autophagy. Matrix Biology 2021;100-101:150-61. [DOI: 10.1016/j.matbio.2021.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
355 Morelli MC, Rendina M, La Manna G, Alessandria C, Pasulo L, Lenci I, Bhoori S, Messa P, Biancone L, Gesualdo L, Russo FP, Petta S, Burra P; Italian Association for the Study of Liver, and the Italian Society of Nephrology. Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN). Dig Liver Dis 2021;53 Suppl 2:S49-86. [PMID: 34074490 DOI: 10.1016/j.dld.2021.03.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
356 Mezzano G, Cárdenas A, Aguilar F, Pavesi M, Solé C, Napoleone L, Graupera I, Juanola A, Carol M, Pose E, Fabrellas N, Hernaez R, Martínez J, Saliba F, Arroyo V, Sola E, Gines P. Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF). Digestive and Liver Disease 2021;53:738-45. [DOI: 10.1016/j.dld.2020.12.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
357 Kano N, Want EJ, Mcphail MJW. Metabolomics in Advanced Liver Disease. Curr Treat Options Gastro 2021;19:380-397. [DOI: 10.1007/s11938-021-00347-w] [Reference Citation Analysis]
358 Baiges A, Bureau C, García-Pagán JC. Failure to control variceal bleeding: Definition matters. J Hepatol 2021;74:1491-2. [PMID: 33482274 DOI: 10.1016/j.jhep.2021.01.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
359 Xu X, Tan J, Wang H, Zhao W, Qin B. Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days. Front Med (Lausanne) 2021;8:646875. [PMID: 34136498 DOI: 10.3389/fmed.2021.646875] [Reference Citation Analysis]
360 Figueiredo LM, Rafael MA, Alexandrino G, Branco JC, Carvalho R, Costa MN, Martins A. Risk factors for the emergence of multidrug-resistant organisms in liver cirrhosis. Gastroenterol Hepatol 2021:S0210-5705(21)00163-1. [PMID: 34052400 DOI: 10.1016/j.gastrohep.2021.04.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
361 Arab JP, Arrese M, Singal AK. Diagnosis of Alcohol-Associated Hepatitis: When Is Liver Biopsy Required? Clin Liver Dis 2021;25:571-84. [PMID: 34229840 DOI: 10.1016/j.cld.2021.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
362 Balcar L, Semmler G, Pomej K, Simbrunner B, Bauer D, Hartl L, Jachs M, Paternostro R, Bucsics T, Pinter M, Trauner M, Mandorfer M, Reiberger T, Scheiner B. Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failure. United European Gastroenterol J 2021;9:427-37. [PMID: 34050619 DOI: 10.1002/ueg2.12089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
363 Rutledge SM, Im GY. Current and Future Biomarkers in Alcoholic Hepatitis. Clin Liver Dis 2021;25:493-516. [PMID: 34229836 DOI: 10.1016/j.cld.2021.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
364 Siramolpiwat S, Kerdsuknirun J, Tharavanij T. An impact of relative adrenal insufficiency on short-term outcomes in non-critically ill cirrhotic patients: A prospective cohort study. Int J Clin Pract 2021;75:e14362. [PMID: 33993598 DOI: 10.1111/ijcp.14362] [Reference Citation Analysis]
365 Yang YY, Hsu YC. Effectiveness of sepsis bundle application and outcomes predictors to cirrhotic patients with septic shock. BMC Infect Dis 2021;21:483. [PMID: 34039297 DOI: 10.1186/s12879-021-06194-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
366 Patidar KR, Peng JL, Pike F, Orman ES, Glick M, Kettler CD, Nephew LD, Desai AP, Nair K, Khan BA, Buckley CA, Machado RF, Chalasani NP, Ghabril MS. Associations Between Mean Arterial Pressure and Poor ICU Outcomes in Critically Ill Patients With Cirrhosis: Is 65 The Sweet Spot? Crit Care Med 2020;48:e753-60. [PMID: 32618694 DOI: 10.1097/CCM.0000000000004442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
367 Terres AZ, Balbinot RS, Muscope ALF, Eberhardt LZ, Balensiefer JIL, Cini BT, Rost GL, Longen ML, Schena B, Balbinot RA, Balbinot SS, Soldera J. Predicting mortality for cirrhotic patients with acute oesophageal variceal haemorrhage using liver‐specific scores. GastroHep 2021;3:236-46. [DOI: 10.1002/ygh2.460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
368 Vipani A, Lindenmeyer CC, Sundaram V. Treatment of Severe Acute on Chronic Liver Failure: Management of Organ Failures, Investigational Therapeutics, and the Role of Liver Transplantation. J Clin Gastroenterol 2021;55:667-76. [PMID: 34028394 DOI: 10.1097/MCG.0000000000001568] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
369 Wolter K, Praktiknjo M, Boie J, Decker G, Nadal J, Jansen C, Keller WIY, Meyer C, Trebicka J, Attenberger U, Thomas D. Glue Embolization of Gastroesophageal Varices during Transjugular Intrahepatic Portosystemic Shunt (TIPS) Improves Survival Compared to Coil-only Embolization-A Single-Center Retrospective Study. Cardiovasc Intervent Radiol 2021;44:1240-50. [PMID: 34021379 DOI: 10.1007/s00270-021-02852-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
370 Valantine B, Sundaray N, Mishra D, Sahu S, Narayan J, Panda BN, Singh A. Predictors of early mortality among patients with acute-on-chronic liver failure. JGH Open 2021;5:686-94. [PMID: 34124387 DOI: 10.1002/jgh3.12557] [Reference Citation Analysis]
371 Engelmann C, Martino VD, Kerbert AJC, Weil-Verhoeven D, Aehling NF, Herber A, Thévenot T, Berg T. The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure. Semin Liver Dis 2021;41:298-307. [PMID: 33992029 DOI: 10.1055/s-0041-1723034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
372 Kumar R, Mehta G, Jalan R. Acute-on-chronic liver failure. Clin Med (Lond). 2020;20:501-504. [PMID: 32934045 DOI: 10.7861/clinmed.2020-0631] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
373 Liu SY, Tsai IT, Hsu YC. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. Int J Mol Sci 2021;22:5170. [PMID: 34068269 DOI: 10.3390/ijms22105170] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
374 Pereira R, Buglevski M, Perdigoto R, Marcelino P, Saliba F, Blot S, Starkopf J. Intra-abdominal hypertension and abdominal compartment syndrome in the critically ill liver cirrhotic patient-prevalence and clinical outcomes. A multicentric retrospective cohort study in intensive care. PLoS One 2021;16:e0251498. [PMID: 33984016 DOI: 10.1371/journal.pone.0251498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
375 Wang YC, Yong CC, Lin CC, Alam H, Naseer F, Lin YH, Yeh CH, Wang SH, Lin TS, Lin TL, Lee WF, Chan YC, Wang CC, Chen CL. Excellent Outcome in Living Donor Liver Transplantation: Treating Patients With Acute-on-Chronic Liver Failure. Liver Transpl 2021. [PMID: 33977657 DOI: 10.1002/lt.26096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
376 Thongprayoon C, Kaewput W, Petnak T, O'Corragain OA, Boonpheng B, Bathini T, Vallabhajosyula S, Pattharanitima P, Lertjitbanjong P, Qureshi F, Cheungpasitporn W. Impact of Palliative Care Services on Treatment and Resource Utilization for Hepatorenal Syndrome in the United States. Medicines (Basel) 2021;8:21. [PMID: 34065828 DOI: 10.3390/medicines8050021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
377 Allegretti AS, Parada XV, Endres P, Zhao S, Krinsky S, St Hillien SA, Kalim S, Nigwekar SU, Flood JG, Nixon A, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Regner KR, Belcher JM, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT; HRS-HARMONY study investigators. Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study. Clin Transl Gastroenterol 2021;12:e00359. [PMID: 33979307 DOI: 10.14309/ctg.0000000000000359] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
378 Yazawa M, Shibagaki Y. III. Acute Kidney Injury and Multiple/Distant Organ Failure. J Jpn Soc Intern Med 2021;110:912-921. [DOI: 10.2169/naika.110.912] [Reference Citation Analysis]
379 Fan X, Fang J, Wu X, Poulsen K, Miyata T, Kim A, Yu L, Wang X, Zhang X, Zhang K, Han Q, Liu Z. Effect of HIV infection on pre- and post-liver transplant mortality in patients with organ failure. HIV Med 2021;22:662-73. [PMID: 33964108 DOI: 10.1111/hiv.13113] [Reference Citation Analysis]
380 Zipprich A, Ripoll C. [Cirrhosis]. Dtsch Med Wochenschr 2021;146:684-97. [PMID: 33957691 DOI: 10.1055/a-1218-9159] [Reference Citation Analysis]
381 Kuramitsu K, Yano Y, Komatsu S, Tanaka M, Kido M, Fukumoto T. Indication of Liver Transplantation in the Treatment of Newly Categorized Acute-on-Chronic Liver Failure In Japan. Transplant Proc 2021;53:1611-5. [PMID: 33965241 DOI: 10.1016/j.transproceed.2021.03.022] [Reference Citation Analysis]
382 Gambino C, Piano S. Identifying the four shades of acute decompensation of cirrhosis. United European Gastroenterol J 2021;9:421-2. [PMID: 33939291 DOI: 10.1002/ueg2.12074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
383 Queck A, Ferstl P, Bruns T, Trebicka J. Infektionen und Lebertransplantation. Gastroenterologe 2021;16:186-193. [DOI: 10.1007/s11377-021-00521-7] [Reference Citation Analysis]
384 Solé C, Ginès P. Reply. Gastroenterology 2021;160:2206. [PMID: 33484681 DOI: 10.1053/j.gastro.2021.01.204] [Reference Citation Analysis]
385 Bruns T, Trautwein C. Pathogenese und Progression der Leberzirrhose: aktuelle Perspektiven. Gastroenterologe 2021;16:137-148. [DOI: 10.1007/s11377-021-00517-3] [Reference Citation Analysis]
386 Sundaram V, Jalan R, Shah P, Singal AK, Patel AA, Wu T, Noureddin M, Mahmud N, Wong RJ. Acute on Chronic Liver Failure From Nonalcoholic Fatty Liver Disease: A Growing and Aging Cohort With Rising Mortality. Hepatology 2021;73:1932-44. [PMID: 32961608 DOI: 10.1002/hep.31566] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
387 Ji Y, Li L. Lower serum chloride concentrations are associated with increased risk of mortality in critically ill cirrhotic patients: an analysis of the MIMIC-III database. BMC Gastroenterol 2021;21:200. [PMID: 33933032 DOI: 10.1186/s12876-021-01797-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
388 Ferstl PG, Schulz M, Trebicka J. Akute Dekompensation und akut-auf-chronisches Leberversagen. Gastroenterologe 2021;16:179-185. [DOI: 10.1007/s11377-021-00520-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
389 Kluwe J, Zipprich A. Portale Hypertension und Varizen. Gastroenterologe 2021;16:149-159. [DOI: 10.1007/s11377-021-00516-4] [Reference Citation Analysis]
390 Weng F. Comment on 'Long-term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus-related decompensated cirrhosis'. J Viral Hepat 2021;28:1098. [PMID: 33876512 DOI: 10.1111/jvh.13515] [Reference Citation Analysis]
391 Mezzano G, Cárdenas A. Hyperkalemia in patients with cirrhosis and acute-on-chronic liver failure. Dig Liver Dis 2021;53:923. [PMID: 33903057 DOI: 10.1016/j.dld.2021.03.018] [Reference Citation Analysis]
392 Kim JE, Sinn DH, Choi GS, Kim JM, Joh JW, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure. Dig Liver Dis 2021;53:1004-10. [PMID: 33931340 DOI: 10.1016/j.dld.2021.03.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
393 Wong YJ, Kumar R, Chua YJJ, Ang TL. Long-term albumin infusion in decompensated cirrhosis: A review of current literature . World J Hepatol 2021; 13(4): 421-432 [PMID: 33959225 DOI: 10.4254/wjh.v13.i4.421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
394 Borgonovo A, Baldin C, Maggi DC, Victor L, Bansho ETO, Piedade J, Wildner LM, Guimarães L, Bazzo ML, Rocha T, Dantas-Corrêa EB, Alcântara C, Fernandes F, Narciso-Schiavon JL, Pereira GHS, Schiavon LL. Systemic Inflammatory Response Syndrome in Patients Hospitalized for Acute Decompensation of Cirrhosis. Can J Gastroenterol Hepatol 2021;2021:5581587. [PMID: 33987144 DOI: 10.1155/2021/5581587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 Samala N, Abdallah W, Poole A, Shamseddeen H, S Are V, S Orman E, Patidar KR, Vuppalanchi R. Insight into an acute hepatitis A outbreak in Indiana. J Viral Hepat 2021;28:964-71. [PMID: 33763937 DOI: 10.1111/jvh.13504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
396 Cardoso CC, Matiollo C, Pereira CHJ, Fonseca JS, Alves HEL, Silva OMD, Menegassi VS, Schiavon LL, Santos-Silva MC. B-cell compartment abnormalities are associated with ACLF and mortality in patients with liver cirrhosis. Clin Res Hepatol Gastroenterol 2021;45:101698. [PMID: 33852953 DOI: 10.1016/j.clinre.2021.101698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
397 Hilscher MB, Kamath PS. Predicting Outcomes and Use and Abuse of Prognostic Models. Liver Transplantation 2021. [DOI: 10.1002/9781119634010.ch2] [Reference Citation Analysis]
398 Yin J, Quan W, Kong X, Liu C, Lu B, Lin W. Utilizing a Solvatochromic Optical Agent to Monitor the Polarity Changes in Dynamic Liver Injury Progression. ACS Appl Bio Mater 2021;4:3630-8. [PMID: 35014449 DOI: 10.1021/acsabm.1c00130] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
399 Lucey MR. Overview on Organ Donation and Liver Transplantation. Liver Transplantation 2021. [DOI: 10.1002/9781119634010.ch1] [Reference Citation Analysis]
400 Perricone G, Jalan R. Assessment and Management of the Liver Transplant Candidate with Acute‐on‐Chronic Liver Failure. Liver Transplantation 2021. [DOI: 10.1002/9781119634010.ch12] [Reference Citation Analysis]
401 Nevens F, Gustot T, Laterre PF, Lasser LL, Haralampiev LE, Vargas V, Lyubomirova D, Albillos A, Najimi M, Michel S, Stoykov I, Gordillo N, Vainilovich Y, Barthel V, Clerget-Chossat N, Sokal EM. A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation. JHEP Rep 2021;3:100291. [PMID: 34169246 DOI: 10.1016/j.jhepr.2021.100291] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
402 Padia G, Mahajan B, Kumar A, Sonika U, Dahale AS, Sachdeva S, Dalal A, George R. Cystatin C and interleukin-6 for prognosticating patients with acute decompensation of cirrhosis. JGH Open 2021;5:459-64. [PMID: 33860096 DOI: 10.1002/jgh3.12516] [Reference Citation Analysis]
403 Adenote A, Dumic I, Madrid C, Barusya C, Nordstrom CW, Rueda Prada L. NAFLD and Infection, a Nuanced Relationship. Can J Gastroenterol Hepatol 2021;2021:5556354. [PMID: 33977096 DOI: 10.1155/2021/5556354] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
404 Mendizabal M, Ridruejo E, Piñero F, Anders M, Padilla M, Toro LG, Torre A, Montes P, Urzúa A, Gonzalez Ballerga E, Silveyra MD, Michelato D, Díaz J, Peralta M, Pages J, García SR, Gutierrez Lozano I, Macias Y, Cocozzella D, Chavez-Tapia N, Tagle M, Dominguez A, Varón A, Vera Pozo E, Higuera-de la Tijera F, Bustios C, Conte D, Escajadillo N, Gómez AJ, Tenorio L, Castillo Barradas M, Schinoni MI, Bessone F, Contreras F, Nazal L, Sanchez A, García M, Brutti J, Cabrera MC, Miranda-Zazueta G, Rojas G, Cattaneo M, Castro-Narro G, Rubinstein F, Silva MO. Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection. Ann Hepatol 2021;25:100350. [PMID: 33864948 DOI: 10.1016/j.aohep.2021.100350] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
405 Hoshi H, Chu PS, Yoshida A, Taniki N, Morikawa R, Yamataka K, Noguchi F, Kasuga R, Tabuchi T, Ebinuma H, Saito H, Kanai T, Nakamoto N. Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis. PLoS One 2021;16:e0250062. [PMID: 33848309 DOI: 10.1371/journal.pone.0250062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
406 Yao X, Yu H, Fan G, Xiang H, Long L, Xu H, Wu Z, Chen M, Xi W, Gao Z, Liu C, Gong W, Yang A, Sun K, Yu R, Liang J, Xie B, Sun S. Impact of the Gut Microbiome on the Progression of Hepatitis B Virus Related Acute-on-Chronic Liver Failure. Front Cell Infect Microbiol 2021;11:573923. [PMID: 33889550 DOI: 10.3389/fcimb.2021.573923] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
407 Shang J, Wang M, Wen Q, Ma Y, Chen F, Xu Y, Liu CH, Bai L, Tang H. A novel prognostic model to predict outcome of artificial liver support system treatment. Sci Rep 2021;11:7510. [PMID: 33820919 DOI: 10.1038/s41598-021-87055-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
408 Kaps L, Ahlbrand CJ, Gadban R, Nagel M, Labenz C, Klimpke P, Holtz S, Boedecker S, Michel M, Kremer WM, Hilscher M, Galle PR, Kraus D, Schattenberg JM, Weinmann-Menke J. Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care. PLoS One 2021;16:e0249342. [PMID: 33793644 DOI: 10.1371/journal.pone.0249342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
409 Singanayagam A, Triantafyllou E. Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting. Front Immunol 2021;12:661182. [PMID: 33868313 DOI: 10.3389/fimmu.2021.661182] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
410 Chen L, Zhang J, Lu T, Cai J, Zheng J, Yao J, Yi S, Li H, Chen G, Zhao H, Zhang Y, Yang Y. A nomogram to predict survival in patients with acute-on-chronic hepatitis B liver failure after liver transplantation. Ann Transl Med 2021;9:555. [PMID: 33987253 DOI: 10.21037/atm-20-6180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
411 Khan MU, Mushtaq K, Alkaabi SR. Acute-on-Chronic Liver Failure: Possibly the Main Culprit of Increased Mortality in COVID-19 Patients with Liver Disease. Gastroenterology 2021;160:1894-5. [PMID: 32682764 DOI: 10.1053/j.gastro.2020.06.094] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
412 Lv Y, Wang Z, Li K, Wang Q, Bai W, Yuan X, Yu T, Niu J, Yang Z, Zhu X, Zhao J, Xue H, Jiang Z, Zhuge Y, Zhang C, Sun J, Ding P, Ren W, Li Y, Zhang K, Zhang W, Guo W, Luo B, Li X, Yuan J, Han N, Zhu Y, He C, Yin Z, Fan D, Han G. Risk Stratification Based on Chronic Liver Failure Consortium Acute Decompensation Score in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding. Hepatology 2021;73:1478-93. [PMID: 32706906 DOI: 10.1002/hep.31478] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
413 Rhee H, Berenger B, Mehta RL, Macedo E. Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy With Calcium-Containing Solutions: A Cohort Study. Am J Kidney Dis 2021:S0272-6386(21)00504-7. [PMID: 33798636 DOI: 10.1053/j.ajkd.2021.01.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
414 Chang J, Bamarni A, Böhling N, Zhou X, Klein LM, Meinke J, Duerr GD, Lingohr P, Wehner S, Brol MJ, Rockstroh JK, Kalff JC, Manekeller S, Meyer C, Spengler U, Jansen C, Arroyo V, Strassburg CP, Trebicka J, Praktiknjo M. Elective Surgery but not Transjugular Intrahepatic Portosystemic Shunt Precipitates Acute-On-Chronic Liver Failure. Hepatol Commun 2021;5:1265-77. [PMID: 34278174 DOI: 10.1002/hep4.1712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
415 Tornai D, Vitalis Z, Jonas A, Janka T, Foldi I, Tornai T, Sipeki N, Csillag A, Balogh B, Sumegi A, Foldesi R, Papp M, Antal-Szalmas P. Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality. Clin Res Hepatol Gastroenterol 2021;45:101579. [PMID: 33773436 DOI: 10.1016/j.clinre.2020.11.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
416 Terres AZ, Balbinot RS, Muscope ALF, Longen ML, Schena B, Cini BT, Luis Rost G Jr, Balensiefer JIL, Eberhardt LZ, Balbinot RA, Balbinot SS, Soldera J. Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortality. Gastroenterol Hepatol 2021:S0210-5705(21)00086-8. [PMID: 33746028 DOI: 10.1016/j.gastrohep.2021.02.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
417 Trebicka J, Sundaram V, Moreau R, Jalan R, Arroyo V. Liver Transplantation for Acute-on-Chronic Liver Failure: Science or Fiction? Liver Transpl. 2020;26:906-915. [PMID: 32365422 DOI: 10.1002/lt.25788] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 25.0] [Reference Citation Analysis]
418 Cardoso CC, Matiollo C, Pereira CHJ, Fonseca JS, Alves HEL, da Silva OM, de Souza Menegassi V, Dos Santos CR, de Moraes ACR, de Lucca Schiavon L, Santos-Silva MC. Patterns of dendritic cell and monocyte subsets are associated with disease severity and mortality in liver cirrhosis patients. Sci Rep 2021;11:5923. [PMID: 33723292 DOI: 10.1038/s41598-021-85148-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
419 Reichert MC, Schneider C, Greinert R, Casper M, Grünhage F, Wienke A, Zipprich A, Lammert F, Ripoll C. Isolated bacterial infection without decompensation has no impact on survival of compensated patients with cirrhosis. Liver Int 2021;41:1370-8. [PMID: 33641234 DOI: 10.1111/liv.14842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
420 Ge J, Najafi N, Zhao W, Somsouk M, Fang M, Lai JC. A Methodology to Generate Longitudinally Updated Acute-On-Chronic Liver Failure Prognostication Scores From Electronic Health Record Data. Hepatol Commun 2021;5:1069-80. [PMID: 34141990 DOI: 10.1002/hep4.1690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
421 Li B, Yang C, Qian Z, Huang Y, Wang X, Zhong G, Chen J. Spontaneous Fungal Ascites Infection in Patients with Cirrhosis: An Analysis of 10 Cases. Infect Dis Ther 2021;10:1033-43. [PMID: 33709385 DOI: 10.1007/s40121-021-00422-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
422 Juanola A, Solé C, Toapanta D, Ginès P, Solà E. Monitoring Renal Function and Therapy of Hepatorenal Syndrome Patients with Cirrhosis. Clin Liver Dis 2021;25:441-60. [PMID: 33838860 DOI: 10.1016/j.cld.2021.01.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
423 Borzio M, Dionigi E. Acute on Chronic Liver Failure: Role of the Bacterial Infections. Liver Pathology 2021. [DOI: 10.5772/intechopen.93440] [Reference Citation Analysis]
424 Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, Barnes E. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol 2021;18:348-64. [PMID: 33692570 DOI: 10.1038/s41575-021-00426-4] [Cited by in Crossref: 127] [Cited by in F6Publishing: 142] [Article Influence: 127.0] [Reference Citation Analysis]
425 Ferstl P, Trebicka J. Acute Decompensation and Acute-on-Chronic Liver Failure. Clin Liver Dis 2021;25:419-30. [PMID: 33838858 DOI: 10.1016/j.cld.2021.01.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
426 Piano S, Angeli P. Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation? Clin Liver Dis 2021;25:357-72. [PMID: 33838855 DOI: 10.1016/j.cld.2021.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
427 Manning C, Elzubeir A, Alam S. The role of pre-emptive Transjugular Intrahepatic Portosystemic Shunt in acute variceal bleeding: a literature review. Ther Adv Chronic Dis 2021;12:2040622321995771. [PMID: 33747427 DOI: 10.1177/2040622321995771] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
428 Samuel D. Systemic inflammation and liver cirrhosis complications: Driving or secondary event? How to square the circle? J Hepatol 2021;74:508-10. [PMID: 33478857 DOI: 10.1016/j.jhep.2021.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
429 Chiriac S, Stanciu C, Singeap AM, Sfarti CV, Cuciureanu T, Trifan A. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhotic patients with acute-on-chronic liver failure. Turk J Gastroenterol 2020;31:868-76. [PMID: 33625999 DOI: 10.5152/tjg.2020.19838] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
430 Maiwall R, Bajpai M, Choudhury AK, Kumar A, Sharma MK, Duan Z, Yu C, Hu J, Ghazinian H, Ning Q, Ma K, Lee GH, Lim SG, Shah S, Kalal C, Dokmeci A, Kumar G, Jain P, Rao Pasupuleti SS, Paulson I, Kumar V, Sarin SK; AARC working Party. Therapeutic plasma-exchange improves systemic inflammation and survival in acute-on-chronic liver failure: A propensity-score matched study from AARC. Liver Int 2021;41:1083-96. [PMID: 33529450 DOI: 10.1111/liv.14806] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
431 Maiwall R, Pasupuleti SSR, Chandel SS, Narayan A, Jain P, Mitra LG, Kumar G, Moreau R, Sarin SK. Co-orchestration of acute kidney injury and non-kidney organ failures in critically ill patients with cirrhosis. Liver Int 2021;41:1358-69. [PMID: 33534915 DOI: 10.1111/liv.14809] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
432 Premkumar M, Mehtani R, Divyaveer S, Kajal K, Kulkarni AV, Ahmed S, Kaur H, Kaur H, Dhiman R, Duseja A, De A. Clinical Validation of Global Coagulation Tests to Guide Blood Component Transfusions in Cirrhosis and ACLF. J Clin Transl Hepatol 2021;9:210-9. [PMID: 34007803 DOI: 10.14218/JCTH.2020.00121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
433 Shah S, Goldberg DS. Acute-on-chronic liver failure: update on pathogenesis, therapeutic targets, predictive models, and liver transplantation. Curr Opin Gastroenterol 2021;37:173-8. [PMID: 33606401 DOI: 10.1097/MOG.0000000000000722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
434 Triantafyllou E, Gudd CL, Mawhin MA, Husbyn HC, Trovato FM, Siggins MK, O'Connor T, Kudo H, Mukherjee SK, Wendon JA, Bernsmeier C, Goldin RD, Botto M, Khamri W, McPhail MJ, Possamai LA, Woollard KJ, Antoniades CG, Thursz MR. PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury. J Clin Invest 2021;131:140196. [PMID: 33320839 DOI: 10.1172/JCI140196] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]
435 Chen X, Zhao Y, Chen W, Shao X, Huang Z, Granito A. Lactate and Bilirubin Index: A New Indicator to Predict Critically Ill Cirrhotic Patients’ Prognosis. Canadian Journal of Gastroenterology and Hepatology 2021;2021:1-7. [DOI: 10.1155/2021/6624177] [Reference Citation Analysis]
436 Khatua CR, Sahu SK, Meher D, Nath G, Singh SP. Acute kidney injury in hospitalized cirrhotic patients: Risk factors, type of kidney injury, and survival. JGH Open 2021;5:199-206. [PMID: 33553656 DOI: 10.1002/jgh3.12467] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
437 Banc-Husu AM, Neighbors K, Rychlik K, Mohammad S, Harris ZL, Alonso EM. Admission Characteristics Identify Risk of Pediatric Acute-on-Chronic Liver Failure. J Pediatr Gastroenterol Nutr 2020;70:783-8. [PMID: 32141996 DOI: 10.1097/MPG.0000000000002695] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
438 Logre E, Bert F, Khoy-Ear L, Janny S, Giabicani M, Grigoresco B, Toussaint A, Dondero F, Dokmak S, Roux O, Francoz C, Soubrane O, Durand F, Paugam-Burtz C, Weiss E. Risk Factors and Impact of Perioperative Prophylaxis on the Risk of Extended-spectrum β-Lactamase-producing Enterobacteriaceae-related Infection Among Carriers Following Liver Transplantation. Transplantation 2021;105:338-45. [PMID: 32217945 DOI: 10.1097/TP.0000000000003231] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
439 Alukal JJ, Zhang T, Thuluvath PJ. Outcomes of status 1 liver transplantation for Budd-Chiari Syndrome with fulminant hepatic failure. Am J Transplant. 2020;. [PMID: 33236517 DOI: 10.1111/ajt.16410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
440 Weiss E, de la Grange P, Defaye M, Lozano JJ, Aguilar F, Hegde P, Jolly A, Moga L, Sukriti S, Agarwal B, Gurm H, Tanguy M, Poisson J, Clària J, Abback PS, Périanin A, Mehta G, Jalan R, Francoz C, Rautou PE, Lotersztajn S, Arroyo V, Durand F, Moreau R. Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF. Front Immunol 2020;11:619039. [PMID: 33613548 DOI: 10.3389/fimmu.2020.619039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
441 Barbuti RC, Schiavon LL, Oliveira CP, Alvares-DA-Silva MR, Sassaki LY, Passos MDCF, Farias AQ, Barros LL, Barreto BP, Albuquerque GBML, Alves AM, Navarro-Rodriguez T, Bittencourt PL. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG). Arq Gastroenterol 2020;57:381-98. [PMID: 33331485 DOI: 10.1590/S0004-2803.202000000-72] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
442 Wong F, Boyer TD, Sanyal AJ, Pappas SC, Escalante S, Jamil K. Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome. Nephrol Dial Transplant. 2020;35:1554-1561. [PMID: 30887050 DOI: 10.1093/ndt/gfz048] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
443 Monteiro S, Grandt J, Uschner FE, Kimer N, Madsen JL, Schierwagen R, Klein S, Welsch C, Schäfer L, Jansen C, Claria J, Alcaraz-Quiles J, Arroyo V, Moreau R, Fernandez J, Bendtsen F, Mehta G, Gluud LL, Møller S, Praktiknjo M, Trebicka J. Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation. Gut 2021;70:379-87. [PMID: 32241903 DOI: 10.1136/gutjnl-2019-320170] [Cited by in Crossref: 26] [Cited by in F6Publishing: 34] [Article Influence: 26.0] [Reference Citation Analysis]
444 Kuo CC, Huang CH, Chang C, Chen PC, Chen BH, Chen WT, Ho YP. Comparing CLIF-C ACLF, CLIF-C ACLFlactate, and CLIF-C ACLF-D Prognostic Scores in Acute-on-Chronic Liver Failure Patients by a Single-Center ICU Experience. J Pers Med 2021;11:79. [PMID: 33572927 DOI: 10.3390/jpm11020079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
445 Piano S, Tonon M, Angeli P. Changes in the epidemiology and management of bacterial infections in cirrhosis. Clin Mol Hepatol 2021;27:437-45. [PMID: 33504138 DOI: 10.3350/cmh.2020.0329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
446 Kulkarni AV, Anand L, Vyas AK, Premkumar M, Choudhury AK, Trehanpati N, Benjamin J, Kumar G, Joshi YK, Sarin SK. Omega-3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute-on-chronic liver failure: An open-label randomized controlled trial. J Gastroenterol Hepatol 2021;36:1953-61. [PMID: 33450081 DOI: 10.1111/jgh.15400] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
447 Rueschenbaum S, Ciesek S, Queck A, Widera M, Schwarzkopf K, Brüne B, Welsch C, Wedemeyer H, Zeuzem S, Weigert A, Lange CM. Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver Failure. Front Immunol 2020;11:534731. [PMID: 33574809 DOI: 10.3389/fimmu.2020.534731] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
448 Yu Z, Zhang Y, Cao Y, Xu M, You S, Chen Y, Zhu B, Kong M, Song F, Xin S, Duan Z, Han T. A dynamic prediction model for prognosis of acute-on-chronic liver failure based on the trend of clinical indicators. Sci Rep 2021;11:1810. [PMID: 33469110 DOI: 10.1038/s41598-021-81431-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
449 Blaya D, Pose E, Coll M, Lozano JJ, Graupera I, Schierwagen R, Jansen C, Castro P, Fernandez S, Sidorova J, Vasa-Nicotera M, Solà E, Caballería J, Trebicka J, Ginès P, Sancho-Bru P. Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure. JHEP Rep 2021;3:100233. [PMID: 33665588 DOI: 10.1016/j.jhepr.2021.100233] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
450 Morais Rateke EC, Matiollo C, de Andrade Moura EQ, Andrigueti M, Maccali C, Fonseca JS, Canova SMF, Narciso-Schiavon JL, Schiavon LL. Low sodium to potassium ratio in spot urine sample is associated with progression to acute kidney injury and mortality in hospitalized patients with cirrhosis. Dig Liver Dis 2021;53:1159-66. [PMID: 33446446 DOI: 10.1016/j.dld.2020.12.117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
451 Rueschenbaum S, Cai C, Schmidt M, Schwarzkopf K, Dittmer U, Zeuzem S, Welsch C, Lange CM. Translation of IRF-1 Restricts Hepatic Interleukin-7 Production to Types I and II Interferons: Implications for Hepatic Immunity. Front Immunol 2020;11:581352. [PMID: 33584648 DOI: 10.3389/fimmu.2020.581352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
452 Du L, Ma Y, Zhou S, Chen F, Xu Y, Wang M, Lei X, Feng P, Tang H, Bai L. A prognostic score for patients with acute-on-chronic liver failure treated with plasma exchange-centered artificial liver support system. Sci Rep 2021;11:1469. [PMID: 33446902 DOI: 10.1038/s41598-021-81019-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
453 Caputo F, Testino G. Orthotopic liver transplantation for patients with end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis. Minerva Surg 2021;76:444-9. [PMID: 33433074 DOI: 10.23736/S2724-5691.20.08685-X] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
454 Zhang J, Luo H, Han Y, Zhou X. Sequential versus mono double plasma molecular adsorption system in acute-on-chronic liver failures: A propensity-score matched study. Int J Artif Organs 2021;:391398820987565. [PMID: 33435806 DOI: 10.1177/0391398820987565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
455 Duah A, Agyei-Nkansah A, Osei-Poku F, Duah F, Ampofo-Boobi D, Peprah B. The Prevalence, Predictors, and In-Hospital Mortality of Hepatic Encephalopathy in Patients with Liver Cirrhosis Admitted at St. Dominic Hospital in Akwatia, Ghana. Can J Gastroenterol Hepatol 2020;2020:8816522. [PMID: 33425806 DOI: 10.1155/2020/8816522] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
456 Campello E, Zanetto A, Radu CM, Bulato C, Truma A, Spiezia L, Senzolo M, Garcia-Tsao G, Simioni P. Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis. Dig Liver Dis 2021;53:879-88. [PMID: 33431230 DOI: 10.1016/j.dld.2020.12.118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
457 Qiao L, Wang X, Deng G, Huang Y, Chen J, Meng Z, Zheng X, Shi Y, Qian Z, Liu F, Gao Y, Lu X, Liu J, Gu W, Zhang Y, Wang T, Wu D, Dong F, Sun X, Li H. Cohort profile: a multicentre prospective validation cohort of the Chinese Acute-on-Chronic Liver Failure (CATCH-LIFE) study. BMJ Open 2021;11:e037793. [PMID: 33419900 DOI: 10.1136/bmjopen-2020-037793] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
458 Liu LX, Zhang Y, Nie Y, Zhu X. Assessing the Prediction Effect of Various Prognosis Model for 28-Day Mortality in Acute-on-Chronic Liver Failure Patients. Risk Manag Healthc Policy 2020;13:3155-63. [PMID: 33402854 DOI: 10.2147/RMHP.S281999] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
459 Kim JE, Chun S, Sinn DH, Kim NJ, Kim S, Kang W, Kim JM, Choi GS, Joh JW, Cho D. Initial experience with high-volume plasma exchange in patients with acute liver failure. J Clin Apher. 2021;36:379-389. [PMID: 33400840 DOI: 10.1002/jca.21873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
460 Nie Y, Liu LX, Chen T, Zhang Y, Zhu X. Serum lactate level predicts 6-months mortality in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective study. Epidemiol Infect 2021;149:e26. [PMID: 33397544 DOI: 10.1017/S0950268820003143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
461 Cao Z, Liu Y, Cai M, Xu Y, Xiang X, Zhao G, Cai W, Wang H, Wang W, Xie Q. The Use of NACSELD and EASL-CLIF Classification Systems of ACLF in the Prediction of Prognosis in Hospitalized Patients With Cirrhosis. Am J Gastroenterol 2020;115:2026-35. [PMID: 32858565 DOI: 10.14309/ajg.0000000000000771] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
462 Baldin C, Piedade J, Guimarães L, Victor L, Duarte J, Veiga Z, Alcântara C, Fernandes F, Pereira JL, Pereira G. CLIF-C AD Score Predicts Development of Acute Decompensations and Survival in Hospitalized Cirrhotic Patients. Dig Dis Sci 2021. [PMID: 33389350 DOI: 10.1007/s10620-020-06791-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
463 Petrushenko VV, Grebeniuk DI, Gladkykh VY. EFFICACY OF A PROLONGED PHOSPHATIDYLCHOLINE REGIMEN IN PATIENTS WITH ESOPHAGEAL AND GASTRIC VARICEAL BLEEDING. VPBM 2021;2:119. [DOI: 10.29254/2077-4214-2021-2-160-119-122] [Reference Citation Analysis]
464 Delgado Ayala F, Ceballos Vázquez Tagle BG, Curiel Rivas JA, Díaz Greene EJ, Rodríguez Weber FL. Insuficiencia hepática aguda sobre crónica. Acta Médica Grupo Ángeles 2021;19:524-534. [DOI: 10.35366/102540] [Reference Citation Analysis]
465 Clariot S, Bensahli SB, Levesque E. Acute-on-Chronic Liver Failure en réanimation. Anesthésie & Réanimation 2021;7:8-14. [DOI: 10.1016/j.anrea.2020.11.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
466 Chartier M, Alvarez F. Acute-on-Chronic Liver Failure. Liver Diseases in the Pediatric Intensive Care Unit 2021. [DOI: 10.1007/978-3-030-79132-2_3] [Reference Citation Analysis]
467 Solà E, Pose E, Campion D, Piano S, Roux O, Simon-Talero M, Uschner F, de Wit K, Zaccherini G, Alessandria C, Beuers U, Caraceni P, Francoz C, Mookerjee RP, Trebicka J, Vargas V, Serra M, Torres F, Montagnese S, Krag A, Hernaez R, Korenjak M, Watson H, Abraldes JG, Kamath PS, Ginès P; LiverHope Consortium Investigators. Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. J Hepatol 2021;74:200-19. [PMID: 32896580 DOI: 10.1016/j.jhep.2020.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
468 Roy J. Liver Failure and the Kidneys. Liver Diseases in the Pediatric Intensive Care Unit 2021. [DOI: 10.1007/978-3-030-79132-2_5] [Reference Citation Analysis]
469 Liu H, Li Y, Gao F, Meng P, Yu H, Wu T, Zhou Y, Jiang Y, Wang X. Serum Clusterin: A Potential Marker for Assessing the Clinical Severity and Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Dis Markers 2020;2020:8814841. [PMID: 33381244 DOI: 10.1155/2020/8814841] [Reference Citation Analysis]
470 Solé C, Guilly S, Da Silva K, Llopis M, Le-Chatelier E, Huelin P, Carol M, Moreira R, Fabrellas N, De Prada G, Napoleone L, Graupera I, Pose E, Juanola A, Borruel N, Berland M, Toapanta D, Casellas F, Guarner F, Doré J, Solà E, Ehrlich SD, Ginès P. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis. Gastroenterology 2021;160:206-218.e13. [PMID: 32941879 DOI: 10.1053/j.gastro.2020.08.054] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 48.0] [Reference Citation Analysis]
471 Wu D, Zhang S, Xie Z, Chen E, Rao Q, Liu X, Huang K, Yang J, Xiao L, Ji F, Jiang Z, Zhao Y, Ouyang X, Zhu D, Dai X, Hou Z, Liu B, Deng B, Zhou N, Gao H, Sun Z, Li L. Plasminogen as a prognostic biomarker for HBV-related acute-on-chronic liver failure. J Clin Invest 2020;130:2069-80. [PMID: 32175919 DOI: 10.1172/JCI130197] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
472 Passi NN, Mcphail MJ. The patient with cirrhosis in the intensive care unit and the management of acute-on-chronic liver failure. Journal of the Intensive Care Society 2022;23:78-86. [DOI: 10.1177/1751143720978849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
473 Hsu YC, Yang YY, Tsai IT. Lymphocyte-to-monocyte ratio predicts mortality in cirrhotic patients with septic shock. Am J Emerg Med 2021;40:70-6. [PMID: 33348227 DOI: 10.1016/j.ajem.2020.11.071] [Reference Citation Analysis]
474 Wirtz TH, Reuken PA, Jansen C, Fischer P, Bergmann I, Backhaus C, Emontzpohl C, Reißing J, Brandt EF, Koenen MT, Schneider KM, Schierwagen R, Brol MJ, Chang J, Zimmermann HW, Köse-Vogel N, Eggermann T, Kurth I, Stoppe C, Bucala R, Bernhagen J, Praktiknjo M, Stallmach A, Trautwein C, Trebicka J, Bruns T, Berres ML. Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis. JHEP Rep 2021;3:100221. [PMID: 33659891 DOI: 10.1016/j.jhepr.2020.100221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
475 Hietanen S, Herajärvi J, Lehtonen A, Lahtinen S, Liisanantti J. Treatment profile and long-term outcome of intensive care unit-admitted patients with liver cirrhosis or other liver disease in relation to alcohol consumption. Scand J Gastroenterol 2021;56:180-7. [PMID: 33332198 DOI: 10.1080/00365521.2020.1861646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
476 Shi H, Xiao G, Liao M, Zheng L, Jie Y, Lin G, Chong Y. Inappropriate cessation of nucleos(t)ide analog associated with reduced liver transplant-free survival in patients with HBV-related acute on chronic liver failure. Biomed Pharmacother 2021;134:111118. [PMID: 33341047 DOI: 10.1016/j.biopha.2020.111118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
477 Kumar U, Sharma S, Durgappa M, Gupta N, Raj R, Kumar A, Sharma PN, Krishna VP, Kumar RV, Guleria A, Saraswat VA, Pande G, Kumar D. Serum Metabolic Disturbances Associated with Acute-on-chronic Liver Failure in Patients with Underlying Alcoholic Liver Diseases: An Elaborative NMR-based Metabolomics Study. J Pharm Bioallied Sci 2021;13:276-82. [PMID: 34349490 DOI: 10.4103/JPBS.JPBS_333_20] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
478 Zanetto A, Rinder HM, Senzolo M, Simioni P, Garcia-Tsao G. Reduced Clot Stability by Thromboelastography as a Potential Indicator of Procedure-Related Bleeding in Decompensated Cirrhosis. Hepatol Commun 2021;5:272-82. [PMID: 33553974 DOI: 10.1002/hep4.1641] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
479 Casulleras M, Zhang IW, López-Vicario C, Clària J. Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure. Cells 2020;9:E2632. [PMID: 33302342 DOI: 10.3390/cells9122632] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
480 Li Q, Wang J, Lu M, Qiu Y, Lu H. Acute-on-Chronic Liver Failure From Chronic-Hepatitis-B, Who Is the Behind Scenes. Front Microbiol 2020;11:583423. [PMID: 33365018 DOI: 10.3389/fmicb.2020.583423] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
481 Yoon KT, Liu H, Lee SS. β-blockers in advanced cirrhosis: More friend than enemy. Clin Mol Hepatol 2021;27:425-36. [PMID: 33317244 DOI: 10.3350/cmh.2020.0234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
482 Sun F, Tan W, Dan Y, Wang X, Guo Y, Deng G. Copy number gain of pro-inflammatory genes in patients with HBV-related acute-on-chronic liver failure. BMC Med Genomics 2020;13:180. [PMID: 33261607 DOI: 10.1186/s12920-020-00835-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
483 Trebicka J, Bork P, Krag A, Arumugam M. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure. Nat Rev Gastroenterol Hepatol 2021;18:167-80. [PMID: 33257833 DOI: 10.1038/s41575-020-00376-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 21.0] [Reference Citation Analysis]
484 Lisman T, Arefaine B, Adelmeijer J, Zamalloa A, Corcoran E, Smith JG, Bernal W, Patel VC. Global hemostatic status in patients with acute-on-chronic liver failure and septics without underlying liver disease. J Thromb Haemost 2021;19:85-95. [PMID: 33006808 DOI: 10.1111/jth.15112] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
485 Ge J, Najafi N, Zhao W, Somsouk M, Fang M, Lai JC. A methodology to generate longitudinally updated ACLF prognostication scores from electronic health record data.. [DOI: 10.1101/2020.11.23.20237081] [Reference Citation Analysis]
486 Jing J, Sang XX, You SL, Zhu B, Cui YF, Li CY, Wang ZX, Zhao X, Liu XY, Tian M, Ren YB, Yu SM, Xiao XH, Wang JB, Niu M, Wang RL. Metabolomic profiles of breath odor compounds for prognostic prediction in patients with acute-on-chronic liver failure: A pilot study. Hepatol Res 2021;51:490-502. [PMID: 33227168 DOI: 10.1111/hepr.13594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
487 Bartoletti M, Baldassarre M, Domenicali M, Lewis RE, Giannella M, Antognoli A, Rinaldi M, Zaccherini G, Verucchi G, Marconi L, Tamè M, Berardi S, Napoli L, Siniscalchi A, Fabbri A, Biselli M, Tufoni M, Pavarin RM, Trevisani F, Viale P, Bernardi M, Caraceni P. Prognostic Role of Bacterial and Fungal Infections in Patients With Liver Cirrhosis With and Without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study. Open Forum Infect Dis 2020;7:ofaa453. [PMID: 33209950 DOI: 10.1093/ofid/ofaa453] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
488 Li C, Su H, Hu J. The periscreen strip is an accurate and rapid method to diagnose spontaneous bacterial peritonitis among patients with acute-on-chronic liver failure. European Journal of Gastroenterology & Hepatology 2021;33:e206-13. [DOI: 10.1097/meg.0000000000002007] [Reference Citation Analysis]
489 Liu F, Zou Z, Shen L, Wu W, Luo J, Lankford S, Yang Y, Huang H, You S, Zhu B, Li J, Mu J, Zhang Y, Xin S. A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure. Sci Rep 2020;10:20176. [PMID: 33214662 DOI: 10.1038/s41598-020-77235-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
490 Laique SN, Zhang N, Hewitt WR, Bajaj J, Vargas HE. Increased access to liver transplantation for patients with acute on chronic liver failure after implementation of Share 35 Rule: An analysis from the UNOS database. Ann Hepatol 2021;23:100288. [PMID: 33217586 DOI: 10.1016/j.aohep.2020.100288] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
491 Peschel G, Kraft IC, Ilkhtchoui R, Schmid S, Sinner B, Scherer MN, Mueller-Schilling M, Weigand K. Definition, reasons, and risk factors for mortality of patients listed for liver transplantation - a single-center study. Z Gastroenterol 2020;58:1065-73. [PMID: 33197949 DOI: 10.1055/a-1246-3144] [Reference Citation Analysis]
492 Iacob S, Ghioca M, Csiki IE, Tomescu D, Droc G, Hrehoret D, Brasoveanu V, Pietrareanu C, Iacob R, Gheorghe C, Popescu I, Gheorghe L. Pre and post-liver transplant outcome of cirrhotic patients with acute on chronic liver failure. Medicine (Baltimore) 2020;99:e22419. [PMID: 33126299 DOI: 10.1097/MD.0000000000022419] [Reference Citation Analysis]
493 Hung CC, Hsu YC, Lin KH. Comparing Mortality Risk Predictive Ability of Different Scoring Systems in Cirrhotic Patients with Bacteremia. Emerg Med Int 2020;2020:8596567. [PMID: 33163235 DOI: 10.1155/2020/8596567] [Reference Citation Analysis]
494 Chen J, Huang ZB, Li H, Zheng X, Chen JJ, Wang XB, Qian ZP, Liu XX, Fan XG, Hu XW, Liao CJ, Long LY, Huang Y. Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study. Infect Dis Ther 2021;10:281-90. [PMID: 33146854 DOI: 10.1007/s40121-020-00362-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
495 Steiner-Temnykh L, Dakhoul L, Slaven J, Nephew L, Patidar KR, Orman E, Desai AP, Vilar-Gomez E, Kubal C, Ekser B, Chalasani N, Ghabril M. Comorbidity Burden May Be Associated with Increased Mortality in Patients with Severe Acute Liver Injury Referred for Liver Transplantation. Ann Transplant 2020;25:e926453. [PMID: 33139688 DOI: 10.12659/AOT.926453] [Reference Citation Analysis]
496 Lin YJ, Chen RJ, Tang JH, Yu CS, Wu JL, Chen LC, Chang SS. Machine-Learning Monitoring System for Predicting Mortality Among Patients With Noncancer End-Stage Liver Disease: Retrospective Study. JMIR Med Inform 2020;8:e24305. [PMID: 33124991 DOI: 10.2196/24305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
497 Mücke MM, Rüschenbaum S, Mayer A, Mücke VT, Schwarzkopf KM, Zeuzem S, Kehrmann J, Scholtysik R, Lange CM. Stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis: an exploratory study. Gut Pathog 2020;12:51. [PMID: 33133240 DOI: 10.1186/s13099-020-00389-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
498 Zulian Terres A, Sartori Balbinot R, Laura Facco Muscope A, Luisa Longen M, Schena B, Teston Cini B, Luis Rost G, Isabel Leichtweis Balensiefer J, Zanotto Eberhardt L, Angelo Balbinot R, Sartori Balbinot S, Soldera J. Predicting mortality for hepatorenal syndrome with liver‐specific scores. GastroHep 2020;2:336-43. [DOI: 10.1002/ygh2.429] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
499 Aghili M, Neelathahalli Kasturirangan M. Identifying characteristics of drug-related problems in critically ill patients with decompensated liver cirrhosis. Eur J Gastroenterol Hepatol 2019;31:1569-76. [PMID: 31464786 DOI: 10.1097/MEG.0000000000001492] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
500 Shah S, Goldberg DS, Kaplan DE, Sundaram V, Taddei TH, Mahmud N. Patient Frailty Is Independently Associated With the Risk of Hospitalization for Acute-on-Chronic Liver Failure. Liver Transpl 2021;27:16-26. [PMID: 32946660 DOI: 10.1002/lt.25896] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
501 Zaccherini G, Tufoni M, Bernardi M. Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature. Hepat Med 2020;12:153-72. [PMID: 33149707 DOI: 10.2147/HMER.S264231] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
502 Amin A, Mookerjee RP. Acute-on-chronic liver failure: definition, prognosis and management. Frontline Gastroenterol 2020;11:458-67. [PMID: 33101624 DOI: 10.1136/flgastro-2018-101103] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
503 Magro B, Mazzola A, Munteanu M, Goumard C, Martinez V, Bernard D, Scatton O, Battaglia S, Celsa C, Cammà C, Conti F. Consequences of Extended Spectrum Beta-Lactamase-Producing Enterobacteriaceae and Methicillin-Resistant Staphylococcus aureus Carriage in Awaiting Liver Transplant Patients. Liver Transpl 2021;27:43-54. [PMID: 32955790 DOI: 10.1002/lt.25897] [Reference Citation Analysis]
504 Martucci G, Volpes R, Panarello G, Tuzzolino F, Di Carlo D, Ricotta C, Gruttadauria S, Conaldi PG, Luca A, Amrein K, Arcadipane A. Vitamin D levels in liver transplantation recipients and early postoperative outcomes: Prospective observational DLiverX study. Clin Nutr 2021;40:2355-63. [PMID: 33158589 DOI: 10.1016/j.clnu.2020.10.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
505 Mu X, Tong J, Xu X, Chen J, Su H, Liu X, Pang F, Zhai X, Wang L, Wang Y, Guan C, Wang F, Hu J. World Gastroenterology Organisation classification and a new type-based prognostic model for hepatitis B virus-related acute-on-chronic liver failure. Clin Res Hepatol Gastroenterol 2021;45:101548. [PMID: 33554865 DOI: 10.1016/j.clinre.2020.09.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
506 Casulleras M, Flores-costa R, Duran-güell M, Alcaraz-quiles J, Sanz S, Titos E, López-vicario C, Fernández J, Horrillo R, Costa M, de la Grange P, Moreau R, Arroyo V, Clària J. Albumin internalizes and inhibits endosomal TLR signaling in leukocytes from patients with decompensated cirrhosis. Sci Transl Med 2020;12. [DOI: 10.1126/scitranslmed.aax5135] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
507 Méndez-Guerrero O, Calle-Rodas DA, Cervantes-Alvarez E, Alatorre-Arenas E, Pérez-Escobar J, Navarro-Alvarez N, Torre A. Renal and brain failure predict mortality of patients with acute-on-chronic liver failure admitted to the intensive care unit. Ann Hepatol 2021;22:100270. [PMID: 33091594 DOI: 10.1016/j.aohep.2020.09.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
508 Hause J, Rice JP. Transplants for Acute Alcoholic Hepatitis: Controversies and Early Successes. Clin Liver Dis 2021;25:229-52. [PMID: 33978581 DOI: 10.1016/j.cld.2020.08.010] [Reference Citation Analysis]
509 Mauro E, Crespo G, Martinez-Garmendia A, Gutierrez-Acevedo MN, Diaz JM, Saidman J, Bermudez C, Ortiz-Patron J, Garcia-Olveira L, Zalazar F, Narvaez A, Spina JC, Orta R, Savluk L, Piano S, Marciano S, Gadano A. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List. Transplantation. 2020;104:e188-e198. [PMID: 32150034 DOI: 10.1097/tp.0000000000003222] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
510 Claude C, Deep A, Kneyber M, Siddiqui S, Renolleau S, Morin L, Jacquemin E, Teglas JP, Gajdos V, Tissières P, Durand P; ESPNIC liver failure, support working group. pCLIF-SOFA is a reliable outcome prognostication score of critically ill children with cirrhosis: an ESPNIC multicentre study. Ann Intensive Care 2020;10:137. [PMID: 33052510 DOI: 10.1186/s13613-020-00753-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
511 Çoruh B, Pasnick S, Acho M, Bass GD, Baston CM, Elizabeth Card M, Gallo de Moraes A, Griffeth VEM, Kanj A, Leveno MJ, Lovin D, Maximous SI, Pearson SD, Stephens RS, Wolfe KS, Zakhary B, McSparron JI, Hayes MM. ATS Core Curriculum 2020. Adult Critical Care Medicine. ATS Sch 2020;1:436-55. [PMID: 33870312 DOI: 10.34197/ats-scholar.2020-0015RE] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
512 Hu C, Huang K, Zhao L, Zhang F, Wu Z, Li L. Serum ammonia is a strong prognostic factor for patients with acute-on-chronic liver failure. Sci Rep. 2020;10:16970. [PMID: 33046732 DOI: 10.1038/s41598-020-73603-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
513 Assis-Mendonça GR, Cunha-Silva M, Fernandes MF, Torres LD, de Almeida Verissimo MP, Okano MTN, Mazo DF, Lalli CA, Sevá-Pereira T, Stelini RF, da Costa LBE. Massive iron overload and acute-on-chronic liver failure in a patient with Diamond-Blackfan anaemia: a case report. BMC Gastroenterol 2020;20:332. [PMID: 33045993 DOI: 10.1186/s12876-020-01468-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
514 Arora A, Kumar A, Prasad N, Duseja A, Acharya SK, Agarwal SK, Aggarwal R, Anand AC, Bhalla AK, Choudhary NS, Chawla YK, Dhiman RK, Dixit VK, Gopalakrishnan N, Gupta A, Hegde UN, Jasuja S, Jha V, Kher V, Kumar A, Madan K, Maiwall R, Mathur RP, Nayak SL, Pandey G, Pandey R, Puri P, Rai RR, Raju SB, Rana DS, Rao PN, Rathi M, Saraswat VA, Saxena S, Shalimar, Sharma P, Singh SP, Singal AK, Soin AS, Taneja S, Varughese S. INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease. J Clin Exp Hepatol 2021;11:354-86. [PMID: 33994718 DOI: 10.1016/j.jceh.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
515 Kedarisetty CK, Bhargav VY, Karthikeyan M, Venkataraman J, Sathiyasekaran BWC. Wilson Disease Presenting as Acute on Chronic Liver Failure: A Mystery yet to be Solved!! J Clin Exp Hepatol 2020;10:529-30. [PMID: 33029060 DOI: 10.1016/j.jceh.2020.04.013] [Reference Citation Analysis]
516 Marciano S, Mauro E, Giunta D, Torres MC, Diaz JM, Bermudez C, Gutierrez-Acevedo MN, Narvaez A, Ortíz J, Dirchwolf M, Pollarsky F, Rojas-Saunero LP, Gadano A. Impact of acute-on-chronic liver failure on post-transplant survival and on kidney outcomes. Eur J Gastroenterol Hepatol 2019;31:1157-64. [PMID: 31385871 DOI: 10.1097/MEG.0000000000001467] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
517 Khanam A, Kottilil S. Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for Therapeutics. Front Immunol 2020;11:2013. [PMID: 33117329 DOI: 10.3389/fimmu.2020.02013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
518 Mücke VT, Maria Schwarzkopf K, Thomas D, Mücke MM, Rüschenbaum S, Trebicka J, Pfeilschifter J, Zeuzem S, Lange CM, Grammatikos G. Serum Sphingosine-1-Phosphate Is Decreased in Patients With Acute-on-Chronic Liver Failure and Predicts Early Mortality. Hepatol Commun 2020;4:1477-86. [PMID: 33024917 DOI: 10.1002/hep4.1561] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
519 Cornman-Homonoff J, Madoff DC. Commentary on: "Rebleeding and Mortality Risk Are Increased by ACLF but Reduced by Pre-emptive TIPS". AJR Am J Roentgenol 2021;216:878. [PMID: 33025807 DOI: 10.2214/AJR.20.24811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
520 Aslan AT, Balaban HY. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment. World J Gastroenterol 2020; 26(37): 5543-5560 [PMID: 33071523 DOI: 10.3748/wjg.v26.i37.5543] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 30] [Article Influence: 16.0] [Reference Citation Analysis]
521 Marciano S, Valverde M, Dirchwolf M, Gutierrez-Acevedo MN, Gadano A. The Importance of Knowing the Local Epidemiology When a Patient With Cirrhosis Acquires a Bacterial Infection. Clin Liver Dis (Hoboken) 2020;16:87-90. [PMID: 33005387 DOI: 10.1002/cld.911] [Reference Citation Analysis]
522 Zanetto A, Rinder HM, Campello E, Saggiorato G, Deng Y, Ciarleglio M, Wilson FP, Senzolo M, Gavasso S, Bulato C, Simioni P, Garcia-Tsao G. Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features. Hepatology 2020;72:1327-40. [PMID: 32614088 DOI: 10.1002/hep.31443] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 19.0] [Reference Citation Analysis]
523 Chan M, So V, Irwin MG. Clinical aspects of hepatic disease. Anaesthesia & Intensive Care Medicine 2020;21:498-502. [DOI: 10.1016/j.mpaic.2020.07.009] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
524 Nie Y, Zhang Y, Liu LX, Zhu X. Serum Lactate Level Predicts Short-Term and Long-Term Mortality of HBV-ACLF Patients: A Prospective Study. Ther Clin Risk Manag 2020;16:849-60. [PMID: 32982257 DOI: 10.2147/TCRM.S272463] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
525 Zhai XR, Tong JJ, Wang HM, Xu X, Mu XY, Chen J, Liu ZF, Wang Y, Su HB, Hu JH. Infection deteriorating hepatitis B virus related acute-on-chronic liver failure: a retrospective cohort study. BMC Gastroenterol 2020;20:320. [PMID: 32993547 DOI: 10.1186/s12876-020-01473-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
526 Li FF, Liu N, Liu W, Li M, Zhang F, Dong Z, Zhang JL, Sun H. Role of dihydroceramides in the progression of acute-on-chronic liver failure in rats. Chin Med J (Engl) 2020;133:198-204. [PMID: 31880746 DOI: 10.1097/CM9.0000000000000601] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
527 Xie C, Kuo YF, Singal AK. Changing Population of Liver Transplant Recipients in the Era of Direct-acting Antiviral Therapy. J Clin Transl Hepatol 2020;8:262-6. [PMID: 33083248 DOI: 10.14218/JCTH.2020.00032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
528 Lin X, Huang X, Wang L, Feng S, Chen X, Cai W, Huang Z. Prognostic Value of Acute-On-Chronic Liver Failure (ACLF) Score in Critically Ill Patients with Cirrhosis and ACLF. Med Sci Monit 2020;26:e926574. [PMID: 32978936 DOI: 10.12659/MSM.926574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
529 Bartoletti M, Giannella M, Lewis RE, Caraceni P, Tedeschi S, Paul M, Schramm C, Bruns T, Merli M, Cobos-Trigueros N, Seminari E, Retamar P, Muñoz P, Tumbarello M, Burra P, Torrani Cerenzia M, Barsic B, Calbo E, Maraolo AE, Petrosillo N, Galan-Ladero MA, D'Offizi G, Zak-Doron Y, Rodriguez-Baño J, Baldassarre M, Verucchi G, Domenicali M, Bernardi M, Viale P; ESGBIS/BICHROME study group. Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study. Clin Infect Dis 2019;69:1731-9. [PMID: 30649218 DOI: 10.1093/cid/ciz032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
530 Ye J, Wu Y, Li M, Gong X, Zhong B. Keratin 8 Mutations Were Associated With Susceptibility to Chronic Hepatitis B and Related Progression. J Infect Dis 2020;221:464-73. [PMID: 31515557 DOI: 10.1093/infdis/jiz467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
531 Cardoso FS, Pereira R, Laranjo A, Gamelas V, Bagulho L, Germano N, Karvellas CJ. Positive fluid balance was associated with mortality in patients with acute-on-chronic liver failure: A cohort study. J Crit Care 2021;63:238-42. [PMID: 32988683 DOI: 10.1016/j.jcrc.2020.09.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
532 Patidar KR, Xu C, Shamseddeen H, Cheng YW, Ghabril MS, Mukthinuthalapati VVPK, Fricker ZP, Akinyeye S, Nephew LD, Desai AP, Anderson M, El-Achkar TM, Chalasani NP, Orman ES. Development and Validation of a Model to Predict Acute Kidney Injury in Hospitalized Patients With Cirrhosis. Clin Transl Gastroenterol 2019;10:e00075. [PMID: 31478958 DOI: 10.14309/ctg.0000000000000075] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
533 Shin J, Yu JH, Jin YJ, Yim HJ, Jung YK, Yang JM, Song DS, Kim YS, Kim SG, Kim DJ, Suk KT, Yoon EL, Lee SS, Kim CW, Kim HY, Jang JY, Jeong SW. Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding. Clin Mol Hepatol 2020;26:540-53. [PMID: 32937688 DOI: 10.3350/cmh.2020.0034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
534 Zhang Y, Nie Y, Liu L, Zhu X. Assessing the prognostic scores for the prediction of the mortality of patients with acute-on-chronic liver failure: a retrospective study. PeerJ 2020;8:e9857. [PMID: 32983642 DOI: 10.7717/peerj.9857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
535 Lin Y, Chen R, Tang J, Yu C, Wu JL, Chen L, Chang S. Machine-Learning Monitoring System for Predicting Mortality Among Patients With Noncancer End-Stage Liver Disease: Retrospective Study (Preprint).. [DOI: 10.2196/preprints.24305] [Reference Citation Analysis]
536 Gomaa SH, Shamseya MM, Madkour MA. Clinical utility of urinary neutrophil gelatinase-associated lipocalin and serum cystatin C in a cohort of liver cirrhosis patients with renal dysfunction: a challenge in the diagnosis of hepatorenal syndrome.Eur J Gastroenterol Hepatol. 2019;31:692-702. [PMID: 30601335 DOI: 10.1097/MEG.0000000000001347] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
537 Arshad A, Irshad L, Nabavi T, Whitehouse T. Acute-on-chronic liver failure: to admit to intensive care or not? Br J Hosp Med (Lond) 2020;81:1-6. [PMID: 32990068 DOI: 10.12968/hmed.2020.0310] [Reference Citation Analysis]
538 Mayr U, Lukas M, Elnegouly M, Vogt C, Bauer U, Ulrich J, Schmid RM, Huber W, Lahmer T. Ascitic Interleukin 6 Is Associated with Poor Outcome and Spontaneous Bacterial Peritonitis: A Validation in Critically Ill Patients with Decompensated Cirrhosis. J Clin Med 2020;9:E2865. [PMID: 32899730 DOI: 10.3390/jcm9092865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
539 Lee HW, Yip TC, Tse YK, Wong GL, Kim BK, Kim SU, Park JY, Kim DY, Chan HL, Ahn SH, Wong VW. Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B. Clin Gastroenterol Hepatol. 2020;. [PMID: 32889148 DOI: 10.1016/j.cgh.2020.08.064] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
540 Zaccherini G, Weiss E, Moreau R. Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment. JHEP Rep 2021;3:100176. [PMID: 33205036 DOI: 10.1016/j.jhepr.2020.100176] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 15.0] [Reference Citation Analysis]
541 Hernaez R, Patel A, Jackson LK, Braun UK, Walling AM, Rosen HR. Considerations for Prognosis, Goals of Care, and Specialty Palliative Care for Hospitalized Patients With Acute-on-Chronic Liver Failure. Hepatology 2020;72:1109-16. [PMID: 32416642 DOI: 10.1002/hep.31316] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
542 Fung J, Mak LY, Chan AC, Chok KS, Wong TC, Cheung TT, Dai WC, Sin SL, She WH, Ma KW, Seto WK, Lai CL, Lo CM, Yuen MF. Model for End-Stage Liver Disease With Additional Criteria to Predict Short-Term Mortality in Severe Flares of Chronic Hepatitis B. Hepatology 2020;72:818-28. [PMID: 31872444 DOI: 10.1002/hep.31086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
543 Artzner T, Michard B. Caring for Cirrhotic Patients With Multiple Organ Failure in the ICU: A Change of Paradigm Is Underway. Critical Care Medicine 2020;48:e842-3. [DOI: 10.1097/ccm.0000000000004403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
544 Revathy MS, M MYC, M M, G S. STUDY OF CELLULITIS IN CIRRHOSIS IN A TERTIARY CARE CENTER. ijsr 2020. [DOI: 10.36106/ijsr/2414560] [Reference Citation Analysis]
545 Farias AQ, Bittencourt PL. Acute-on-Chronic Liver Failure: Which Definition Is Appropriate in Latin America? Clin Liver Dis (Hoboken) 2020;16:114-6. [PMID: 33005392 DOI: 10.1002/cld.945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
546 Huang AC, Gardner JM, Hameed B. Non-selective Beta-Blockers in Decompensated Cirrhosis. Curr Hepatology Rep 2020;19:186-196. [DOI: 10.1007/s11901-020-00529-7] [Reference Citation Analysis]
547 Oliveira Coberllini Jacques R, Silva Massignan L, Schumacher Winkler M, Sartori Balbinot R, Balbinot RA, Sartori Balbinot S, Soldera J. Liver‐specific scores as predictors of mortality in spontaneous bacterial peritonitis. GastroHep 2020;2:224-31. [DOI: 10.1002/ygh2.419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
548 Lin S, Yan YY, Wu YL, Wang MF, Zhu YY, Wang XZ. Development of a novel score for the diagnosis of bacterial infection in patients with acute-on-chronic liver failure. World J Gastroenterol 2020; 26(32): 4857-4865 [PMID: 32921962 DOI: 10.3748/wjg.v26.i32.4857] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
549 Sundaram V, Mahmud N, Perricone G, Katarey D, Wong RJ, Karvellas CJ, Fortune BE, Rahimi RS, Maddur H, Jou JH, Kriss M, Stein LL, Lee M, Jalan R; Multi-Organ Dysfunction, Evaluation for Liver Transplantation (MODEL) Consortium. Longterm Outcomes of Patients Undergoing Liver Transplantation for Acute-on-Chronic Liver Failure. Liver Transpl 2020;26:1594-602. [PMID: 32574423 DOI: 10.1002/lt.25831] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
550 Sharma S, Agarwal S, Gunjan D, Kaushal K, Anand A, Mohta S, Shalimar, Saraya A. Long-term Outcomes with Carvedilol versus Propranolol in Patients with Index Variceal Bleed: 6-year Follow-up Study. J Clin Exp Hepatol 2021;11:343-53. [PMID: 33994717 DOI: 10.1016/j.jceh.2020.08.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
551 Stotts MJ, Lisman T, Intagliata NM. The Spectrum of Disease Severity in Cirrhosis and Its Implications for Hemostasis. Semin Thromb Hemost 2020;46:716-23. [PMID: 32820482 DOI: 10.1055/s-0040-1715449] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
552 Seeßle J, Löhr J, Kirchner M, Michaelis J, Merle U. Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients. BMC Gastroenterol 2020;20:271. [PMID: 32807080 DOI: 10.1186/s12876-020-01413-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
553 Shalimar, Elhence A, Vaishnav M, Kumar R, Pathak P, Soni KD, Aggarwal R, Soneja M, Jorwal P, Kumar A, Khanna P, Singh AK, Biswas A, Nischal N, Dar L, Choudhary A, Rangarajan K, Mohan A, Acharya P, Nayak B, Gunjan D, Saraya A, Mahapatra S, Makharia G, Trikha A, Garg P. Poor outcomes in patients with cirrhosis and Corona Virus Disease-19. Indian J Gastroenterol. 2020;39:285-291. [PMID: 32803716 DOI: 10.1007/s12664-020-01074-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 16.5] [Reference Citation Analysis]
554 Aehling NF, Seehofer D, Berg T. [Liver transplantation - current trends]. Dtsch Med Wochenschr 2020;145:1124-31. [PMID: 32791547 DOI: 10.1055/a-0982-0737] [Reference Citation Analysis]
555 Zhou C, Zhang N, He TT, Wang Y, Wang LF, Sun YQ, Jing J, Zhang JJ, Fu SN, Wang X, Liang XX, Li X, Gong M, Li J. High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol 2020; 26(30): 4479-4488 [PMID: 32874059 DOI: 10.3748/wjg.v26.i30.4479] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
556 Camus C, Locher C, Saliba F, Goubaux B, Bonadona A, Lavayssiere L, Paugam C, Quinart A, Barbot O, Dharancy S, Delafosse B, Pichon N, Barraud H, Galbois A, Veber B, Cayot S, Souche B. Outcome of patients treated with molecular adsorbent recirculating system albumin dialysis: A national multicenter study. JGH Open 2020;4:757-63. [PMID: 32782967 DOI: 10.1002/jgh3.12359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
557 Wang S, Xiong H, Luo C, Zhao H, Fan Y, Zhang T, Wang L, Wang Q, Xie W. Acute-on-Chronic Liver Failure in Pregnant Patients with Chronic Hepatitis B: A Retrospective Observational Case Series Study. Gastroenterol Res Pract 2020;2020:9831687. [PMID: 32849869 DOI: 10.1155/2020/9831687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
558 Faivre M, Cottet V, Bour JB, Richou C, Valmary-Degano S, Thiefin G, Andreoletti L, Geist C, Schvoerer E, Malvé B, Habersetzer F, Fafi-Kremer S, Binquet C, Jouve JL, Bronowicki JP, Doffoel M, Hillon P, Herbein G, Monnet E, Di Martino V; CirCE Study Group. Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis: A Preliminary Study. J Clin Gastroenterol 2019;53:236-41. [PMID: 30383568 DOI: 10.1097/MCG.0000000000001039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
559 Batra RK. Utility of Liver Transplantation Within the Bounds of Non-futility. Curr Transpl Rep 2020;7:187-93. [DOI: 10.1007/s40472-020-00288-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
560 Chang Y, Liu QY, Zhang Q, Rong YM, Lu CZ, Li H. Role of nutritional status and nutritional support in outcome of hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol 2020; 26(29): 4288-4301 [PMID: 32848334 DOI: 10.3748/wjg.v26.i29.4288] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
561 Wang X, Sun M, Yang X, Gao L, Weng M, Yang D, Li H, Zhou X, Li J, Qin S, Zhou D, Wu X, Tang S, Zeng W. Value of Liver Regeneration in Predicting Short-Term Prognosis for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure. Biomed Res Int 2020;2020:5062873. [PMID: 32832550 DOI: 10.1155/2020/5062873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
562 Praktiknjo M, Clees C, Pigliacelli A, Fischer S, Jansen C, Lehmann J, Pohlmann A, Lattanzi B, Krabbe VK, Strassburg CP, Arroyo V, Merli M, Meyer C, Trebicka J. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt. Clin Transl Gastroenterol 2019;10:e00025. [PMID: 30939488 DOI: 10.14309/ctg.0000000000000025] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 22.5] [Reference Citation Analysis]
563 Pokorna V, Bodikova S, Kaluzay J, Liskova Z, Jurkovicova O. Acute limb ischemia due to paradoxical embolism treated with systemic thrombolysis. Vnitr Lek 2020;66:e48-e51. [DOI: 10.36290/vnl.2020.090] [Reference Citation Analysis]
564 Weichselbaum L, Azouz A, Smolen KK, Das J, Splittgerber M, Lepida A, Moreno C, Schreiber J, Sersté T, Trepo E, Libert F, Gustot T, Goriely S. Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis. Journal of Hepatology 2020;73:303-314. [DOI: 10.1016/j.jhep.2020.02.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
565 Ehrmann J, Aiglová K, Urban O, Cveková S, Dvoran P. Alcohol-related liver diseases (ALD). Vnitř Lék 2020;66:e3-e15. [DOI: 10.36290/vnl.2020.091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
566 Rashidi-Alavijeh J, Ceylan AS, Wedemeyer H, Kleefisch M, Willuweit K, Lange CM. Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis. PLoS One 2020;15:e0236528. [PMID: 32722691 DOI: 10.1371/journal.pone.0236528] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
567 Riva A, Gray EH, Azarian S, Zamalloa A, McPhail MJW, Vincent RP, Williams R, Chokshi S, Patel VC, Edwards LA. Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis. JHEP Rep 2020;2:100151. [PMID: 32838247 DOI: 10.1016/j.jhepr.2020.100151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
568 Ma Y, Chen F, Liu C, Xu Y, Wang M, Zhou T, Lei X, Feng P, Bai L, Tang H. A novel predictive score for citrate accumulation among patients receiving artificial liver support system therapy with regional citrate anticoagulation. Sci Rep 2020;10:12861. [PMID: 32732928 DOI: 10.1038/s41598-020-69902-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
569 Sundaram V, Shah P, Mahmud N, Lindenmeyer CC, Klein AS, Wong RJ, Karvellas CJ, K. Asrani S, Jalan R. Patients with severe acute-on-chronic liver failure are disadvantaged by model for end-stage liver disease-based organ allocation policy. Aliment Pharmacol Ther. [DOI: 10.1111/apt.15988] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
570 Wu J, Mao W, Li X. Mean Platelet Volume/Lymphocyte Ratio as a Prognostic Indicator for HBV-Related Decompensated Cirrhosis. Gastroenterol Res Pract 2020;2020:4107219. [PMID: 32714387 DOI: 10.1155/2020/4107219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
571 Amaral B, Vicente M, Pereira CSM, Araújo T, Ribeiro A, Pereira R, Perdigoto R, Marcelino P. Approach to the liver transplant early postoperative period: an institutional standpoint. Rev Bras Ter Intensiva 2019;31:561-70. [PMID: 31967233 DOI: 10.5935/0103-507X.20190076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
572 Gao F, Huang XL, Cai MX, Lin MT, Wang BF, Wu W, Huang ZM. Prognostic value of serum lactate kinetics in critically ill patients with cirrhosis and acute-on-chronic liver failure: a multicenter study. Aging (Albany NY) 2019;11:4446-62. [PMID: 31259742 DOI: 10.18632/aging.102062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
573 Fan W, Liao W, Luo Y, You B, Yu J, Li C. Clinical prediction for outcomes of patients with acute-on-chronic liver failure associated with HBV infection: A new model establishment. Open Med (Wars) 2020;15:714-22. [PMID: 33336028 DOI: 10.1515/med-2020-0207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
574 Axley P, Ahmed Z, Arora S, Haas A, Kuo YF, Kamath PS, Singal AK. NASH Is the Most Rapidly Growing Etiology for Acute-on-Chronic Liver Failure-Related Hospitalization and Disease Burden in the United States: A Population-Based Study. Liver Transpl. 2019;25:695-705. [PMID: 30861321 DOI: 10.1002/lt.25443] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 16.0] [Reference Citation Analysis]
575 Bernsmeier C, Cavazza A, Fatourou EM, Theocharidou E, Akintimehin A, Baumgartner B, Dhar A, Auzinger G, Thursz M, Bernal W, Wendon JA, Karvellas CJ, Antoniades CG, McPhail MJW. Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. Aliment Pharmacol Ther 2020;52:855-65. [PMID: 32683724 DOI: 10.1111/apt.15932] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
576 Fuhrmann V, Weber T, Roedl K, Motaabbed J, Tariparast A, Jarczak D, de Garibay APR, Kluwe J, Boenisch O, Herkner H, Kellum JA, Kluge S. Advanced organ support (ADVOS) in the critically ill: first clinical experience in patients with multiple organ failure. Ann Intensive Care 2020;10:96. [PMID: 32676849 DOI: 10.1186/s13613-020-00714-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
577 Avezov SA, Azimova SM, Abdulloev MH. The course and survival of patients with liver cirrhosis and acute liver failure on the background of chronic. jour 2020;98:137-141. [DOI: 10.30629/0023-2149-2020-98-2-137-141] [Reference Citation Analysis]
578 Barloese M, Chitgar M, Hannibal J, Møller S. Pituitary adenylate cyclase-activating peptide: Potential roles in the pathophysiology and complications of cirrhosis. Liver Int 2020;40:2578-89. [PMID: 32654367 DOI: 10.1111/liv.14602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
579 Grønbaek H, Møller HJ, Saliba F, Zeuzem S, Albillos A, Ariza X, Graupera I, Solà E, Amoros A, Pavesi M, Bossen L, Jalan R, Gines P, Arroyo V. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation. J Gastroenterol Hepatol 2021;36:240-8. [PMID: 32478437 DOI: 10.1111/jgh.15125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
580 Aday A, O'Leary JG. Acute on Chronic Liver Failure: Definition and Implications. Clin Liver Dis 2020;24:521-34. [PMID: 32620286 DOI: 10.1016/j.cld.2020.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
581 Doycheva I, Thuluvath PJ. Acute-on-chronic liver failure in liver transplant candidates with non-alcoholic steatohepatitis. Transl Gastroenterol Hepatol 2020;5:38. [PMID: 32632389 DOI: 10.21037/tgh.2019.10.01] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
582 Muller X, Tilmans G, Chenevas-Paule Q, Lebossé F, Antonini T, Poinsot D, Rode A, Guichon C, Schmitt Z, Ducerf C, Mohkam K, Lesurtel M, Mabrut JY. Strategies for liver transplantation during the SARS-CoV-2 outbreak: Preliminary experience from a single center in France. Am J Transplant 2020;20:2989-96. [PMID: 32476233 DOI: 10.1111/ajt.16082] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
583 Kim SW, Yoon JS, Park J, Jung YJ, Lee JS, Song J, Lee HA, Seo YS, Lee M, Park JM, Choi DH, Kim MY, Kang SH, Yang JM, Song DS, Chung SW, Kim MA, Jang HJ, Oh H, Lee CH, Lee YB, Cho EJ, Yu SJ, Kim YJ, Yoon JH, Lee JH. Empirical Treatment With Carbapenem vs Third-generation Cephalosporin for Treatment of Spontaneous Bacterial Peritonitis. Clin Gastroenterol Hepatol 2021;19:976-986.e5. [PMID: 32623007 DOI: 10.1016/j.cgh.2020.06.046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
584 Gao R, Li Y, Cao Y, Zheng R, Tang L, Yang J, Lu X. Glucocorticoid versus traditional therapy for hepatitis B virus-related acute-on-chronic liver failure: A systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e20604. [PMID: 32569189 DOI: 10.1097/MD.0000000000020604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
585 Mahmud N, Sundaram V, Kaplan DE, Taddei TH, Goldberg DS. Grade 1 Acute on Chronic Liver Failure Is a Predictor for Subsequent Grade 3 Failure. Hepatology 2020;72:230-9. [PMID: 31677284 DOI: 10.1002/hep.31012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
586 Tang X, Qi T, Li B, Li H, Huang Z, Zhu Z, Tu M, Gao J, Zhu C, Jiang X, Yu X, Lu G, Xiong M, He Q, Zhou F, Wen W, Chen J, Hou J. Tri-typing of hepatitis B-related acute-on-chronic liver failure defined by the World Gastroenterology Organization. J Gastroenterol Hepatol 2021;36:208-16. [PMID: 32445263 DOI: 10.1111/jgh.15113] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
587 Rosenblatt R, Verna EC. Cystatin C: The Answer or a Call for Better Kidney Biomarkers in Cirrhosis? Transplantation 2020;104:e186-e187. [DOI: 10.1097/tp.0000000000003223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
588 Kade G, Lubas A, Spaleniak S, Wojtecka A, Leśniak K, Literacki S, Niemczyk S, Dyrla P. Application of the Molecular Adsorbent Recirculating System in Type 1 Hepatorenal Syndrome in the Course of Alcohol-Related Acute on Chronic Liver Failure. Med Sci Monit 2020;26:e923805. [PMID: 32602472 DOI: 10.12659/MSM.923805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
589 Bertha M, Maddur H. Highlights From the AASLD/EASL ALD Endpoints Conference 2019. Clinical Liver Disease 2020;15:215-8. [DOI: 10.1002/cld.927] [Reference Citation Analysis]
590 Sokolov AA, Rey SI, Aleksandrova IV, Popov AV, Gendel LL, Gubanova SN, Marchenkova LV, Sudakov MV. Comparison of selective plasma exchange and plasmadialfiltration with MARS and Prometheus systems in the treatment of liver failure. Vestn anesteziol reanimatol 2020;17:39-52. [DOI: 10.21292/2078-5658-2020-17-3-39-52] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
591 Xu X, Hou Z, Xu Y, Gu H, Liang G, Huang Y. The dynamic of platelet count as a novel and valuable predictor for 90-day survival of hepatitis B virus-related acute-on-chronic liver failure patients. Clin Res Hepatol Gastroenterol 2021;45:101482. [PMID: 32600902 DOI: 10.1016/j.clinre.2020.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
592 Lindenmeyer CC, Flocco G, Sanghi V, Lopez R, Kim AJ, Niyazi F, Mehta NA, Kapoor A, Carey WD, Mireles-Cabodevila E, Romero-Marrero C. LIV-4: A novel model for predicting transplant-free survival in critically ill cirrhotics. World J Hepatol 2020; 12(6): 298-311 [PMID: 32742572 DOI: 10.4254/wjh.v12.i6.298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
593 Stockhoff L, Schultalbers M, Tergast TL, Hinrichs JB, Gerbel S, Meine TC, Manns MP, Simon N, Cornberg M, Meyer BC, Maasoumy B. Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites. PLoS One 2020;15:e0235199. [PMID: 32584874 DOI: 10.1371/journal.pone.0235199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
594 Stahl K, Busch M, Fuge J, Schneider A, Manns MP, Seeliger B, Schmidt JJ, Wiesner O, Schmidt BMW, Taubert R, Vondran FWR, Hoeper MM, David S. Therapeutic plasma exchange in acute on chronic liver failure. J Clin Apher. 2020;35:316-327. [PMID: 32583446 DOI: 10.1002/jca.21799] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
595 Yazawa M, Maliakkal B, Nair S, Podila PSB, Agbim UA, Karri S, Khan SD, Maluf D, Eason JD, Molnar MZ, Satapathy SK. Longitudinal Renal Function in Liver Transplant Recipients With Acute-on-Chronic Liver Failure. Clin Transl Gastroenterol 2020;11:e00185. [PMID: 32568475 DOI: 10.14309/ctg.0000000000000185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
596 Wong YJ, Qiu TY, Tam YC, Mohan BP, Gallegos-Orozco JF, Adler DG. Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: A systematic review and meta-analysis. Dig Liver Dis. 2020;52:1137-1142. [PMID: 32586766 DOI: 10.1016/j.dld.2020.05.047] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
597 Mahmud N, Hernaez R, Wu T, Sundaram V. Early Transplantation in Acute on Chronic Liver Failure: Who and When. Curr Hepatol Rep 2020;19:168-73. [PMID: 34277325 DOI: 10.1007/s11901-020-00519-9] [Reference Citation Analysis]
598 Robinson AM, Karvellas CJ, Dionne JC, Featherstone R, Sebastianski M, Vandermeer B, Rewa OG. Continuous renal replacement therapy and transplant-free survival in acute liver failure: protocol for a systematic review and meta-analysis. Syst Rev 2020;9:143. [PMID: 32546277 DOI: 10.1186/s13643-020-01405-7] [Reference Citation Analysis]
599 Xiao C, Gong J, Zhu S, Zhang Z, Xi S, Chong Y, Jie Y, Zhang Q. Nomogram based on blood lipoprotein for estimation of mortality in patients with hepatitis B virus-related acute-on-chronic liver failure. BMC Gastroenterol 2020;20:188. [PMID: 32539733 DOI: 10.1186/s12876-020-01324-w] [Reference Citation Analysis]
600 Feng HL, Li Q, Cao WK, Yang JM. Changes in thyroid function in patients with liver failure and their clinical significance: A clinical study of non-thyroidal illness syndrome in patients with liver failure. Hepatobiliary Pancreat Dis Int 2020;19:561-6. [PMID: 32535064 DOI: 10.1016/j.hbpd.2020.05.001] [Reference Citation Analysis]
601 Xiao KY, Hubbard RA, Kaplan DE, Taddei TH, Goldberg DS, Mahmud N. Models for acute on chronic liver failure development and mortality in a veterans affairs cohort. Hepatol Int 2020;14:587-96. [PMID: 32519219 DOI: 10.1007/s12072-020-10060-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
602 Mattos AA, Wiltgen D, Jotz RF, Dornelles CMR, Fernandes MV, Mattos ÂZ. Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis. Ann Hepatol 2020;19:451-7. [PMID: 32533951 DOI: 10.1016/j.aohep.2020.04.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
603 Abdallah MA, Waleed M, Bell MG, Nelson M, Wong R, Sundaram V, Singal AK. Systematic review with meta-analysis: liver transplant provides survival benefit in patients with acute on chronic liver failure. Aliment Pharmacol Ther 2020;52:222-32. [DOI: 10.1111/apt.15793] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
604 Macnaughtan J, Figorilli F, García-López E, Lu H, Jones H, Sawhney R, Suzuki K, Fairclough S, Marsden J, Moratella A, Cox IJ, Thomas L, Davies N, Williams R, Mookerjee R, Wright G, Jalan R. A Double-Blind, Randomized Placebo-Controlled Trial of Probiotic Lactobacillus casei Shirota in Stable Cirrhotic Patients.Nutrients. 2020;12. [PMID: 32498372 DOI: 10.3390/nu12061651] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
605 Bernardi M, Angeli P, Claria J, Moreau R, Gines P, Jalan R, Caraceni P, Fernandez J, Gerbes AL, O'Brien AJ, Trebicka J, Thevenot T, Arroyo V. Albumin in decompensated cirrhosis: new concepts and perspectives. Gut 2020;69:1127-38. [PMID: 32102926 DOI: 10.1136/gutjnl-2019-318843] [Cited by in Crossref: 87] [Cited by in F6Publishing: 93] [Article Influence: 43.5] [Reference Citation Analysis]
606 Pipa-Muñiz M, Sanmartino S, Mesa A, Álvarez-Navascués C, González-Diéguez ML, Cadahía V, Rodríguez JE, Vega F, Rodríguez M, Costilla-García SM, Varela M. The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization. BMC Gastroenterol. 2020;20:166. [PMID: 32487071 DOI: 10.1186/s12876-020-01307-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
607 Yan H, Jin S, Liang L, Du J, Aithal GP, Li L. Pro-adrenomedullin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival. Scand J Gastroenterol 2020;55:606-14. [PMID: 32476510 DOI: 10.1080/00365521.2020.1764616] [Reference Citation Analysis]
608 Wong F. Latest Treatment of Acute Kidney Injury in Cirrhosis. Curr Treat Options Gastro 2020;18:281-94. [DOI: 10.1007/s11938-020-00292-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
609 Mishra G, Dev A, Paul E, Cheung W, Koukounaras J, Jhamb A, Marginson B, Lim BG, Simkin P, Borsaru A, Burnes J, Goodwin M, Ramachandra V, Spanger M, Lubel J, Gow P, Sood S, Thompson A, Ryan M, Nicoll A, Bell S, Majeed A, Kemp W, Roberts SK; Melbourne Liver Group. Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation. BMC Cancer 2020;20:483. [PMID: 32471447 DOI: 10.1186/s12885-020-06806-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
610 Yang Z, Zhang Z, Cheng Q, Chen G, Li W, Ma K, Guo W, Luo X, Chen T, Ning Q. Plasma perfusion combined with plasma exchange in chronic hepatitis B-related acute-on-chronic liver failure patients. Hepatol Int 2020;14:491-502. [PMID: 32472309 DOI: 10.1007/s12072-020-10053-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
611 Dong X, He J, Chen W, Su R, Xu Y, Sheng X, Li L, Cao H. Characteristics and outcomes of acute-on-chronic liver failure patients with or without cirrhosis using two criteria. Sci Rep 2020;10:8577. [PMID: 32444697 DOI: 10.1038/s41598-020-65529-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
612 Matiollo C, Rateke ECM, de Oliveira KG, Turnes BL, da Silva TE, Maccali C, Latini AS, Narciso-Schiavon JL, Schiavon LL. Elevated neopterin levels are associated with acute-on-chronic liver failure and mortality in patients with liver cirrhosis. Dig Liver Dis 2020;52:753-60. [PMID: 32434738 DOI: 10.1016/j.dld.2020.03.024] [Reference Citation Analysis]
613 Liu J, Gao Y, Wang X, Qian Z, Chen J, Huang Y, Meng Z, Lu X, Deng G, Liu F, Zhang Z, Li H, Zheng X. Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis: Multidrug-Resistant Pathogens and Antibiotic Strategies. Yonsei Med J 2020;61:145-53. [PMID: 31997623 DOI: 10.3349/ymj.2020.61.2.145] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
614 Chen BH, Tseng HJ, Chen WT, Chen PC, Ho YP, Huang CH, Lin CY. Comparing Eight Prognostic Scores in Predicting Mortality of Patients with Acute-On-Chronic Liver Failure Who Were Admitted to an ICU: A Single-Center Experience. J Clin Med. 2020;9. [PMID: 32443729 DOI: 10.3390/jcm9051540] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
615 Chen W, You J, Chen J, Zhu Y. Combining the serum lactic acid level and the lactate clearance rate into the CLIF-SOFA score for evaluating the short-term prognosis of HBV-related ACLF patients. Expert Rev Gastroenterol Hepatol 2020;14:483-9. [PMID: 32432893 DOI: 10.1080/17474124.2020.1763172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
616 Niewiński G, Morawiec S, Janik MK, Grąt M, Graczyńska A, Zieniewicz K, Raszeja-Wyszomirska J. Acute-On-Chronic Liver Failure: The Role of Prognostic Scores in a Single-Center Experience. Med Sci Monit 2020;26:e922121. [PMID: 32415953 DOI: 10.12659/MSM.922121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
617 Liu H, Zhang Q, Liu L, Cao Y, Ye Q, Liu F, Liang J, Wen J, Li Y, Han T. Effect of artificial liver support system on short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Artif Organs 2020;44:E434-47. [PMID: 32320491 DOI: 10.1111/aor.13710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
618 Madsen BS, Thiele M, Detlefsen S, Sørensen MD, Kjaergaard M, Møller LS, Rasmussen DN, Schlosser A, Holmskov U, Trebicka J, Sorensen GL, Krag A; GALAXY consortium. Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar-associated protein 4. Liver Int 2020;40:1701-12. [PMID: 32339377 DOI: 10.1111/liv.14491] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
619 Nielsen MC, Hvidbjerg Gantzel R, Clària J, Trebicka J, Møller HJ, Grønbæk H. Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure. Cells 2020;9:E1175. [PMID: 32397365 DOI: 10.3390/cells9051175] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 17.5] [Reference Citation Analysis]
620 de Sausmarez E, Crowest P, Fry S, Hodgson L. Predicting outcome in liver patients admitted to intensive care: A dual-centre non-specialist hospital external validation of the Liver injury and Failure evaluation score. J Intensive Care Soc 2021;22:152-8. [PMID: 34025755 DOI: 10.1177/1751143720924352] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
621 Pereira R, Bagulho L, Cardoso FS. Acute-on-chronic liver failure syndrome - clinical results from an intensive care unit in a liver transplant center. Rev Bras Ter Intensiva 2020;32:49-57. [PMID: 32401978 DOI: 10.5935/0103-507x.20200009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
622 Makkar K, Tomer S, Verma N, Rathi S, Arora SK, Taneja S, Duseja A, Chawla YK, Dhiman RK. Neutrophil dysfunction predicts 90-day survival in patients with acute on chronic liver failure: A longitudinal case-control study. JGH Open 2020;4:595-602. [PMID: 32782944 DOI: 10.1002/jgh3.12344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
623 Gao F, Lin MT, Yang XY, Cai MX, Nan H, Xie W, Huang ZM. Metabolic acidosis in critically ill patients with cirrhosis: Epidemiology and short-term mortality risk factors. Turk J Gastroenterol 2019;30:883-91. [PMID: 31633484 DOI: 10.5152/tjg.2019.18813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
624 Schmid S, Scherm S, Haderer M, Gülow K, Müller-schilling M. Infektionen bei Leberzirrhose – von bakterieller Translokation über spontan-bakterielle Peritonitis und Pneumonie zum akut-auf-chronischen Leberversagen. Gastroenterologe 2020;15:201-210. [DOI: 10.1007/s11377-020-00439-6] [Reference Citation Analysis]
625 Bosch J, Gracia-Sancho J, Abraldes JG. Cirrhosis as new indication for statins. Gut 2020;69:953-62. [PMID: 32139553 DOI: 10.1136/gutjnl-2019-318237] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 23.0] [Reference Citation Analysis]
626 Bartoletti M, Rinaldi M, Pasquini Z, Scudeller L, Piano S, Giacobbe DR, Maraolo AE, Bussini L, Del Puente F, Incicco S, Angeli P, Giannella M, Baldassarre M, Caraceni P, Campoli C, Morelli MC, Cricca M, Ambretti S, Gentile I, Bassetti M, Viale P. Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case-control-control study. Clin Microbiol Infect 2021;27:276-82. [PMID: 32360775 DOI: 10.1016/j.cmi.2020.04.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
627 Singal AK, Arora S, Wong RJ, Satapathy SK, Shah VH, Kuo YF, Kamath PS. Increasing Burden of Acute-On-Chronic Liver Failure Among Alcohol-Associated Liver Disease in the Young Population in the United States. Am J Gastroenterol. 2020;115:88-95. [PMID: 31651447 DOI: 10.14309/ajg.0000000000000411] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 15.0] [Reference Citation Analysis]
628 Yoon EL, Kim TY, Lee CH, Kim TH, Cho HC, Lee SS, Kim SE, Kim HY, Kim CW, Song DS, Yang JM, Sinn DH, Jung YK, Yim HJ, Kim HS, Sohn JH, Kim JH, Choe WH, Lee BS, Kim MY, Jeong SW, Choi E, Kim DJ; Korean Acute-on-Chronic Liver Failure (KACLiF) Study Group. Long-term Prognosis of Acute-on-Chronic Liver Failure Survivors. J Clin Gastroenterol 2019;53:134-41. [PMID: 29369242 DOI: 10.1097/MCG.0000000000000987] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
629 Grensemann J, Busse D, König C, Roedl K, Jäger W, Jarczak D, Iwersen-Bergmann S, Manthey C, Kluge S, Kloft C, Fuhrmann V. Acute-on-chronic liver failure alters meropenem pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study. Ann Intensive Care 2020;10:48. [PMID: 32323030 DOI: 10.1186/s13613-020-00666-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
630 Li Q, Lu Q, Zhu MQ, Huang C, Yu KK, Huang YX, Zhao X, Luo XG, Zheng JM. Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure. BMC Gastroenterol 2020;20:106. [PMID: 32293297 DOI: 10.1186/s12876-020-01258-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
631 Artzner T, Michard B, Weiss E, Barbier L, Noorah Z, Merle J, Paugam‐burtz C, Francoz C, Durand F, Soubrane O, Pirani T, Theocharidou E, O’grady J, Bernal W, Heaton N, Salamé E, Bucur P, Barraud H, Lefebvre F, Serfaty L, Besch C, Bachellier P, Schneider F, Levesque E, Faitot F. Liver transplantation for critically ill cirrhotic patients: Stratifying utility based on pretransplant factors. Am J Transplant 2020;20:2437-48. [DOI: 10.1111/ajt.15852] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 19.5] [Reference Citation Analysis]
632 Wallace SJ, Swann R, Donnelly M, Kemp L, Guaci J, Murray A, Spoor J, Lin N, Miller M, Dalton HR, Hussaini SH, Gunson R, Simpson K, Stanley A, Fraser A. Mortality and morbidity of locally acquired hepatitis E in the national Scottish cohort: a multicentre retrospective study. Aliment Pharmacol Ther 2020;51:974-86. [DOI: 10.1111/apt.15704] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
633 Perdigoto DN, Figueiredo P, Tomé L. The Role of the CLIF-C OF and the 2016 MELD in Prognosis of Cirrhosis with and without Acute-on-Chronic Liver Failure. Ann Hepatol 2019;18:48-57. [PMID: 31113608 DOI: 10.5604/01.3001.0012.7862] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
634 Grigorenko EA, Mitkovskaya NP, Rummo OO. Prognostic factors for survival of patients on the liver transplant waiting list. SMJ 2020;35:70-79. [DOI: 10.29001/2073-8552-2020-35-1-70-79] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
635 Li X, Wang L, Yang X, Huang C. Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis. Balkan Med J 2020;37:196-202. [PMID: 32270948 DOI: 10.4274/balkanmedj.galenos.2020.2019.9.31] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
636 Tonon M, Piano S, Gambino CG, Romano A, Pilutti C, Incicco S, Brocca A, Sticca A, Bolognesi M, Angeli P. Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2020;. [PMID: 32272250 DOI: 10.1016/j.cgh.2020.03.065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
637 Blasi A, Patel VC, Adelmeijer J, Azarian S, Hernandez Tejero M, Calvo A, Fernández J, Bernal W, Lisman T. Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute-on-Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival. Hepatology 2020;71:1381-90. [PMID: 31465557 DOI: 10.1002/hep.30915] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 22.0] [Reference Citation Analysis]
638 Avila MA, Dufour JF, Gerbes AL, Zoulim F, Bataller R, Burra P, Cortez-Pinto H, Gao B, Gilmore I, Mathurin P, Moreno C, Poznyak V, Schnabl B, Szabo G, Thiele M, Thursz MR. Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting. Gut 2020;69:764-80. [PMID: 31879281 DOI: 10.1136/gutjnl-2019-319720] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 28.5] [Reference Citation Analysis]
639 Yu Z, Li J, Ren Z, Sun R, Zhou Y, Zhang Q, Wang Q, Cui G, Li J, Li A, Duan Z, Xu Y, Wang Z, Yin P, Piao H, Lv J, Liu X, Wang Y, Fang M, Zhuang Z, Xu G, Kan Q. Switching from Fatty Acid Oxidation to Glycolysis Improves the Outcome of Acute-On-Chronic Liver Failure. Adv Sci (Weinh) 2020;7:1902996. [PMID: 32274306 DOI: 10.1002/advs.201902996] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
640 Fernández J, Angeli P, Trebicka J, Merli M, Gustot T, Alessandria C, Aagaard NK, de Gottardi A, Welzel TM, Gerbes A, Soriano G, Vargas V, Albillos A, Salerno F, Durand F, Bañares R, Stauber R, Prado V, Arteaga M, Hernández-tejero M, Aziz F, Morando F, Jansen C, Lattanzi B, Moreno C, Campion D, Gronbaek H, Garcia R, Sánchez C, García E, Amorós A, Pavesi M, Clària J, Moreau R, Arroyo V. Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. Clinical Gastroenterology and Hepatology 2020;18:963-973.e14. [DOI: 10.1016/j.cgh.2019.07.055] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 22.0] [Reference Citation Analysis]
641 Yang L, Wu T, Li J, Xin J, Shi D, Jiang J, Liang X, Lu Y, Yao H, Zhang H, Sun S, Li T, Mohamed Hassan Mohamed H, Li J, Ren K, Guo B, Zhou X, Chen J, Hao S, Chen J, Xin S, Pan C, Han T, Chen Y, Lin S, Duan Z, Xu X, Huang J, Chen X, Li L, Li J; Chinese Group on the Study of Severe Hepatitis B (COSSH). Artificial liver treatment improves survival in patients with hepatitis B virus-related acute-on-chronic liver failure: A case-control matched analysis. Hepatol Res 2020;50:656-70. [PMID: 32134538 DOI: 10.1111/hepr.13497] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
642 Hadrich D. New EU projects delivering human microbiome applications. Future Sci OA 2020;6:FSO474. [PMID: 32670603 DOI: 10.2144/fsoa-2020-0028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
643 Praktiknjo M, Monteiro S, Grandt J, Kimer N, Madsen JL, Werge MP, William P, Brol MJ, Turco L, Schierwagen R, Chang J, Klein S, Uschner FE, Welsch C, Moreau R, Schepis F, Bendtsen F, Gluud LL, Møller S, Trebicka J. Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure. Liver Int 2020;40:1457-66. [PMID: 32162397 DOI: 10.1111/liv.14433] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
644 Tufoni M, Zaccherini G, Caraceni P, Bernardi M. Albumin: Indications in chronic liver disease. United European Gastroenterol J 2020;8:528-35. [PMID: 32213034 DOI: 10.1177/2050640620910339] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
645 Li C, Su HB, Liu XY, Hu JH. Clinical characteristics and 28-d outcomes of bacterial infections in patients with hepatitis B virus-related acute-on-chronic liver failure. World J Clin Cases 2020; 8(6): 1042-1055 [PMID: 32258075 DOI: 10.12998/wjcc.v8.i6.1042] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
646 Chen SH, Wan QS, Wang T, Zhang KH. Fluid Biomarkers for Predicting the Prognosis of Liver Cirrhosis. Biomed Res Int 2020;2020:7170457. [PMID: 32280697 DOI: 10.1155/2020/7170457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
647 Jiang W, Hu Y, Sun Y, Shen Y, Xun Y. Prevalence and short‐term outcome of acute kidney injury in patients with acute‐on‐chronic liver failure: A meta‐analysis. J Viral Hepat 2020;27:810-7. [DOI: 10.1111/jvh.13287] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
648 Agbim U, Sharma A, Maliakkal B, Karri S, Yazawa M, Goldkamp W, Podila PSB, Vanatta JM, Gonzalez H, Molnar MZ, Nair SP, Eason JD, Satapathy SK. Outcomes of Liver Transplant Recipients With Acute-on-Chronic Liver Failure Based on EASL-CLIF Consortium Definition: A Single-center Study. Transplant Direct 2020;6:e544. [PMID: 32309630 DOI: 10.1097/TXD.0000000000000984] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
649 Li B, Gao Y, Wang X, Qian Z, Meng Z, Huang Y, Deng G, Lu X, Liu F, Zheng X, Li H, Chen J. Clinical features and outcomes of bacterascites in cirrhotic patients: A retrospective, multicentre study. Liver Int. 2020;40:1447-1456. [PMID: 32128975 DOI: 10.1111/liv.14418] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
650 Schultalbers M, Tergast TL, Simon N, Kabbani AR, Kimmann M, Zu Siederdissen CH, Gerbel S, Manns MP, Cornberg M, Maasoumy B. Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites. United European Gastroenterol J 2020;8:567-76. [PMID: 32213043 DOI: 10.1177/2050640620913732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
651 Queck A, Bode H, Uschner FE, Brol MJ, Graf C, Schulz M, Jansen C, Praktiknjo M, Schierwagen R, Klein S, Trautwein C, Wasmuth HE, Berres ML, Trebicka J, Lehmann J. Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis. Front Immunol 2020;11:354. [PMID: 32218781 DOI: 10.3389/fimmu.2020.00354] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
652 Zhang X, Ying Y, Zhou P, Liu X, Li R, Tao Y, Dong M, Zhu B, Qi X, Wang Q, Zhang X, Wu J, Zheng J, Zhao W, Zhang W, Wang Z, Zhang J, Huang Y. A Stepwise Evaluation of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure to Optimize the Indication for Urgent Liver Transplantation. Dig Dis Sci 2021;66:284-95. [PMID: 32140946 DOI: 10.1007/s10620-020-06149-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
653 Olson JC. Acute-on-chronic liver failure: management and prognosis. Curr Opin Crit Care 2019;25:165-70. [PMID: 30676328 DOI: 10.1097/MCC.0000000000000595] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
654 Jalan R, Perricone G, Moreau R, Arroyo V, Williams R. Acute-on-Chronic Liver Failure: A New Disease or an Old One Hiding in Plain Sight? Clin Liver Dis (Hoboken) 2020;15:S45-51. [PMID: 32140213 DOI: 10.1002/cld.859] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
655 Fernández J, Arroyo V. Cirrhosis and ascites. Oxford Textbook of Medicine 2020. [DOI: 10.1093/med/9780198746690.003.0318] [Reference Citation Analysis]
656 Nanchal R, Subramanian R, Karvellas CJ, Hollenberg SM, Peppard WJ, Singbartl K, Truwit J, Al-khafaji AH, Killian AJ, Alquraini M, Alshammari K, Alshamsi F, Belley-cote E, Cartin-ceba R, Dionne JC, Galusca DM, Huang DT, Hyzy RC, Junek M, Kandiah P, Kumar G, Morgan RL, Morris PE, Olson JC, Sieracki R, Steadman R, Taylor B, Alhazzani W. Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations. Critical Care Medicine 2020;48:e173-91. [DOI: 10.1097/ccm.0000000000004192] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 16.5] [Reference Citation Analysis]
657 Macnaughtan J, Jalan R. Liver failure. Oxford Textbook of Medicine 2020. [DOI: 10.1093/med/9780198746690.003.0321] [Reference Citation Analysis]
658 Shalimar, Rout G, Kumar R, Singh AD, Sharma S, Gunjan D, Saraya A, Nayak B, Acharya SK. Persistent or incident hyperammonemia is associated with poor outcomes in acute decompensation and acute-on-chronic liver failure. JGH Open 2020;4:843-50. [PMID: 33102753 DOI: 10.1002/jgh3.12314] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
659 Devarbhavi H, Choudhury AK, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Chawla YK, Dhiman RK, Duseja A, Taneja S, Ning Q, Jia JD, Duan Z, Yu C, Eapen CE, Goel A, Tan SS, Hamid SS, Butt AS, Jafri W, Kim DJ, Hu J, Sood A, Midha V, Shukla A, Ghazinian H, Sahu MK, Treeprasertsuk S, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Kalal C, Abbas Z, Sollano JD, Prasad VGM, Payawal DA, Dokmeci AK, Rao PN, Shrestha A, Lau GK, Yuen MF, Saraswat VA, Shiha G, Yokosuka O, Kedarisetty CK, Jain P, Bhatia P, Sarin SK; APASL ACLF working party. Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients. Am J Gastroenterol. 2019;114:929-937. [PMID: 31021832 DOI: 10.14309/ajg.0000000000000201] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
660 Reichert MC, Ripoll C, Casper M, Greinert R, Vandieken E, Grünhage F, Appenrodt B, Zipprich A, Lammert F. Common NOD2 Risk Variants as Major Susceptibility Factors for Bacterial Infections in Compensated Cirrhosis. Clin Transl Gastroenterol 2019;10:e00002. [PMID: 30702490 DOI: 10.14309/ctg.0000000000000002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
661 Zhang Y, Xu BY, Wang XB, Zheng X, Huang Y, Chen J, Meng ZJ, Gao YH, Qian ZP, Liu F, Lu XB, Shi Y, Shang J, Li H, Wang SY, Yin S, Sun SN, Hou YX, Xiong Y, Chen J, Li BL, Lei Q, Gao N, Ji LJ, Li J, Jie FR, Zhao RH, Liu JP, Lin TF, Chen LY, Tan WT, Zhang Q, Zou CC, Huang ZB, Jiang XH, Luo S, Liu CY, Zhang YY, Li T, Ren HT, Wang SJ, Deng GH, Xiong SE, Liu XX, Wang C, Yuan W, Gu WY, Qiao L, Wang TY, Wu DD, Dong FC, Li H, Hua J. Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute Decompensation. Clin Gastroenterol Hepatol 2020;18:2564-2572.e1. [PMID: 32109631 DOI: 10.1016/j.cgh.2020.02.037] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 14.5] [Reference Citation Analysis]
662 Millson C, Considine A, Cramp ME, Holt A, Hubscher S, Hutchinson J, Jones K, Leithead J, Masson S, Menon K, Mirza D, Neuberger J, Prasad R, Pratt A, Prentice W, Shepherd L, Simpson K, Thorburn D, Westbrook R, Tripathi D. Adult liver transplantation: A UK clinical guideline - part 1: pre-operation. Frontline Gastroenterol 2020;11:375-84. [PMID: 32879721 DOI: 10.1136/flgastro-2019-101215] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
663 Ramzan M, Iqbal A, Murtaza HG, Javed N, Rasheed G, Bano K. Comparison of CLIF-C ACLF Score and MELD Score in Predicting ICU Mortality in Patients with Acute-On-Chronic Liver Failure. Cureus 2020;12:e7087. [PMID: 32226688 DOI: 10.7759/cureus.7087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
664 Wan J, Roberts LN, Hendrix W, Konings J, Ow TW, Rabinowich L, Barbouti O, de Laat B, Arya R, Patel VC, Roest M, Lisman T, Bernal W. Whole blood thrombin generation profiles of patients with cirrhosis explored with a near patient assay. J Thromb Haemost 2020;18:834-43. [PMID: 31997515 DOI: 10.1111/jth.14751] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
665 Schaapman JJ, Amoros À, van der Reijden JJ, Laleman W, Zeuzem S, Bañares R, Jalan R, Arroyo V, Clària J, Verspaget HW, Coenraad MJ. Genetic variants of innate immunity receptors are associated with mortality in cirrhotic patients with bacterial infection. Liver Int 2020;40:646-53. [PMID: 31991025 DOI: 10.1111/liv.14392] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
666 Wan SZ, Nie Y, Zhang Y, Liu C, Zhu X. Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department. Dis Markers 2020;2020:5193028. [PMID: 32148566 DOI: 10.1155/2020/5193028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
667 Cao ZJ, Liu YH, Zhu CW, Yin S, Wang WJ, Tang WL, Zhao GD, Xu YM, Chen L, Zhou TH, Cai MH, Wang H, Cai W, Bao SS, Li H, Xie Q. Bacterial infection triggers and complicates acute-on-chronic liver failure in patients with hepatitis B virus-decompensated cirrhosis: A retrospective cohort study. World J Gastroenterol 2020; 26(6): 645-656 [PMID: 32103873 DOI: 10.3748/wjg.v26.i6.645] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
668 Sadick V, Bowcock E, Lane S, Seppelt I. Survival and predictors of outcome among patients with decompensated liver disease in a non-liver transplant intensive care unit. Pessimism is historical and unjustified. Intern Med J 2019;49:745-52. [PMID: 30379403 DOI: 10.1111/imj.14151] [Reference Citation Analysis]
669 Liotta EM, Karvellas CJ, Kim M, Batra A, Naidech A, Prabhakaran S, Sorond FA, Kimberly WT, Maas MB. Serum osmolality, cerebrospinal fluid specific gravity and overt hepatic encephalopathy severity in patients with liver failure. Liver Int 2020;40:1977-86. [PMID: 32020734 DOI: 10.1111/liv.14400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
670 Paugam-burtz C, Levesque E, Louvet A, Thabut D, Amathieu R, Bureau C, Camus C, Chanques G, Faure S, Ferrandière M, Francoz C, Galbois A, Gustot T, Ichai C, Ichai P, Jaber S, Lescot T, Moreau R, Roullet S, Saliba F, Thévenot T, Velly L, Weiss E. Management of liver failure in general intensive care unit. Anaesthesia Critical Care & Pain Medicine 2020;39:143-61. [DOI: 10.1016/j.accpm.2019.06.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
671 Arora V, Maiwall R, Rajan V, Jindal A, Muralikrishna Shasthry S, Kumar G, Jain P, Sarin SK. Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure. Hepatology 2020;71:600-10. [PMID: 30076614 DOI: 10.1002/hep.30208] [Cited by in Crossref: 71] [Cited by in F6Publishing: 80] [Article Influence: 35.5] [Reference Citation Analysis]
672 Engelmann C, Tacke F. Dekompensierte Leberzirrhose und akut-auf-chronisches Leberversagen. Gastroenterologe 2020;15:22-33. [DOI: 10.1007/s11377-019-00407-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
673 Rifaie N, Saner FH. Critical care management in patients with acute liver failure. Best Pract Res Clin Anaesthesiol 2020;34:89-99. [PMID: 32334790 DOI: 10.1016/j.bpa.2020.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
674 GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020;5:245-66. [PMID: 31981519 DOI: 10.1016/S2468-1253(19)30349-8] [Cited by in Crossref: 434] [Cited by in F6Publishing: 450] [Article Influence: 217.0] [Reference Citation Analysis]
675 Rosenblatt R, Shen N, Tafesh Z, Cohen‐mekelburg S, Crawford CV, Kumar S, Lucero C, Brown RS, Jesudian A, Fortune BE. The North American Consortium for the Study of End‐Stage Liver Disease–Acute‐on‐Chronic Liver Failure Score Accurately Predicts Survival: An External Validation Using a National Cohort. Liver Transpl 2019;26:187-95. [DOI: 10.1002/lt.25696] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
676 Kulkarni AV, Kumar P, Rao NP, Reddy N. Terlipressin-induced ischaemic skin necrosis. BMJ Case Rep 2020;13:e233089. [PMID: 31948983 DOI: 10.1136/bcr-2019-233089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
677 Ibidapo-Obe O, Stengel S, Köse-Vogel N, Quickert S, Reuken PA, Busch M, Bauer M, Stallmach A, Bruns T. Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal Inflammation. Cell Mol Gastroenterol Hepatol 2020;9:661-77. [PMID: 31954178 DOI: 10.1016/j.jcmgh.2020.01.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
678 Bajaj JS, Tandon P, OʼLeary JG, Wong F, Biggins SW, Garcia-Tsao G, Kamath PS, Maliakkal B, Fallon MB, Lai JC, Thuluvath PJ, Vargas HE, Subramanian RM, Thacker LR, Reddy KR. Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial Peritonitis. Am J Gastroenterol 2019;114:599-606. [PMID: 30694868 DOI: 10.14309/ajg.0000000000000044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
679 Cisilotto J, do Amaral AE, Rosolen D, Rode MP, Silva AH, Winter E, da Silva TE, Fischer J, Matiollo C, Rateke ECM, Narciso-Schiavon JL, Schiavon LL, Creczynski-Pasa TB. MicroRNA profiles in serum samples from Acute-On-Chronic Liver Failure patients and miR-25-3p as a potential biomarker for survival prediction. Sci Rep 2020;10:100. [PMID: 31919459 DOI: 10.1038/s41598-019-56630-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
680 Engelmann C, Thomsen KL, Mookerjee RP. Response to Intensive Care Is the Key to Prognosticate Patients With Severe Acute-on-Chronic Liver Failure. Crit Care Med 2019;47:e384-5. [PMID: 30882451 DOI: 10.1097/CCM.0000000000003619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
681 Tong JJ, Zhao W, Mu XY, Xu X, Su HB, Liu XY, Chen J, Zhai XR, Wang Y, Hu JH. Predictive value of the Chinese group on the study of severe hepatitis B-acute-on-chronic liver failure score in the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Chin Med J (Engl) 2019;132:1541-9. [PMID: 31188162 DOI: 10.1097/CM9.0000000000000298] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
682 Cullaro G, Sharma R, Trebicka J, Cárdenas A, Verna EC. Precipitants of Acute-on-Chronic Liver Failure: An Opportunity for Preventative Measures to Improve Outcomes. Liver Transpl 2020;26:283-93. [PMID: 31714011 DOI: 10.1002/lt.25678] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
683 Mielnicki W, Dyla A, Karczewski M. Clinical effectiveness of MARS treatment - multidirectional analysis of positive clinical response to treatment. Clin Exp Hepatol 2019;5:271-8. [PMID: 31893237 DOI: 10.5114/ceh.2019.89163] [Reference Citation Analysis]
684 Shalimar, Sharma S, Gamanagatti SR, Chauhan A, Vuyyuru SK, Elhence A, Rout G, Saraya A, Gunjan D, Nayak B, Kumar R, Acharya SK. Acute-on-Chronic Liver Failure in Budd–Chiari Syndrome: Profile and Predictors of Outcome. Dig Dis Sci 2020;65:2719-29. [DOI: 10.1007/s10620-019-06005-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
685 Glass DM, Al-khafaji A. The Clinical Spectrum and Manifestations of Acute and Acute on Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
686 Ginès P, Ariza X. Hepatorenal Syndrome. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.65716-1] [Reference Citation Analysis]
687 Riordan SM. Hepatic Encephalopathy. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_64] [Reference Citation Analysis]
688 Rice JP. Acute Alcoholic Hepatitis. The Critically Ill Cirrhotic Patient 2020. [DOI: 10.1007/978-3-030-24490-3_10] [Reference Citation Analysis]
689 Ahn JC, Shah VH. Alcoholic Hepatitis and Alcohol-Related Acute on Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_14] [Reference Citation Analysis]
690 Da BL, Nguyen A, Khan A, Dieterich DT. Viral Hepatitis Non: B, C, D and Acute and Acute on Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_10] [Reference Citation Analysis]
691 Leventhal TM, Kc M, Steer CJ. Liver Regeneration in Acute and Acute-on-Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_4] [Reference Citation Analysis]
692 Garcia-martinez R, Diaz-ruiz R, Millan J, Bañares R. Chronic Liver Failure and Acute-on-Chronic Liver Failure. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_33] [Reference Citation Analysis]
693 Paterno F, Salcedo RO, Pyrsopoulos N, Guarrera JV. Liver Transplantation for Acute and Acute on Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_15] [Reference Citation Analysis]
694 Shin NR, Gu N, Choi HS, Kim H. Combined effects of Scutellaria baicalensis with metformin on glucose tolerance of patients with type 2 diabetes via gut microbiota modulation. American Journal of Physiology-Endocrinology and Metabolism 2020;318:E52-61. [DOI: 10.1152/ajpendo.00221.2019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
695 Olson JC. Intensive Care Management of Patients with Cirrhosis. The Critically Ill Cirrhotic Patient 2020. [DOI: 10.1007/978-3-030-24490-3_6] [Reference Citation Analysis]
696 Arora V, Jagdish RK, Sarin SK. Acute-on-Chronic Liver Failure. Liver Immunology 2020. [DOI: 10.1007/978-3-030-51709-0_32] [Reference Citation Analysis]
697 Dellatore P, Mishra A, Rustgi V. Prognostic Models in Acute and Acute on Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_5] [Reference Citation Analysis]
698 Land WG. Solid Organ Injury. Damage-Associated Molecular Patterns in Human Diseases 2020. [DOI: 10.1007/978-3-030-53868-2_9] [Reference Citation Analysis]
699 Teschke R. Acetaminophen syn. Paracetamol: Acute Liver Injury and Acute on Chronic Liver Failure with Case Analysis and Causality Assessment Using RUCAM. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_12] [Reference Citation Analysis]
700 Thuluvath PJ, Thuluvath AJ, Savva Y, Zhang T. Karnofsky Performance Status Following Liver Transplantation in Patients With Multiple Organ Failures and Probable Acute-on-Chronic Liver Failure. Clinical Gastroenterology and Hepatology 2020;18:234-41. [DOI: 10.1016/j.cgh.2019.03.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
701 Lingiah V, Niazi M, Pyrsopoulos N. Acute and Acute on Chronic Liver Failure: Mechanisms of Disease and Multi-systemic Involvement. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_2] [Reference Citation Analysis]
702 Tafesh ZH, Pyrsopoulos N. Classification and Epidemiologic Aspects of Acute and Acute on Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_1] [Reference Citation Analysis]
703 Wood SL. Acute Liver Failure and Acute Decompensation of Chronic Liver Failure. Emergency Department Critical Care 2020. [DOI: 10.1007/978-3-030-28794-8_15] [Reference Citation Analysis]
704 Pedersen MR, Tujios SR. Acute on Chronic Liver Failure. The Critically Ill Cirrhotic Patient 2020. [DOI: 10.1007/978-3-030-24490-3_11] [Reference Citation Analysis]
705 Riordan SM. Non-Intensive Care Unit Management of Acute and Acute on Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_7] [Reference Citation Analysis]
706 Arroyo V, Clària J, Trebicka J. Liver Failure, Acute-on-Chronic. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.65780-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
707 Stirnimann G. Evidence for the Assessment of Physical Frailty and Sarcopenia in Hospitalized Patients and the Role of Assessing Changes Over Time. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_11] [Reference Citation Analysis]
708 Sy AM, O’brien CB. Viral Hepatitis B, C and D in ALF and ALF/CLD. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_9] [Reference Citation Analysis]
709 Engelmann C, Böhlig A, Berg T. Leberzirrhose und deren Komplikationen. Pathologie 2020. [DOI: 10.1007/978-3-642-04557-8_10] [Reference Citation Analysis]
710 Hernández-tejero M, Carpio A, Fernández J. Cirrhosis; Management of Spontaneous Bacterial Peritonitis and Other Infections. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.65722-7] [Reference Citation Analysis]
711 Shaw J, Bajaj JS. Infections in Critically Ill Cirrhosis Patients. The Critically Ill Cirrhotic Patient 2020. [DOI: 10.1007/978-3-030-24490-3_7] [Reference Citation Analysis]
712 Brumer R, Navabi S, Pyrsopoulos N. Looking Past Orthotopic Liver Transplantation: A Review of Emerging Strategies for Managing Acute and Acute-on-Chronic Liver Failure. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_17] [Reference Citation Analysis]
713 Koola JD, Ho S, Chen G, Perkins AM, Cao A, Davis SE, Matheny ME. Development of a national Department of Veterans Affairs mortality risk prediction model among patients with cirrhosis. BMJ Open Gastroenterol 2019;6:e000342. [PMID: 31875140 DOI: 10.1136/bmjgast-2019-000342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
714 Mahmud N, Hubbard RA, Kaplan DE, Taddei TH, Goldberg DS. Risk prediction scores for acute on chronic liver failure development and mortality. Liver Int 2020;40:1159-67. [PMID: 31840390 DOI: 10.1111/liv.14328] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
715 Klein LM, Chang J, Gu W, Manekeller S, Jansen C, Lingohr P, Praktiknjo M, Kalf JC, Schulz M, Spengler U, Strassburg C, Cárdenas A, Arroyo V, Trebicka J. The Development and Outcome of Acute-on-Chronic Liver Failure After Surgical Interventions. Liver Transpl 2020;26:227-37. [PMID: 31693788 DOI: 10.1002/lt.25675] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
716 Perricone G, Jalan R. Acute-on-Chronic Liver Failure: A Distinct Clinical Syndrome That Has Reclassified Cirrhosis. Clin Liver Dis (Hoboken) 2019;14:171-5. [PMID: 31879558 DOI: 10.1002/cld.857] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
717 MacDonald AJ, Karvellas CJ. Acute kidney injury: A critical care perspective for orthotopic liver transplantation. Best Pract Res Clin Anaesthesiol 2020;34:69-78. [PMID: 32334788 DOI: 10.1016/j.bpa.2019.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
718 Tomescu D, Popescu M, Biancofiore G. Liver transplantation for acute-on-chronic liver failure. Best Pract Res Clin Anaesthesiol 2020;34:25-33. [PMID: 32334784 DOI: 10.1016/j.bpa.2019.12.001] [Reference Citation Analysis]
719 Fuhrmann V, Bauer M, Wilmer A. The persistent potential of extracorporeal therapies in liver failure. Intensive Care Med 2020;46:528-30. [PMID: 31822935 DOI: 10.1007/s00134-019-05886-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
720 Brenig R, Pop OT, Triantafyllou E, Geng A, Singanayagam A, Perez-Shibayama C, Besse L, Cupovic J, Künzler P, Boldanova T, Brand S, Semela D, Duong FH, Weston CJ, Ludewig B, Heim MH, Wendon J, Antoniades CG, Bernsmeier C. Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis. Life Sci Alliance 2020;3:e201900465. [PMID: 31822557 DOI: 10.26508/lsa.201900465] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
721 Pirani T, Wendon J. Acute-on-chronic liver failure. Challenging Concepts in Critical Care 2019. [DOI: 10.1093/med/9780198814924.003.0011] [Reference Citation Analysis]
722 Horvatits T, Drolz A, Trauner M, Fuhrmann V. Liver Injury and Failure in Critical Illness. Hepatology 2019;70:2204-15. [PMID: 31215660 DOI: 10.1002/hep.30824] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 17.0] [Reference Citation Analysis]
723 Choudhary NS, Saraf N, Saigal S, Soin AS. Letter to the Editor: Incidence and Mortality of Acute on Chronic Liver Failure Using Two Definitions in Patients With Compensated Cirrhosis. Hepatology 2019;70:2235-6. [PMID: 31243777 DOI: 10.1002/hep.30837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
724 Choudhury A, Sarin SK. Letter to the Editor: Tale of Two ACLF Definitions: Choices Are Getting Clearer. Hepatology 2019;70:2233-5. [PMID: 31243776 DOI: 10.1002/hep.30836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
725 Bourlière M, Pol S. Abstracts. Liver Int 2019;39:2420-2468. [DOI: 10.1111/liv.14255] [Reference Citation Analysis]
726 Mahmud N, Kaplan DE, Taddei TH, Goldberg DS. Reply. Hepatology 2019;70:2236-8. [PMID: 31243784 DOI: 10.1002/hep.30835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
727 Bataller R, Cabezas J, Aller R, Ventura-cots M, Abad J, Albillos A, Altamirano J, Arias-loste MT, Bañares R, Caballería J, Caballería L, Carrión JA, Diago M, Fernández-rodríguez C, Gallego R, García-cortes M, García-monzón C, Genescà J, Ginés P, Hernandez-guerra M, Jorquera F, Lligoña A, Molina E, Pareja MJ, Planas R, Tomé S, Salmerón J, Romero-gómez M. Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. Gastroenterología y Hepatología (English Edition) 2019;42:657-676. [DOI: 10.1016/j.gastre.2019.09.003] [Reference Citation Analysis]
728 Xiao LL, Xu XW, Huang KZ, Zhao YL, Zhang LJ, Li LJ. Artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis. Biomed Res Int 2019;2019:3757149. [PMID: 31871940 DOI: 10.1155/2019/3757149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
729 Bataller R, Cabezas J, Aller R, Ventura-Cots M, Abad J, Albillos A, Altamirano J, Arias-Loste MT, Bañares R, Caballería J, Caballería L, Carrión JA, Diago M, Fernández Rodríguez C, Gallego R, García-Cortes M, García-Monzón C, Genescà J, Ginés P, Hernandez-Guerra M, Jorquera F, Lligoña A, Molina E, Pareja MJ, Planas R, Tomé S, Salmerón J, Romero-Gómez M. Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. Gastroenterol Hepatol 2019;42:657-76. [PMID: 31771785 DOI: 10.1016/j.gastrohep.2019.09.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
730 Cannon MD, Martin P, Carrion AF. Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death. Dig Dis Sci 2020;65:31-7. [PMID: 31768880 DOI: 10.1007/s10620-019-05943-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
731 Facciorusso A. Hepatorenal Syndrome Type 1: Current Challenges And Future Prospects.Ther Clin Risk Manag. 2019;15:1383-1391. [PMID: 31819465 DOI: 10.2147/TCRM.S205328] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
732 Xie Z, Violetta L, Chen E, Huang K, Wu D, Xu X, Ouyang X, Zhao Y, Li L. A prognostic model for hepatitis B acute-on-chronic liver failure patients treated using a plasma exchange-centered liver support system. J Clin Apher 2020;35:94-103. [PMID: 31769901 DOI: 10.1002/jca.21762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
733 Solé C, Solà E, Ginès P. Are We Ready to Evaluate Adrenal Function in Patients With Decompensated Cirrhosis and Acute-on-Chronic Liver Failure? Clin Gastroenterol Hepatol 2020;18:1040-2. [PMID: 31759163 DOI: 10.1016/j.cgh.2019.11.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
734 Miranda-Zazueta G, León-Garduño LAP, Aguirre-Valadez J, Torre-Delgadillo A. Bacterial infections in cirrhosis: Current treatment. Ann Hepatol 2020;19:238-44. [PMID: 32317149 DOI: 10.1016/j.aohep.2019.09.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
735 Gustot T. JHEP Reports: The fourth issue. JHEP Rep 2019;1:257-8. [PMID: 32039375 DOI: 10.1016/j.jhepr.2019.09.004] [Reference Citation Analysis]
736 Testino G, Vignoli T, Patussi V, Scafato E, Caputo F; SIA board (Appendix A) and the external expert supervisors (Appendix B). Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol (SIA). Dig Liver Dis 2020;52:21-32. [PMID: 31757596 DOI: 10.1016/j.dld.2019.09.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
737 Leal C, Prado V, Colan J, Chavez-Rivera K, Sendino O, Blasi A, Roura P, Juanola A, Rodriguez de Miguel C, Pavesi M, Gomez C, Guarner C, Guarner-Argente C, Fernández J, Cardenas A. Adverse Events and Acute Chronic Liver Failure in Patients With Cirrhosis Undergoing Endoscopic Retrograde Cholangiopancreatography: A Multicenter Matched-Cohort Study. Am J Gastroenterol 2019;114:89-97. [PMID: 30177786 DOI: 10.1038/s41395-018-0218-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
738 Asrani SK, Hall L, Hagan M, Sharma S, Yeramaneni S, Trotter J, Talwalkar J, Kanwal F. Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study. Am J Gastroenterol 2019;114:98-106. [PMID: 30333543 DOI: 10.1038/s41395-018-0365-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
739 Huang K, Ji F, Xie Z, Wu D, Xu X, Gao H, Ouyang X, Xiao L, Zhou M, Zhu D, Li L. Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: Classification and regression tree analysis. Sci Rep 2019;9:16462. [PMID: 31712684 DOI: 10.1038/s41598-019-53029-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
740 Kok B, Duarte-Rojo A, Tandon P. Predicting Functional Status After Transplantation in Patients With Acute-on-Chronic Liver Failure. Clin Gastroenterol Hepatol 2020;18:54-6. [PMID: 31705879 DOI: 10.1016/j.cgh.2019.05.048] [Reference Citation Analysis]
741 Allaire M, Cadranel JF, Nguyen TTN, Garioud A, Zougmore H, Heng R, Perignon C, Ollivier-Hourmand I, Dao T. Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review. Clin Res Hepatol Gastroenterol 2020;44:264-74. [PMID: 31706985 DOI: 10.1016/j.clinre.2019.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
742 Wu T, Sundaram V. Transplantation for Acute-on-Chronic Liver Failure. Clin Liver Dis (Hoboken) 2019;14:152-5. [PMID: 31709045 DOI: 10.1002/cld.852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
743 Lebossé F, Gudd C, Tunc E, Singanayagam A, Nathwani R, Triantafyllou E, Pop O, Kumar N, Mukherjee S, Hou TZ, Quaglia A, Zoulim F, Wendon J, Dhar A, Thursz M, Antoniades CG, Khamri W. CD8+T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction. EBioMedicine 2019;49:258-68. [PMID: 31678004 DOI: 10.1016/j.ebiom.2019.10.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
744 Shah T, Tapper EB. ERCP in Patients With Cirrhosis: "Risky Business" Or "Just Do it"? Am J Gastroenterol 2019;114:19-20. [PMID: 30315309 DOI: 10.1038/s41395-018-0271-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
745 Chen F, Shi Y, Liu X, Lei L, Xu J. Corticosteroid improves liver function but does not curb the clinical progression of hepatitis B virus-related acute-on-chronic pre-liver failure. Expert Rev Gastroenterol Hepatol 2019;13:1129-35. [PMID: 31674256 DOI: 10.1080/17474124.2019.1688143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
746 Lebossé F, Gudd C, Tunc E, Singanayagam A, Nathwani R, Triantafyllou E, Pop O, Kumar N, Mukherjee S, Hou TZ, Quaglia A, Zoulim F, Wendon J, Dhar A, Thursz M, Antoniades CG, Khamri W. CD8+T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction. EBioMedicine 2019;49:258-68. [PMID: 31678004 DOI: 10.1016/j.ebiom.2019.10.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
747 Hoppmann NA, Gray ME, McGuire BM. Drug-Induced Liver Injury in the Setting of Chronic Liver Disease. Clin Liver Dis 2020;24:89-106. [PMID: 31753253 DOI: 10.1016/j.cld.2019.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
748 Chen CH, Chang CL, Chen KH, Cheng BC, Chen HH, Chiang JY, Sung PH, Yip HK. Level and Value of T Cell-derived Circulating Microparticles in Liver Cirrhosis Patients. In Vivo 2019;33:2265-72. [PMID: 31662566 DOI: 10.21873/invivo.11732] [Reference Citation Analysis]
749 Jayaraman T, Lee YY, Chan WK, Mahadeva S. Epidemiological differences of common liver conditions between Asia and the West. JGH Open. 2020;4:332-339. [PMID: 32514433 DOI: 10.1002/jgh3.12275] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
750 Chen T, Yang Z, Choudhury AK, Al Mahtab M, Li J, Chen Y, Tan SS, Han T, Hu J, Hamid SS, Huei LG, Ghazinian H, Nan Y, Chawla YK, Yuen MF, Devarbhavi H, Shukla A, Abbas Z, Sahu M, Dokmeci AK, Lesmana LA, Lesmana CRA, Xin S, Duan Z, Guo W, Ma K, Zhang Z, Cheng Q, Jia J, Sharma BC, Sarin SK, Ning Q. Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region. Hepatol Int. 2019;13:695-705. [PMID: 31650510 DOI: 10.1007/s12072-019-09992-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
751 Sharma S, Lal SB, Sachdeva M, Bhatia A, Varma N. Role of Granulocyte Colony Stimulating Factor on the Short-Term Outcome of Children with Acute on Chronic Liver Failure. J Clin Exp Hepatol 2020;10:201-10. [PMID: 32405176 DOI: 10.1016/j.jceh.2019.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
752 Ingraham NE, Tignanelli CJ, Menk J, Chipman JG. Pre- and Peri-Operative Factors Associated with Chronic Critical Illness in Liver Transplant Recipients. Surg Infect (Larchmt) 2020;21:246-54. [PMID: 31618109 DOI: 10.1089/sur.2019.192] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
753 Singal AK, Kamath PS. Acute on chronic liver failure in non-alcoholic fatty liver and alcohol associated liver disease. Transl Gastroenterol Hepatol 2019;4:74. [PMID: 31728431 DOI: 10.21037/tgh.2019.09.11] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
754 Pose E, Napoleone L, Amin A, Campion D, Jimenez C, Piano S, Roux O, Uschner FE, de Wit K, Zaccherini G, Alessandria C, Angeli P, Bernardi M, Beuers U, Caraceni P, Durand F, Mookerjee RP, Trebicka J, Vargas V, Andrade RJ, Carol M, Pich J, Ferrero J, Domenech G, Llopis M, Torres F, Kamath PS, Abraldes JG, Solà E, Ginès P. Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Gastroenterol Hepatol 2020;5:31-41. [PMID: 31607677 DOI: 10.1016/S2468-1253(19)30320-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 15.7] [Reference Citation Analysis]
755 Garcia-Tsao G. Prophylactic Antibiotics in Cirrhosis: Are They Promoting or Preventing Infections? Clin Liver Dis (Hoboken) 2019;14:98-102. [PMID: 31632658 DOI: 10.1002/cld.819] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
756 Wong F. Clinical Consequences of Infection in Cirrhosis: Organ Failures and Acute-on-Chronic Liver Failure. Clin Liver Dis (Hoboken) 2019;14:92-7. [PMID: 31632657 DOI: 10.1002/cld.813] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
757 Aller MA, Arias N, Blanco-Rivero J, Arias J. Metabolism in Acute-On-Chronic Liver Failure: The Solution More than the Problem. Arch Med Res 2019;50:271-84. [PMID: 31593852 DOI: 10.1016/j.arcmed.2019.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
758 Piano S, Angeli P. Current Concepts on Bacterial and Fungal Infections in Cirrhosis. Clin Liver Dis (Hoboken) 2019;14:87-91. [PMID: 31632656 DOI: 10.1002/cld.799] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
759 Piano S, Favaretto E, Tonon M, Antonelli G, Brocca A, Sticca A, Mareso S, Gringeri E, Scaroni C, Plebani M, Russo FP, Burra P, Cillo U, Angeli P. Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure. Clin Gastroenterol Hepatol. 2020;18:1188-1196.e3. [PMID: 31589973 DOI: 10.1016/j.cgh.2019.09.035] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
760 Yoon EL, Kim TY, Song DS, Kim HY, Kim CW, Jung YK, Sinn DH, Jang JY, Kim MY, Jeong SW, Kim SG, Suk KT, Kim DJ, Liver Failure KACLiF Study Group OBOTKA. The Impact of Previous Acute Decompensation on the Long-Term Prognosis of Alcoholic Hepatitis in Cirrhotic Patients. J Clin Med 2019;8:E1600. [PMID: 31623316 DOI: 10.3390/jcm8101600] [Reference Citation Analysis]
761 Yan X, Shao R, Wang Y, Mao X, Lei J, Zhang L, Zheng J, Liu A, Zhao H, Gao F, Wang J, Li P, Yao S, Xu M, Xu J, Liu D, Mi Y, Gong X, Ye J, Deng M, Dang T, Ji J, Shao C, Liu C, Gu Y, Wu Y, Wang F, Teng G, Li X, Qi X, Ju S, Qi X. Functional magnetic resonance imaging-based assessment of terlipressin vs. octreotide on renal function in cirrhotic patients with acute variceal bleeding (CHESS1903): study protocol of a multicenter randomized controlled trial. Ann Transl Med 2019;7:586. [PMID: 31807567 DOI: 10.21037/atm.2019.09.141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
762 Aby ES, Lee E, Saggi SS, Viramontes MR, Grotts JF, Agopian VG, Busuttil RW, Saab S. Pretransplant Sarcopenia in Patients With NASH Cirrhosis Does Not Impact Rehospitalization or Mortality. Journal of Clinical Gastroenterology 2019;53:680-5. [DOI: 10.1097/mcg.0000000000001109] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
763 da Silva Boteon APC, Chauhan A, Boteon YL, Tillakaratne S, Gunson B, Elsharkawy AM, Ford A, Bangash M, Murphy N, Armstrong MJ, Rajoriya N, Perera MTP. Predictive factors for 28-day mortality in acute-on-chronic liver failure patients admitted to the intensive care unit. Digestive and Liver Disease 2019;51:1416-22. [DOI: 10.1016/j.dld.2019.04.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
764 Korf H, du Plessis J, van Pelt J, De Groote S, Cassiman D, Verbeke L, Ghesquière B, Fendt SM, Bird MJ, Talebi A, Van Haele M, Feio-Azevedo R, Meelberghs L, Roskams T, Mookerjee RP, Mehta G, Jalan R, Gustot T, Laleman W, Nevens F, van der Merwe SW. Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacity. Gut 2019;68:1872-83. [PMID: 30580251 DOI: 10.1136/gutjnl-2018-316888] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 13.3] [Reference Citation Analysis]
765 Intagliata NM, Davis JP, Lafond J, Erdbruegger U, Greenberg CS, Northup PG, Caldwell SH. Acute kidney injury is associated with low factor XIII in decompensated cirrhosis. Digestive and Liver Disease 2019;51:1409-15. [DOI: 10.1016/j.dld.2019.03.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
766 Bañares R, Ibáñez-samaniego L, Torner JM, Pavesi M, Olmedo C, Catalina MV, Albillos A, Larsen FS, Nevens F, Hassanein T, Schmidt H, Heeman U, Jalan R, Moreau R, Arroyo V. Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity. Therap Adv Gastroenterol 2019;12:175628481987956. [DOI: 10.1177/1756284819879565] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
767 Mouliade C, Dépret F, Rosenbaum B, Mallet V. L’hépatite hypoxique : ce que le réanimateur doit savoir. Méd Intensive Réa . [DOI: 10.3166/rea-2019-0125] [Reference Citation Analysis]
768 Karvellas CJ, Garcia-Lopez E, Fernandez J, Saliba F, Sy E, Jalan R, Pavesi M, Gustot T, Ronco JJ, Arroyo V; Chronic Liver Failure Consortium and European Foundation for the Study of Chronic Liver Failure. Dynamic Prognostication in Critically Ill Cirrhotic Patients With Multiorgan Failure in ICUs in Europe and North America: A Multicenter Analysis. Crit Care Med. 2018;46:1783-1791. [PMID: 30106759 DOI: 10.1097/ccm.0000000000003369] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
769 Pereira G, Baldin C, Piedade J, Reis V, Valdeolivas T, Victor L, Guimarães L, Duarte J, Veiga Z, Alcântara C, Fernandes F, Pereira JL. Combination and sequential evaluation of acute-on-chronic liver failure (ACLF) and hyponatremia and prognosis in cirrhotic patients. Dig Liver Dis 2020;52:91-7. [PMID: 31542220 DOI: 10.1016/j.dld.2019.08.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
770 McPhail MJW, Parrott F, Wendon JA, Harrison DA, Rowan KA, Bernal W. Incidence and Outcomes for Patients With Cirrhosis Admitted to the United Kingdom Critical Care Units. Crit Care Med 2018;46:705-12. [PMID: 29309369 DOI: 10.1097/CCM.0000000000002961] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 10.7] [Reference Citation Analysis]
771 Martin Mateos R, Albillos A. Sepsis in Patients With Cirrhosis Awaiting Liver Transplantation: New Trends and Management. Liver Transpl 2019;25:1700-9. [DOI: 10.1002/lt.25621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
772 Lucey MR. Alcohol-Associated Cirrhosis. Clin Liver Dis 2019;23:115-26. [PMID: 30454826 DOI: 10.1016/j.cld.2018.09.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
773 Scheiner B, Semmler G, Maurer F, Schwabl P, Bucsics TA, Paternostro R, Bauer D, Simbrunner B, Trauner M, Mandorfer M, Reiberger T. Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease. Liver Int 2020;40:194-204. [PMID: 31444993 DOI: 10.1111/liv.14229] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
774 Rajaram P, Subramanian RM. Adding to the Repertoire of Scoring Systems in Acute-on-Chronic Liver Failure: Will Simplicity Be Outdone by Complexity? Crit Care Med 2018;46:1875-6. [PMID: 30312234 DOI: 10.1097/CCM.0000000000003398] [Reference Citation Analysis]
775 Torner M, Mangal A, Scharnagl H, Jansen C, Praktiknjo M, Queck A, Gu W, Schierwagen R, Lehmann J, Uschner FE, Graf C, Strassburg CP, Fernandez J, Stojakovic T, Woitas R, Trebicka J. Sex specificity of kidney markers to assess prognosis in cirrhotic patients with TIPS. Liver Int 2020;40:186-93. [PMID: 31448496 DOI: 10.1111/liv.14230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
776 Aspinall RJ. Reducing recurrent hospital admissions in patients with decompensated cirrhosis. Br J Hosp Med (Lond) 2018;79:93-6. [PMID: 29431486 DOI: 10.12968/hmed.2018.79.2.93] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
777 Hadfield NJ, Selvendran S, Johnston MP. Fatal Pneumocystis jirovecii pneumonia in a non-immunocompromised patient with alcohol-related liver cirrhosis. Scott Med J 2019;64:148-53. [PMID: 31474180 DOI: 10.1177/0036933019872629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
778 Wang Y, Liu H, Liu S, Yang C, Jiang Y, Wang S, Liu A, Peppelenbosch MP, Kamar N, Pan Q, Zhao J. Incidence, predictors and prognosis of genotype 4 hepatitis E related liver failure: A tertiary nested case-control study. Liver Int 2019;39:2291-300. [PMID: 31436371 DOI: 10.1111/liv.14221] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
779 Shalimar, Sheikh MF, Mookerjee RP, Agarwal B, Acharya SK, Jalan R. Prognostic Role of Ammonia in Patients With Cirrhosis. Hepatology 2019;70:982-94. [PMID: 30703853 DOI: 10.1002/hep.30534] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 17.7] [Reference Citation Analysis]
780 Kabbani AR, Tergast TL, Manns MP, Maasoumy B. [Treatment strategies for acute-on-chronic liver failure]. Med Klin Intensivmed Notfmed 2021;116:3-16. [PMID: 31463674 DOI: 10.1007/s00063-019-00613-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
781 Mookerjee RP, Thomsen KL. Editorial: evaluating cirrhosis progression-lessons from the heart. Authors' reply. Aliment Pharmacol Ther 2019;50:710-1. [PMID: 31456296 DOI: 10.1111/apt.15463] [Reference Citation Analysis]
782 Gupta T, Lochan D, Verma N, Rathi S, Agrawal S, Duseja A, Taneja S, Chawla YK, Dhiman RK. Prediction of 28-day mortality in acute decompensation of cirrhosis through the presence of multidrug-resistant infections at admission. J Gastroenterol Hepatol 2020;35:461-6. [PMID: 31334860 DOI: 10.1111/jgh.14788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
783 Waller K, James C, de Jong A, Blackmore L, Ma Y, Stagg A, Kelsell D, O'Dwyer M, Hutchins R, Alazawi W. ADAM17-Mediated Reduction in CD14++CD16+ Monocytes ex vivo and Reduction in Intermediate Monocytes With Immune Paresis in Acute Pancreatitis and Acute Alcoholic Hepatitis. Front Immunol 2019;10:1902. [PMID: 31507587 DOI: 10.3389/fimmu.2019.01902] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
784 Wang C, Ma DQ, Luo S, Wang CM, Ding DP, Tian YY, Ao KJ, Zhang YH, Chen Y, Meng ZJ. Incidence of infectious complications is associated with a high mortality in patients with hepatitis B virus-related acute-on-chronic liver failure. World J Clin Cases 2019; 7(16): 2204-2216 [PMID: 31531315 DOI: 10.12998/wjcc.v7.i16.2204] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
785 Wang C, Ma D, Luo S, Wang C, Ding D, Tian Y, Ao K, Zhang Y, Chen Y, Meng Z. Incidence of infectious complications is associated with a high mortality in patients with hepatitis B virus-related acute-on-chronic liver failure. WJCC 2019;7:2204-16. [DOI: 10.12998/wjge.v7.i16.2204] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
786 Becares N, Härmälä S, China L, Colas RA, Maini AA, Bennet K, Skene SS, Shabir Z, Dalli J, O'Brien A. Immune Regulatory Mediators in Plasma from Patients With Acute Decompensation Are Associated With 3-Month Mortality. Clin Gastroenterol Hepatol 2020;18:1207-1215.e6. [PMID: 31446184 DOI: 10.1016/j.cgh.2019.08.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
787 Patidar KR, Garimella PS, Macedo E, Slaven JE, Ghabril MS, Weber RE, Anderson M, Orman ES, Nephew LD, Desai AP, Chalasani NP, El-Achkar TM. Admission plasma uromodulin and the risk of acute kidney injury in hospitalized patients with cirrhosis: a pilot study. Am J Physiol Gastrointest Liver Physiol 2019;317:G447-52. [PMID: 31411505 DOI: 10.1152/ajpgi.00158.2019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
788 Piano S, Brocca A, Mareso S, Angeli P. Infections complicating cirrhosis. Liver Int. 2018;38 Suppl 1:126-133. [PMID: 29427501 DOI: 10.1111/liv.13645] [Cited by in Crossref: 87] [Cited by in F6Publishing: 93] [Article Influence: 29.0] [Reference Citation Analysis]
789 Mücke MM, Mücke VT, Lange CM, Zeuzem S. Managing hepatitis C in patients with the complications of cirrhosis. Liver Int 2018;38 Suppl 1:14-20. [PMID: 29427491 DOI: 10.1111/liv.13636] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
790 Moon AM, Singal AG, Tapper EB. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol. 2020;18:2650-2666. [PMID: 31401364 DOI: 10.1016/j.cgh.2019.07.060] [Cited by in Crossref: 255] [Cited by in F6Publishing: 285] [Article Influence: 85.0] [Reference Citation Analysis]
791 Coppin L, Najimi M, Bodart J, Rouchon MS, van der Smissen P, Eeckhoudt S, Dahlqvist G, Castanares-Zapatero D, Komuta M, Brouns SL, Baaten CC, Heemskerk JWM, Horman S, Belmonte N, Sokal E, Stéphenne X. Clinical Protocol to Prevent Thrombogenic Effect of Liver-Derived Mesenchymal Cells for Cell-Based Therapies. Cells 2019;8:E846. [PMID: 31394759 DOI: 10.3390/cells8080846] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
792 Kimmann M, Tergast TL, Schultalbers M, Laser H, Gerbel S, Manns MP, Cornberg M, Maasoumy B. Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis. PLoS One 2019;14:e0220666. [PMID: 31374111 DOI: 10.1371/journal.pone.0220666] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
793 Tergast TL, Kimmann M, Laser H, Gerbel S, Manns MP, Cornberg M, Maasoumy B. Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosis. Aliment Pharmacol Ther. 2019;50:696-706. [PMID: 31373713 DOI: 10.1111/apt.15439] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
794 Zaccherini G, Baldassarre M, Bartoletti M, Tufoni M, Berardi S, Tamè M, Napoli L, Siniscalchi A, Fabbri A, Marconi L, Antognoli A, Iannone G, Domenicali M, Viale P, Trevisani F, Bernardi M, Caraceni P. Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation. JHEP Rep 2019;1:270-7. [PMID: 32039378 DOI: 10.1016/j.jhepr.2019.07.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
795 Wu J, Guo N, Zhang X, Xiong C, Liu J, Xu Y, Fan J, Yu J, Zhao X, Liu B, Wang W, Zhang J, Cao H, Li L. HEV-LFS : A novel scoring model for patients with hepatitis E virus-related liver failure. J Viral Hepat 2019;26:1334-43. [PMID: 31294523 DOI: 10.1111/jvh.13174] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
796 Cai Q, Zhu M, Duan J, Wang H, Sheng J. Establishment of prognostic scoring models for different etiologies of acute decompensation in hospitalized patients with cirrhosis. J Int Med Res 2019;47:4492-504. [PMID: 31364441 DOI: 10.1177/0300060519862065] [Reference Citation Analysis]
797 Wong YJ, Kalki RC, Lin KW, Kumar R, Tan J, Teo EK, Li JW, Ang TL. Short- and long-term predictors of spontaneous bacterial peritonitis in Singapore. Singapore Med J 2020;61:419-25. [PMID: 31363784 DOI: 10.11622/smedj.2019085] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
798 Chancharoenthana W, Leelahavanichkul A. Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand? World J Gastroenterol 2019; 25(28): 3684-3703 [PMID: 31391766 DOI: 10.3748/wjg.v25.i28.3684] [Cited by in CrossRef: 30] [